Berberine

1. 11-Hydroxylation of ProtoBerberine by the Novel Berberine -Utilizing Aerobic Bacterium Sphingobium sp. Strain BD3100
2. 12-Oxo-phytodienoic acid induces accumulation of Berberine bridge enzyme transcript in a manner analogous to methyl jasmonate
3. 13-(2-Methylbenzyl) Berberine Is a More Potent Inhibitor of MexXY-Dependent Aminoglycoside Resistance than Berberine
4. 13-[CH2CO-Cys-(Bzl)-OBzl]-Berberine : Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein
5. 13-MethylBerberine , a Berberine analogue with stronger anti-adipogenic effects on mouse 3T3-L1 cells
6. 146. Synthetical experiments on protopine and allied alkaloids. Part II. New synthesis of the Berberine ring-system, and of a ring-homologue of the aporphine alkaloids
7. 166. The isomerization of Berberine and cotarnine bases in presence of alkali
8. 18F-Berberine Derivatives: a Potential Molecular Imaging Agent for Tumor Targeting by PET/CT Tumor
9. 1H NMR investigation of the interaction of Berberine and sanguinarine with DNA.
10. 1H-NMR-based metabonomics of the protective effect of Coptis chinensis and Berberine on cinnabar-induced hepatotoxicity and nephrotoxicity in rats
11. 2 new fluorochromation methods for blood smears and chromosomes using Berberine sulfate following deoxyribonucleoprotein denaturation
12. 2469-PUB: Exploring the Mechanisms of Berberine against Type 2 Diabetes Mellitus and Its Complications by Network Pharmacology
13. 5′-Methoxyhydnocarpin-D and Pheophorbide A: Berberis Species Components that Potentiate Berberine Growth Inhibition of Resistant Staphylococcus aureus
14. 6. Berberine -INDUCED UPREGULATION OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS IMPROVES ENDOTHELIAL FUNCTION AND …
15. 611-P: Berberine Prevented High-Fat Diet-Induced Metabolic Disorders via Inhibition of Whole Lipid Metabolism
16. 62 Cases child bronchneumonia treated by the union of the ion transmission of rhizome of Berberine and ultraviolet radiation
17. 6-S-cysteinylation of bi-covalently attached FAD in Berberine bridge enzyme tunes the redox potential for optimal activity
18. 9-N-Substituted Berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc
19. 9-O-benzoyl-substituted Berberine exerts a triglyceride-lowering effect through AMPK signaling pathway in human hepatoma HepG2 cells
20. 9-O-Butyl-13-(4-isopropylbenzyl) Berberine , KR-72, is a potent antifungal agent that inhibits the growth of Cryptococcus neoformans by regulating gene …
21. 9-ON-aryl/arylalkyl amino carbonyl methyl substituted Berberine analogues induce self-structure in polyadenylic acid
22. 9-Substituted Berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA
23. A 42-markers pharmacokinetic study reveals interactions of Berberine and glycyrrhizic acid in the anti-diabetic Chinese medicine formula Gegen-Qinlian decoction
24. A Berberine group, the 13-methyl derivatives
25. A Berberine -aniline blue fluorescent staining procedure for suberin, lignin, and callose in plant tissue
26. A Berberine -Bridge enzyme-like protein is a specific oxidase that modifies cellulose oligomers and plays a role in Arabidopsis immunity and development
27. A Berberine -loaded electrospun poly-(ε-caprolactone) nanofibrous membrane with hemostatic potential and antimicrobial property for wound dressing
28. A biomimetic conversion of Berberine into chelerythrine and dihydrochelerythrine
29. A biotechnological production of Berberine from Thalictrum minus L. cell culture.
30. A Clinical Examination on Effectiveness of Berberine in 89 Premature Beat Cases
31. A clinical study on the short-term effect of Berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
32. A combination of Berberine and-oryzanol for hyperlipidemia therapy: An hypothesis
33. A combination of metabolomics and metallomics studies of urine and serum from hypercholesterolaemic rats after Berberine injection
34. A combination of sulfadimidine, neomycin and Berberine in the treatment of infectious diarrhoea
35. A common and general access to Berberine and benzo [c] phenanthridine alkaloids
36. A comparative study of nine Berberine salts in the solid state: optimization of the photoluminescence and self-association properties through the choice of the anion
37. A concerted mechanism for Berberine bridge enzyme
38. A Contribution to the Pharmacology of Berberine .
39. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine Berberine
40. A highly fluorescent lanthanide metal-organic framework as dual-mode visual sensor for Berberine hydrochloride and tetracycline
41. A highly sensitive and widely adaptable plasmonic aptasensor using Berberine for small-molecule detection
42. A improvement assay for the content datermination of Berberine Hydrochloride tablets
43. A mass spectrometric investigation of novel quadruplex DNA-selective Berberine derivatives
44. A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered Berberine
45. A Mixed Micelle Formulation Strategy for Enhancing Oral Bioavailability of Berberine by Modulating P-glycoprotein
46. A multicenter study effect of Berberine hydrochloride on serum HIF-1αand Caspase-3 levels in patients with acute cerebral infarction
47. A multidrug and toxic compound extrusion transporter mediates Berberine accumulation into vacuoles in Coptis japonica
48. A natural alkaloid, Berberine , as a novel transcriptional repressor of RET proto-oncogene in medullary thyroid carcinoma
49. A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine .
50. A New Berberine -selective Liquid Membrane Electrode [J]
51. A new bioassay system for screening high Berberine -producing cell colonies of Thalictrum minus
52. A New Fluorescence Method for the Determination Trace Amounts of Berberine Using KAuI2
53. A New Method for Improving Detection Limit of Berberine Polyvinyl Chloride Ion Selective Electrode [J]
54. A new triple system DNA-Nanosilver-Berberine for cancer therapy
55. A newly identified Berberine derivative induces cancer cell senescence by stabilizing endogenous G-quadruplexes and sparking a DNA damage response at …
56. A novel Berberine ‐metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats
57. A novel injectable in situ forming gel based on carboxymethyl hexanoyl chitosan/hyaluronic acid polymer blending for sustained release of Berberine
58. A novel method to mask the bitter taste of Berberine hydrochloride: Powder surface modification
59. A NOVEL RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF Berberine , QUERCETIN, AND PIPERINE IN AN AYURVEDIC FORMULATION
60. A novel UPLC–MS/MS method for simultaneous quantification of rhein, emodin, Berberine and baicalin in rat plasma and its application in a pharmacokinetic study
61. A paradoxical stimulatory effect of Berberine on guinea-pig ileum contractility: Possible involvement of acetylcholine release from the postganglionic parasympathetic …
62. A Phase I Trial of Berberine in Chinese with Ulcerative Colitis
63. A photochemical approach to the fully functionalized ring system of chilinene, a key alkaloid of the Berberine family
64. A Piezoelectric Sensing Technology for the Determination of Berberine Hydrochloride (BHC)
65. A Possible Cannizzaro’s Reaction of Berberine In Vivo
66. A preliminary investigation of the mechanisms underlying the effect of Berberine in preventing high-fat diet-induced insulin resistance in rats
67. A randomized clinical trial of Berberine hydrochloride in patients with diarrhea‐predominant irritable bowel syndrome
68. A RAPID DETERMINATION OF THE TWO COMPONENTS IN SYNERGIC Berberine CAPSULE
69. A review of the effects of Berberis vulgaris and its major component, Berberine , in metabolic syndrome
70. A review on analytical methods for natural Berberine alkaloids
71. A review on Pharmacological potential of Berberine ; an active component of Himalayan Berberis aristata
72. A room-temperature protocol to access isoquinolines through Ag(i) catalysed annulation of o-(1-alkynyl)arylaldehydes and ketones with NH4OAc: elaboration to Berberine and palmatine†
73. A safer hypoglycemic agent for type 2 diabetes—Berberine organic acid salt
74. A selective and sensitive assay of Berberine using total internal reflected resonance light scattering technique with fluorescein at the water/1, 2-dichloroethane …
75. A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of Berberine , palmatine, coptisine, epiBerberine and …
76. A sensitive optode membrane for Berberine using conjugated polymer as sensing material
77. A Sensitive Resonance Scattering Method for the Determination of Trace Berberine Based on Formation of Particles
78. A sensitive spectrofluorometric method for detection of Berberine hydrochloride using Ag nanoclusters directed by natural fish sperm DNA
79. A simple fluorescence quenching method for Berberine determination using water-soluble CdTe quantum dots as probes
80. A Simple Phosphorescent Method for Berberine Detection Using 3-Mercaptopropionic Acid-capped Manganese-doped ZnS Quantum Dots
81. A simple, fast, and sensitive colorimetric assay for visual detection of Berberine in human plasma by NaHSO 4-optimized gold nanoparticles
82. A single arm pilot study of effects of Berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with …
83. A stereospecific conversion of Berberine into (±)-β-hydrastine
84. A Study for the isolation of the Berberine -type Alkaloid from Coptidis Rhizoma and for their Antitumor Activities
85. A study of chemiluminescence characteristics of a novel peroxyoxalate system using Berberine as the fluorophore
86. A study of the antiarrhythmic mechanism of Berberine on delayed activation potassium current by voltage clamp
87. A study on antioxidant activity of Berberine [J]
88. A Study on Compound Berberine Colon-Specific Tablets’ Preparation and Their Release Characteristics in Vitro and in Vivo.
89. A study on mechanism underlying the inhibition of Berberine on proliferation of human melanoma A375 cells
90. A study on natural dyeing (5)-Adsorption properties of Berberine for silk fabrics
91. A study on the extraction efficiency of Berberine in Coptidis rhizoma
92. A study on the synergism antifungal activity of clotrimazole in combination with Berberine hydrochloride against Candida albicans in vitro
93. A systematic review of the anticancer properties of Berberine , a natural product from Chinese herbs
94. A systematic review of the Berberine in protecting kidneys of diabetic rats [J]
95. A Unified Strategy for the Syntheses of the Isoquinolinium Alkaloids Berberine , Coptisine, and Jatrorrhizine
96. AB229. Effect of Berberine on human sperm parameters in vitro
97. Abilities of Berberine and chemically modified Berberine s to inhibit proliferation of pancreatic cancer cells
98. Abilities of Berberine and chemically modified Berberine s to interact with metformin and inhibit proliferation of pancreatic cancer cells
99. Absorption spectra study of the association nanoparticle system of Berberine -[AuI4]-and its analytical application
100. Absorption, distribution and excretion of Berberine .
101. Abstract A45: Berberine acts as an antagonist to estradiol-induced proliferation by inducing apoptosis in cervical cancer cells
102. Abstract B70: Berberine , a putative bioactive compound from traditional herbal plant, induces apoptosis in MCF‐7 breast cancer cells through p53 activation and …
103. Abstract C38: Berberine /cisplatin-based radiotherapy for cervical cancer: The new and effective method to treat cervical cancer
104. Abstracts: The effects of Coptis japonica root extract and its key component, Berberine , on human subcutaneous adipocytes
105. Acetaldehyde-induced interleukin-1β and tumor necrosis factor-α production is inhibited by Berberine through nuclear factor-κB signaling pathway in HepG2 cells
106. Achyranthis bidentatae radix enhanced articular distribution and anti-inflammatory effect of Berberine in Sanmiao Wan using an acute gouty arthritis rat model
107. Activation of a refolded, Berberine -specific, single-chain Fv fragment by addition of free Berberine
108. Activation of AMP-activated protein kinase is required for Berberine -induced reduction of atherosclerosis in mice: the role of uncoupling protein 2
109. Activation of AMPK by Berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice
110. Activation of AMPK by Berberine promotes adiponectin multimerization in 3T3-L1 adipocytes
111. Activation of IGF-1/IGFBP-3 signaling by Berberine improves intestinal mucosal barrier of rats with acute endotoxemia
112. Activation of peritoneal macrophages by Berberine -type alkaloids in terms of induction of cytostatic activity
113. Activation of the aryl hydrocarbon receptor by Berberine in HepG2 and H4IIE cells: Biphasic effect on CYP1A1
114. Activity of Berberine on Shigella dysenteriae investigated by microcalorimetry and multivariate analysis
115. Activity of isoflavones and Berberine on vasomotor symptoms and lipid profile in menopausal women
116. Acute toxicity of Berberine and its correlation with the blood concentration in mice
117. Addition of Berberine to 5-aminosalicylic acid for treatment of dextran sulfate sodium-induced chronic colitis in C57BL/6 mice
118. Addition of Berberine to preservation solution in an animal model of ex vivo liver transplant preserves mitochondrial function and bioenergetics from the damage …
119. Addition of dichlorocarbene to oxyBerberine and Berberine
120. Adenosine monophosphate-activated protein kinase modulation by Berberine attenuates mitochondrial deficits and redox imbalance in experimental diabetic …
121. Adsorption and reduction of Berberine at a mercury electrode
122. Adsorption characteristics of proteins on membrane surface and effect of protein solution environment on permeation behavior of Berberine
123. Adsorption Effects in Polarography of Berberine
124. Adsorption kinetics and isotherms of Berberine by ZSM-5 molecular sieves from Cortex Phellodendron
125. Adsorption kinetics of Berberine hydrochloride on AB-8 resin [J]
126. Adsorption of Berberine by polymeric resin H103: kinetics and thermodynamics
127. Adsorption of Berberine hydrochloride onto mesoporous carbons with tunable pore size
128. Adsorption of Berberine hydrochloride, ligustrazine hydrochloride, colchicine, and matrine alkaloids on macroporous resins
129. Adsorption of Berberine on commercial minerals
130. Adsorption of penicillin–Berberine ion associates at a water/tetrachloromethane interface and determination of penicillin based on total internal-reflected resonance …
131. Advance in Antimicrobial Activities of Berberine [J]
132. Advance of studies on anti-atherosclerosis mechanism of Berberine
133. Advance on study in anti-atherosclerosis mechanism of Berberine
134. Advances in research of Berberine hydrochloride wastewater treatment technologies
135. Advances in structural modifications and biological activities of Berberine : an active compound in traditional Chinese medicine.
136. Advances in the study of Berberine and its derivatives
137. Advances of the mechanism study on Berberine in the control of blood glucose and lipid as well as metabolism disorders
138. Aggregation of DNA enhanced by the protoBerberine alkaloids, coralyne and Berberine
139. Agonist‐dependent differential effects of Berberine in human platelet aggregation
140. Agonistic effects of Berberine hydrochloride on muscarinic receptors 1
141. Aiming to understand the mechanisms underlying the different responses to Berberine among different cell lines
142. Akt signaling is associated with the Berberine -induced apoptosis of human gastric cancer cells
143. ALA/Berberine Complex
144. Alkaloids as aldose reductase inhibitors, with special reference to Berberine
145. Alkaloids in the nature: pharmacological applications in clinical practice of Berberine and mate tea
146. Alkaloids of the Papaveraceae V. Muramine and Berberine from Argemone squarrosa
147. Allelopathic Effects of Berberine , a Plant Alkaloid, on the Algae, Microcystis aeruginosa (FACHB-905), at Different Initial Densities
148. Allelopathic potential of Berberine from Coptis chinensis Franch on invasive weeds.
149. Allergic Rhinitis: 239 Berberine Inhibits Myofibroblast Differentiation in Nasal Polyp-deroved Fibroblast via P-38 Pathway
150. Allosteric Effect of Cu~(2+)/Zn~(2+) on Binding Process of Bovine Serum Albumin-Berberine Chloride [J]
151. Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by Berberine
152. Alternative final steps in Berberine biosynthesis in Coptis japonica cell cultures
153. Altitudinal variation of Berberine , total phenolics and flavonoid content in Thalictrum foliolosum and their correlation with antimicrobial and antioxidant …
154. Ameliorating effects of Berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia
155. Amelioration effects of Berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro
156. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by Berberine via suppression of MLCK-MLC phosphorylation signaling …
157. Amelioration of intestinal barrier dysfunction by Berberine in the treatment of nonalcoholic fatty liver disease in rats
158. Amelioration of testicular damages in renal ischemia/reperfusion by Berberine : An experimental study
159. Ameliorative effect of Berberine coated bio-active nanoparticles in acetaminophen induced hepato-renal damage in diabetic rats
160. Ameliorative effect of Berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin
161. Ameliorative effect of Berberine on functional disorders and histological damages of pancreas in renal ischemia/reperfusion
162. Ameliorative Effect of Berberine on Neonatally Induced Type 2 Diabetic Neuropathy via Modulation of BDNF, IGF-1, PPAR-γ, and AMPK Expressions
163. Ameliorative effect of Berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin
164. AMELIORATIVE POTENTIAL OF QUERCETIN AND Berberine ON EXPERIMENTALLY INDUCED NEPHROTOXICITY IN RATS
165. Amino-Modified Hydrogen-Bonding Resin and its Adsorption on Berberine
166. Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2β/Cardiolipin/Opa1 pathwayin db/db mice and in Palmitate-treated MIN6 β-cells
167. Amorphous solid dispersion of Berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability
168. An Analytical Study of Berberine
169. An ancient Chinese herb Berberine : new research in Diabetes Mellitus
170. An ATR–FTIR Sensor Unraveling the Drug Intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and Aβ
171. An efficient conversion of Berberine into a rhoeadine via an indenobenzazepine
172. An Experimental Study of Extracting Berberine Hydrochloride from Medicinal Herbs of Barberry and Coptis Root
173. AN EXPERIMENTAL STUDY ON THE PHOTODYNAMIC ACTIVITY OF Berberine IN VITRO OF CANCER CELLS
174. An immobilized cell culture system for Berberine production by Thalictrum minus cells
175. An Infrared Spectroscopy Analysis of Extracting Berberine from Cortex Phallodendri
176. An insight into the molecular mechanism of Berberine towards multiple cancer types through systems pharmacology
177. An Investigation on Extraction of Berberine Hydrochlride from Rhizoma Copidis by Liquid Membrane [J]
178. AN ION-SELECTIVE ELECTRODE USING CHLOROPHYLL AS ELECTROACTIVE MATERIAL-DETERMINATION OF Berberine
179. An isoquinoline alkaloid, Berberine , can inhibit fungal alpha amylase: enzyme kinetic and molecular modeling studies
180. An Observation of Oral Berberine on 36 Children with Ventricular Premature Beats [J]
181. An observational study of the antidiabetic activity of Berberine in newly diagnosed type 2 diabetes mellitus patients
182. An optical fiber sensor for Berberine based on immobilized 1, 4-bis (naphth [2, 1-d] oxazole-2-yl) benzene in a new copolymer
183. An oral cocktail study on potential drug interactions of a proprietary nutraceutical combination containing Berberine and monacolin in healthy volunteers
184. Analysis of Berberine and total alkaloid content in Cortex Phellodendri by near infrared spectroscopy (NIRS) compared with high-performance liquid chromatography …
185. Analysis of Berberine by a Sensitive High Performance Liquid Chromatographic (HPLC) Method
186. Analysis of Berberine content using HPTLC fingerprinting of root and bark of three Himalayan Berberis species
187. Analysis of Content Determination of Berberine Hydrochloride and Emodin and Chrysophanol of Sanhuang Tablets by HPLC [J]
188. Analysis of contents of Berberine in Coptis chinensis of Lichuan
189. Analysis of coptisine, Berberine and palmatine in adulterated Chinese medicine by capillary electrophoresis–electrospray ion trap mass spectrometry
190. Analysis of Curative Effect of Triple Viable Bifidobacterium combined with Berberine in Treatment of Chronic Diarrhea
191. Analysis of Effects of Berberine on the Photosynthesis of Microcystis aeruginosa at Gene Transcriptional Level
192. Analysis of Fibrauretin and Its Adulterant Berberine Hydrochloride by HPLC [J]
193. Analysis of promoters from tyrosine/dihydroxyphenylalanine decarboxylase and Berberine bridge enzyme genes involved in benzylisoquinoline alkaloid biosynthesis …
194. Analysis on Related Factors of Anti-fatigue Effect of Berberine
195. Angiogenic pathway inhibition of Corydalis yanhusuo and Berberine in human umbilical vein endothelial cells
196. Animal experimental study on the mechanism of Berberine in treating chronic heart failure
197. Ann Allergy Asthma Immunol. 2014: Berberine and limonin suppress IgE production by human b cells and peripheral blood mononuclear cells from food-allergic …
198. Antagonism of cholera toxin by Berberine in the gastrointestinal tract of adult rats.
199. Anti-adipogenic activity of Berberine in 3T3-L1 pre-adipocytes cultured in high-glucose medium
200. Anti‐Adipogenic Activity of Berberine is Not Mediated by the WNT/β‐Catenin Pathway
201. Anti-Alzheimer’s potential of Berberine using surface decorated multi-walled carbon nanotubes: a preclinical evidence
202. Anti-amoebic value of Berberine and kurchi alkaloids.
203. Antiangiogenic activity of Berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators
204. Antiangiogenic and antitumor activities of Berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma
205. Anti-apoptotic and moderate anti-inflammatory effects of Berberine in sulfur mustard exposed keratinocytes
206. Anti-arthritic effect of Berberine on adjuvant-induced rheumatoid arthritis in rats
207. Anti‐atherogenic effect of Berberine on LXRα‐ABCA1‐dependent cholesterol efflux in macrophages
208. Anti-atherogenic mechanisms of Berberine
209. Antibacterial activity and mechanism of Berberine against Streptococcus agalactiae
210. Antibacterial activity and mechanism of Berberine on avian Pasteurella multocida
211. Antibacterial activity and structure-activity relationships of Berberine analogs
212. Antibacterial activity of Berberine -NorA pump inhibitor hybrids with a methylene ether linking group
213. Antibacterial Activity of Prulifloxacin Combined with Berberine Chloride in Vitro [J]
214. Antibacterial effects of Berberine on antibiotic-resistant staphylococcus aureus
215. Antibacterial effects of Berberine on three aquatic pathogens in vitro.
216. Antibacterial mechanisms of Berberine and reasons for little resistance of bacteria
217. Antibiotic delivery system using nano‐hydroxyapatite/chitosan bone cement consisting of Berberine
218. Anticachectic effects of the natural herb Coptidis rhizoma and Berberine on mice bearing colon 26/clone 20 adenocarcinoma
219. Anticancer activity of Mahonia leschenaultii methanolic root extract and Berberine on Dalton’s ascitic lymphoma in mice
220. Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice
221. Anti‐cancer Herbal Drug Berberine –Sensitive Determination Using Boron‐doped Diamond Electrode
222. Anti‐Clastogenic Effect of Berberine against DMBA‐Induced Clastogenesis
223. Anticomplement activity of Mahonia aquifolium bisbenzylisoquinoline alkaloids and Berberine extract
224. Anticonvulsant activity of Berberine , an isoquinoline alkaloid in mice
225. Antidiabetic activity of benzyl tetra isoquinoline alkaloid Berberine in streptozotocin-nicotinamide induced type 2 diabetic rats
226. Anti-diabetic effects of cinnamaldehyde and Berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus
227. Antidiabetic properties of Berberine : from cellular pharmacology to clinical effects
228. Antidiarrheal and anti-inflammatory effects of Berberine
229. Anti-Eimeria activity of Berberine and identification of associated gene expression changes in the mouse jejunum infected with Eimeria papillata
230. Antifibrotic cardioprotection of Berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats
231. Antifungal activity of aqueous extracts and of Berberine isolated from Berberis heterophylla
232. Antifungal activity of Berberine hydrochloride and palmatine hydrochloride against Microsporum canis in rabbits and underlying mechanism
233. Antifungal activity of Berberine hydrochloride and palmatine hydrochloride against Microsporum canis-induced dermatitis in rabbits and underlying …
234. Antifungal activity of Berberine iodide, a constituent ofFumaria indica
235. Antifungal Activity of Chaerophylline and Berberine Hydroxide Isolated from Corydalis Species
236. Anti-fungal effect of Berberine on Candida albicans by microcalorimetry with correspondence analysis
237. Antifungal susceptibility analysis of Berberine , baicalin, eugenol and curcumin on Candida albicans
238. Antifungal, Antileishmanial, and Cytotoxicity Activities of Various Extracts of Berberis vulgaris (Berberidaceae) and Its Active Principle Berberine
239. Anti-Helicobacter pylori activity and structure-activity relationships of Berberine derivatives
240. Anti-herpes simplex virus effects of Berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San
241. Anti-hyperglycemic effect of the compatibility of ginsenoside Re and Berberine in different ratio on type 2 diabetes
242. Anti-hypertensive and renoprotective effects of Berberine in spontaneously hypertensive rats
243. Anti-inflammatory activities of pentaherbs formula, Berberine , gallic acid and chlorogenic acid in atopic dermatitis-like skin inflammation
244. ANTI-INFLAMMATORY AND ANALGESIC ACTIONS OF Berberine [J]
245. Anti-Inflammatory and Barrier-Protective Effects of Berberine
246. Anti-inflammatory Effects of Berberine [J]
247. Anti-inflammatory effects of Berberine hydrochloride in an LPS-induced murine model of mastitis
248. Anti‐influenza activity of Berberine improves prognosis by reducing viral replication in mice
249. Anti-Leishmanial Effects of Chitosan-Polyethylene Oxide Nanofibers Containing Berberine : An Applied Model for Leishmania Wound Dressing
250. Antilipemic Effect of Berberine Combined with Atorvastatin on Rats with Hypelipemia
251. Anti-malarial Berberine Alkaloids from Corydalis yanhusuo WT Wang
252. Antimicrobial Activity of Berberine Alone and in Combination with Ampicillin or Oxacillin Against Methicillin-Resistant Staphylococcus aureus
253. Antimicrobial activity of Berberine —a constituent ofMahonia aquifolium
254. Antimicrobial characteristics of Berberine against prosthetic joint infection-related Staphylococcus aureus of different multi-locus sequence types
255. Antimicrobial Natural Product Berberine Is Efficacious for the Treatment of Atrial Fibrillation
256. Antimicrobial Profile of Antidiabetic Drug: Berberine
257. Antimycotic activity of Berberine sulphate: an alkaloid from an Indian medicinal herb
258. Antineoplastic mechanism research progress of Berberine
259. Antinociceptive effect of Berberine on visceral hypersensitivity in rats
260. Anti-obesity effect of Berberine in mice fed a high fat diet
261. Antioxidant activities of Berberine hydrochloride
262. Antioxidant activity of Berberine on benzo (A) pyrene induced experimental lung carcinogenesis in mice
263. Antioxidant activity studies in several system of Berberine and NAC.
264. Anti-Oxidant and Anti-Apoptotic Effects of Berberine in Pentylenetetrazole-Induced Kindling Model in Rat
265. Antioxidant and anti-inflammatory activities of Berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats
266. Antioxidant and anti-inflammatory activities of Berberine in the treatment of diabetes mellitus
267. Antioxidant effect of Berberine and its phenolic derivatives against human fibrosarcoma cells
268. Antioxidant properties of Berberine on cultured rabbit corpus cavernosum smooth muscle cells injured by hydrogen peroxide1
269. Antioxidation of Berberine Hydrochloride to Oils and Fat [J]
270. Antiproliferation of Berberine in combination with fluconazole from the perspectives of reactive oxygen species, ergosterol and drug efflux in a fluconazole …
271. Antiproliferation of Berberine is mediated by epigenetic modification of constitutive androstane receptor (CAR) metabolic pathway in hepatoma cells
272. Anti-proliferation of Berberine on human breast cancer cell line MDA-MB-231 and its relationship to PPARγ
273. Antiproliferative activity of Berberine from Coscinium fenestratum on NCI-H838 cell line
274. Antiproliferative activity of Berberine in vitro and in vivo
275. Anti-Proliferative Activity of Standardized Methanol Extract of Coscinium fenestratum and Its Major Constituent, Berberine , Against Nasopharyngeal Carcinoma Cells
276. ANTISECRETORY EFFECTS OF Berberine [J]
277. Anti-secretory effects of Berberine in human colonic epithelium
278. Antisecretory effects of Berberine in rat ileum
279. Antisecretory effects of Berberine with morphine, clonidine, L-phenylephrine, yohimbrine or neostigmine in pig jejunum
280. Antitubercular Natural Products: Berberine from the Roots of Commercial Hydrastis canadensis Powder. Isolation of Inactive 8-Oxotetrahydrothalifendine …
281. Antitumor Ability of Berberine Accompanied by Modulation of Gut Microbiome in Sarcoma-180 Tumor-bearing Mice
282. Antitumor activity of NAX060: A novel semisynthetic Berberine derivative in breast cancer cells
283. Antitumor effect of Berberine against primary effusion lymphoma via inhibition of NF‐κ B pathway
284. Antitumor effect of Berberine hydrochloride in the serum and plasma on nasopharyngeal carcinoma CNE-1 cell: A comparative study
285. Antitumor effect of novel Berberine derivatives in breast cancer cells
286. Antitumor effects of Berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study
287. Antitumor Effects of Berberine on Gliomas via Inactivation of Caspase-1-Mediated IL-1β and IL-18 Release
288. Antitumor effects of Berberine α-hydroxy β-decanoylethyl sulfonate in vitro [J]
289. Antitumor potential of Berberine and cinnamic acid against solid Ehrlich carcinoma in mice
290. Antiurolithic effect of Berberine is mediated through multiple pathways
291. Antiviral activity of Berberine and related compounds against human cytomegalovirus
292. Anxiolytic effect of Berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors
293. Apoptosis of B16 melanoma cells induced by Berberine α-hydroxy-β-decanoylethyl sulfonate [J]
294. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by Berberine through the activation of caspase-3
295. Apoptosis of MDA-MB-231 cells induced by Berberine alpha-hydroxy beta-decanoylethyl sulfonate
296. Application of 1H-NMR spectroscopy to validation of Berberine alkaloid reagents and to chemical evaluation of Coptidis Rhizoma
297. Application of Berberine on treating type 2 diabetes mellitus
298. Application of metabolomics in treating polycystic ovary syndrome with Berberine based on ultra high performance liquid chromatography-mass spectrometry
299. Application of Orthogonal Test to the Experiment for the Students of the Extraction of Berberine in the Rhizoma Coptidis
300. Application of Thermal Analysis Technology for Berberine Hydrochloride
301. Application of thermochromism in spectrophotometric analysis: Selective determination of Berberine in pharmaceuticals by solvent extraction
302. Application of uniform design for preparation of Berberine hydrochloride liposomes
303. Application of xanthene derivatives for analytical chemistry. Part 44. Spectrophotometric determination of Berberine chloride in pharmaceutical preparations.
304. Applying the Berberine -Pretreated Filter for Inactivating Bioaerosols
305. Approaches to improve the oral bioavailability and effects of novel anticancer drugs Berberine and betulinic acid
306. Aptamer‐functionalized Fe3O4 magnetic nanoparticles as a solid‐phase extraction adsorbent for the selective extraction of Berberine from Cortex phellodendri
307. Aromatization within the putative bio-medical action mechanism of Berberine and related cationic alkaloids with double iso-quinolinoid skeleton. A theoretical study
308. ART. LXVI.–ON Berberine
309. ART. LXVIII.–ON THE OCCURRENCE OF Berberine IN THE ROOT OF THE BARBERRY AND COLUMBO
310. Article Details Development and Validation of Stability Indicating RP-HPLC Method for the Simultaneous Determination of Berberine and Curcumin in an Ayurvedic …
311. Assay of Berberine Hydrochloride in Huanglian Xiaoke Capsules by HPLC
312. Assay of Berberine hydrochloride in Sanhuang Tablets by HPLC
313. Assessing the impact on aqueous solubility of Berberine chloride via co-crystallization with different stoichiometric ratios of pyromellitic dianhydride
314. Assessment of Berberine as a multi-target antimicrobial: a multi-omics study for drug discovery and repositioning
315. ASSESSMENT OF LEARNING AND MEMORY IN INTRAHIPPOCAMPAL KAINATE EPILEPTIC RATS FOLLOWING Berberine ADMINISTRATION
316. Assimilation of Berberine and chelidoxanthine by bacteria
317. Assimilation of Berberine by bacteria
318. Association of Berberine into hydrogel as drug delivery system
319. Astaxanthin plus Berberine : a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome
320. Astaxanthin/Berberine /folic acid/monascus/policosanol/ubidecarenone/rosuvastatin/sertraline interaction
321. Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug Berberine
322. Attenuation of Berberine on lipopolysaccharide-induced inflammatory and apoptosis responses in β-cells via TLR4-independent JNK/NF-κB pathway
323. Automated Online-SPE-HPLC for Rapid Determination of the Content of Berberine in the Chinese Traditional Medicine Compound [J]
324. B-125, a novel Berberine derivative, acts as a better retinoid X receptor a agonist with stronger anti-tumor activity in colon cancer
325. Bacteriostasis test of Berberine and compound Rhizoma coptidis injection on mastitis
326. Bacteriostatic effect of Berberine on rabbit mastitis pathogens
327. Bacterium endotoxin test of medical macrogol 400 Berberine hydrochloride
328. Bacterium endotoxin test of medical macrogol 400 Berberine hydrochloride [J]
329. Baekjeolyusin‐tang and its active component Berberine block the release of collagen and proteoglycan from IL‐1β‐stimulated rabbit cartilage and down‐regulate …
330. Baicalin and Berberine ultradeformable vesicles as potential adjuvant in vitiligo therapy
331. Batch Time Course Behaviors of Growth and Berberine Production in Plant Cell Suspension Cultures of Tlurlictrum rugosum.
332. Behavioral pharmacology of Berberine -type alkaloids.(1) Central depressive action of Coptidis rhizoma and its constituents
333. Behavioral pharmacology of Berberine -type alkaloids.(2) Central depressant effects of tetrahydroBerberine (THB) and related compounds
334. Beneficial effect of Berberine on atherosclerosis based on attenuating vascular inflammation and calcification
335. Beneficial effect of Berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRα and PPARα transcriptional programs
336. Beneficial effects of Berberine on hemodynamics during acute ischemic left ventricular failure in dogs.
337. Beneficial Effects of Berberine on Nonalcoholic Fatty Liver Disease (NAFLD)
338. Beneficial effects of Berberine on oxidized LDL-induced cytotoxicity to human retinal Müller cells
339. Benzenediol-Berberine hybrids: Multifunctional agents for Alzheimer’s disease
340. Berberine
341. Berberine – a novel approach to cholesterol lowering: KONG W, WEI J, ABIDI P et al.: Berberine is a novel cholesterol-lowering drug working through a unique mechanism …
342. Berberine (BBR) Attenuated Palmitic Acid (PA)-Induced Lipotoxicity in Human HK-2 Cells by Promoting Peroxisome Proliferator-Activated Receptor a (PPAR …
343. Berberine Accelerates Odontoblast Differentiation by Wnt/β-Catenin Activation
344. Berberine action targets and its absorption behavior: how to use old drug for new mechanisms
345. Berberine Activates AMPK and Inhibits 3T3-L1 Adipocyte Differentiation
346. Berberine Activates AMPK in L6 Myotubes by a Mechanism Other Than Via Changes in ATP Levels.
347. Berberine activates AMPK to suppress proteolytic processing, nuclear translocation and target DNA binding of SREBP-1c in 3T3-L1 adipocytes
348. Berberine activates aryl hydrocarbon receptor but suppresses CYP1A1 induction through miR-21-3p stimulation in MCF-7 breast cancer cells
349. Berberine activates bitter taste responses of enteroendocrine STC-1 cells
350. Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo
351. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes
352. Berberine activates Nrf2 nuclear translocation and inhibits apoptosis induced by high glucose in renal tubular epithelial cells through a phosphatidylinositol 3-kinase …
353. Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor …
354. Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe−/− mice with hyperhomocysteinemia
355. Berberine activates thermogenesis in white and brown adipose tissue
356. Berberine activates volume-sensitive chloride channel in human colorectal carcinoma cells
357. Berberine acts as a natural inhibitor of Wnt/β‐catenin signaling—Identification of more active 13‐arylalkyl derivatives
358. Berberine Acts As A Novel Autophagy Blocker To Protect Human müLler Cell From 4-hne Induced Cell Death
359. Berberine acts as a putative epigenetic modulator by affecting the histone code
360. Berberine acutely activates the glucose transport activity of GLUT1
361. Berberine acutely inhibits insulin secretion from β-cells through 3′, 5′-cyclic adenosine 5′-monophosphate signaling pathway
362. Berberine acutely inhibits the digestion of maltose in the intestine
363. Berberine adsorption at a mercury electrode
364. Berberine affects osteosarcoma via downregulating the caspase-1/IL-1β signaling axis
365. Berberine against gastrointestinal peptides elevation and mucous secretion in hyperthyroid diarrheic rats
366. Berberine Alkaloid as a Medicament for Prophylaxis and Treatment of Alzheimer’s Disease
367. Berberine alkaloid as a sensitive fluorescent probe for bile salt aggregates
368. Berberine alkaloid: Quantum chemical study of different forms by the DFT and MP2 methods
369. Berberine Alkaloids via 6, 7-Dimethoxy iso quinoline-l-aldoxime
370. Berberine alleviates adipose tissue fibrosis by inducing AMP-activated kinase signaling in high-fat diet-induced obese mice
371. Berberine alleviates amyloid beta-induced injury in Alzheimer’s disease by miR-107/ZNF217
372. Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors
373. Berberine Alleviates Amyloid β-Induced Mitochondrial Dysfunction and Synaptic Loss
374. Berberine Alleviates Amyloid-beta Pathogenesis Via Activating LKB1/AMPK Signaling in the Brain of APP/PS1 Transgenic Mice
375. Berberine alleviates amyloid-beta pathology in the brain of APP/PS1 transgenic mice via inhibiting β/γ-secretases activity and enhancing α-secretases
376. Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes
377. Berberine alleviates chronic inflammation of mouse model of type 2 diabetes by adjusting intestinal microbes and inhibiting TLR4 signaling pathway
378. Berberine alleviates dextran sodium sulfate‑induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress
379. Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS
380. Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C δ pathway
381. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice
382. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids
383. Berberine alleviates ischemic arrhythmias via recovering depressed Ito and ICa currents in diabetic rats
384. Berberine alleviates ischemic arrhythmias via recovering depressed Iₜₒ and ICₐ currents in diabetic rats
385. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3
386. Berberine Alleviates Olanzapine-Induced Adipogenesis via the AMPKα–SREBP Pathway in 3T3-L1 Cells
387. Berberine alleviates oxidative stress in islets of diabetic mice by inhibiting mir‐106b expression and up‐regulating sirt1
388. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK …
389. Berberine alleviates oxidized low‐density lipoprotein‐induced macrophage activation by downregulating galectin‐3 via the NF‐κB and AMPK signaling pathways
390. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway
391. Berberine alleviates paclitaxel-induced neuropathy
392. Berberine alleviates preeclampsia possibly by regulating the expression of interleukin-2/interleukin-10 and Bcl-2/Bax
393. Berberine alleviates symptoms of anxiety by enhancing dopamine expression in rats with post-traumatic stress disorder
394. Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3 β Pathway
395. Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca 2+ handling in smooth …
396. Berberine Alone and in Conjunction With Immunomodulators Down-regulates Pro-inflammatory CD4+ T-Cells: Implications for a Combined Treatment of Inflammatory …
397. Berberine alters epigenetic modifications, disrupts microtubule network, and modulates HPV-18 E6–E7 oncoproteins by targeting p53 in cervical cancer cell HeLa: a …
398. Berberine alters the processing of Alzheimer’s amyloid precursor protein to decrease Aβ secretion
399. Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats
400. Berberine ameliorates allodynia induced by chronic constriction injury of the sciatic nerve in rats
401. Berberine ameliorates blockade of autophagic flux in the liver by regulating cholesterol metabolism and inhibiting COX2-prostaglandin synthesis
402. Berberine ameliorates brain inflammation in poloxamer 407-induced hyperlipidemic rats
403. Berberine ameliorates cartilage degeneration in interleukin‐1β‐stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signalling
404. Berberine ameliorates cellular senescence and extends the lifespan of mice via regulating p16 and cyclin protein expression
405. Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFκB signaling pathway in rats
406. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses
407. Berberine Ameliorates Chronic Ulcerative Colitis Through Suppressing Oncostatin M-Driven Mucosal Inflammation
408. Berberine ameliorates chronic unpredictable mild stress induced depression like behaviors and elevating kelch-like erythroid cell-derived protein with CNC …
409. Berberine ameliorates chronic unpredictable mild stress induced depressive like behaviors and elevating Keap1-Nrf2 antioxidant signaling pathways
410. Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy
411. Berberine ameliorates collagen-induced arthritis in rats associated with anti-inflammatory and anti-angiogenic effects
412. Berberine ameliorates collagen‐induced arthritis in rats by suppressing Th17 cell responses via inducing cortistatin in the gut
413. Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats
414. Berberine ameliorates COX-2 expression in rat small intestinal mucosa partially through PPARγ pathway during acute endotoxemia
415. Berberine ameliorates diabetes-associated cognitive decline through modulation of aberrant inflammation response and insulin signaling pathway in DM rats
416. Berberine ameliorates diabetic mouse renal injury through inhibition of SphK1-S1P signaling pathway
417. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
418. Berberine ameliorates diabetic neuropathic pain in a rat model: involvement of oxidative stress, inflammation, and μ-opioid receptors
419. Berberine ameliorates diabetic neuropathy: TRPV1 modulation by PKC pathway
420. Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway
421. Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity
422. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling
423. Berberine ameliorates experimental varicocele‐induced damages at testis and sperm levels; evidences for oxidative stress and inflammation
424. Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells
425. Berberine ameliorates hepatic steatosis and suppresses liver and adipose tissue inflammation in obesity mice independent of AMPK
426. Berberine ameliorates high glucose-induced cardiomyocyte injury via AMPK signaling activation to stimulate mitochondrial biogenesis and restore autophagic flux
427. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway
428. Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway
429. Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
430. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia
431. Berberine ameliorates intestinal mucosal barrier damage induced by peritoneal air exposure
432. Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms
433. Berberine ameliorates lipid accumulation of mouse primary hepatocytes by decreasing fatty acids uptake
434. Berberine ameliorates lipopolysaccharide‐induced acute lung injury via the PERK‐mediated Nrf2/HO‐1 signaling axis
435. Berberine ameliorates lipopolysaccharide‑induced inflammatory responses in mouse inner medullary collecting duct‑3 cells by downregulation of NF‑κB …
436. Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms
437. Berberine Ameliorates MCAO Induced Cerebral Ischemia/Reperfusion Injury via Activation of the BDNF–TrkB–PI3K/Akt Signaling Pathway
438. Berberine ameliorates methotrexate-induced liver injury by activating Nrf2/HO-1 pathway and PPARγ, and suppressing oxidative stress and apoptosis in rats
439. Berberine ameliorates neonatal necrotizing enterocolitis by activating the phosphoinositide 3-kinase/protein kinase B signaling pathway
440. Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
441. Berberine ameliorates non‑alcoholic steatohepatitis in ApoE-/-mice
442. Berberine ameliorates nonbacterial prostatitis via multi-target metabolic network regulation
443. Berberine ameliorates non‐steroidal anti‐inflammatory drugs‐induced intestinal injury by the repair of enteric nervous system
444. Berberine ameliorates oxidative stress-induced apoptosis by modulating ER stress and autophagy in human nucleus pulposus cells
445. Berberine ameliorates periodontal bone loss by regulating gut microbiota
446. Berberine Ameliorates Pro-inflammatory Cytokine-Induced Endoplasmic Reticulum Stress in Human Intestinal Epithelial Cells In Vitro
447. Berberine AMELIORATES PULMONARY INJURY INDUCED BY ISCHEMIC ACUTE RENAL FAILURE IN RAT
448. Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3‐kinase–protein kinase B pathway in diabetic rats
449. Berberine ameliorates renal injury by regulating G proteins-AC-cAMP signaling in diabetic rats with nephropathy
450. Berberine ameliorates renal injury in a rat model of D‐galactose-induced aging through a PTEN/Akt-dependent mechanism
451. Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway
452. Berberine Ameliorates Renal injury in Diabetic Nephropathy Rats
453. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats
454. Berberine AMELIORATES RENAL ISCHEMIA/REPERFUSION INJURY IN RATS
455. Berberine ameliorates severe acute pancreatitis‑induced intestinal barrier dysfunction via a myosin light chain phosphorylation‑dependent pathway
456. Berberine ameliorates spatial learning memory impairment and modulates cholinergic anti-inflammatory pathway in diabetic rats
457. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation
458. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation
459. Berberine ameliorates type 2 diabetes via modulation of Bifidobacterium species, tumor necrosis factor‐alpha, and lipopolysaccharide
460. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer’s disease transgenic mouse model
461. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux
462. Berberine Analogue Y53 has Improved Antioxidant and Anti-Inflammatory Activities in Diabetic C57BL/6J Mice with Liver Steatosis
463. Berberine Analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure− activity relationships, and cholesterol-lowering …
464. Berberine and a Berberis lycium extract inactivate Cdc25A and induce α-tubulin acetylation that correlate with HL-60 cell cycle inhibition and apoptosis
465. Berberine and amitozine binding with calf thymus DNA
466. Berberine and barberry (Berberis vulgaris): A clinical review
467. Berberine and Berberine -Containing Plants in Pharmacology and Therapeutics
468. Berberine and chemotherapeutic drugs synergistically inhibits cell proliferation and migration of breast cancer cells
469. Berberine and chloramphenicol in the treatment of cholera and severe diarrhoea.
470. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations
471. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives
472. Berberine and coptisine free bases
473. Berberine and coptisine in liquid ammonia
474. Berberine and Dyslipidemia: Different Applications and Biopharmaceutical Formulations Without Statin-Like Molecules—A Meta-Analysis
475. Berberine and evodiamine act synergistically against human breast cancer MCF-7 cells by inducing cell cycle arrest and apoptosis
476. Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic region
477. Berberine and inflammatory bowel disease: A concise review
478. Berberine and itraconazole are not synergistic in vitro against Aspergillus fumigatus isolated from clinical patients
479. Berberine and its derivatives: a patent review (2009–2012)
480. Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects
481. Berberine and its molecular mechanisms in inhibiting the growth of renal carcinoma cell line ACHN.
482. Berberine and its more biologically available derivative, dihydroBerberine , inhibit mitochondrial respiratory complex I: a mechanism for the action of Berberine to …
483. Berberine and its role in chronic disease
484. Berberine and limonin suppress IgE production by human B cells and peripheral blood mononuclear cells from food-allergic patients
485. Berberine and lycopene profiling during the ontogeny of Tinospora cordifolia (Willd.) Miers ex Hook. F. & Thoms fruit
486. Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia
487. Berberine and musculoskeletal disorders: the therapeutic potential and underlying molecular mechanisms
488. Berberine and neurodegeneration: A review of literature
489. Berberine and palmatine inhibit the growth of human rhabdomyosarcoma cells
490. Berberine and Pentoxifylline: A novel combination in amelioration of acute kidney injury
491. Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters
492. Berberine and S allyl cysteine mediated amelioration of DEN+ CCl4 induced hepatocarcinoma
493. Berberine and Sanguinarine quantitation in Argemone mexicana L. (Papaveraceae) tissues by TLC-in situ fluorography
494. Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways
495. Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease
496. Berberine and zinc oxide-based nanoparticles for the chemo-photothermal therapy of lung adenocarcinoma
497. Berberine antifungal activity in fluconazole-resistant pathogenic yeasts: action mechanism evaluated by flow cytometry and biofilm growth inhibition in Candida spp.
498. Berberine as a chemical and pharmacokinetic marker of the butanol-extracted food allergy herbal formula-2
499. Berberine as a factor in the resistance of Mahonia trifoliolata and M. swaseyi to Phymatotrichum root rot
500. Berberine as a natural compound inhibits the development of brown rot fungus Monilinia fructicola
501. Berberine as a natural source inhibitor for mild steel in 1 M H2SO4
502. Berberine as a natural source inhibitor for mild steel in 1 MH {sub 2} SO {sub 4}
503. Berberine as a novel light-up i-motif fluorescence ligand and its application in designing molecular logic systems
504. Berberine as a Photosensitizing Agent for Antitumoral
505. Berberine as a photosensitizing agent for antitumoral photodynamic therapy: Insights into its association to low density lipoproteins
506. Berberine as a potential autophagy modulator
507. Berberine as a potential therapeutic agent in the treatment of acute pancreatitis
508. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms
509. Berberine as a promising safe anti-cancer agent-is there a role for mitochondria?
510. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies
511. Berberine as an Adjuvant and Sensitizer to Current Chemotherapy
512. Berberine as an Environmental-Friendly Inhibitor for Hot-Dip Coated Steels in Diluted Hydrochloric Acid
513. Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells
514. Berberine attenuate staphylococcal enterotoxin B-mediated acute liver injury via regulating HDAC expression
515. Berberine attenuated aging-accelerating effect of high temperature in Drosophila model
516. Berberine Attenuated Oxidative Stress Induced by Sodium Nitrite in Rat Liver
517. Berberine attenuated pro-inflammatory factors and protect against neuronal damage via triggering oligodendrocyte autophagy in spinal cord injury
518. Berberine attenuated proliferation, invasion and migration by targeting the AMPK/HNF4α/WNT5A pathway in gastric carcinoma
519. Berberine attenuated the cytotoxicity induced by t-BHP via inhibiting oxidative stress and mitochondria dysfunction in PC-12 cells
520. Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy
521. Berberine attenuates apoptosis in rat retinal Müller cells stimulated with high glucose via enhancing autophagy and the AMPK/mTOR signaling
522. Berberine attenuates arthritis in adjuvant-induced arthritic rats associated with regulating polarization of macrophages through AMPK/NF-кB pathway
523. Berberine attenuates autophagy in adipocytes by targeting BECN1
524. Berberine attenuates axonal transport impairment and axonopathy induced by calyculin a in N2a cells
525. Berberine attenuates Aβ25-35-induced apoptosis in primary cultured hippocampal neurons.
526. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study
527. Berberine attenuates calyculin A-induced cytotoxicity and Tau hyperphosphorylation in HEK293 cells
528. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes
529. Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats
530. Berberine attenuates CCN2-induced IL-1β expression and prevents cartilage degradation in a rat model of osteoarthritis
531. Berberine attenuates cerebral ischemia-reperfusion injury via activating PI3K-Akt signaling in a rat model of type 2 diabetes
532. Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway
533. Berberine attenuates cigarette smoke-induced acute lung inflammation
534. Berberine attenuates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice
535. Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling …
536. Berberine attenuates convulsing behavior and extracellular glutamate and aspartate changes in 4-aminopyridine treated rats
537. Berberine attenuates depressive-like behaviors by suppressing neuro-inflammation in stressed mice
538. Berberine attenuates development of the hepatic gluconeogenesis and lipid metabolism disorder in type 2 diabetic mice and in palmitate-incubated HepG2 …
539. Berberine attenuates doxorubicin-induced cardiotoxicity in mice
540. Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice
541. Berberine attenuates hepatic oxidative stress in rats with non‑alcoholic fatty liver disease via the Nrf2/ARE signalling pathway
542. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21
543. Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in …
544. Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression …
545. Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice
546. Berberine Attenuates Hyperlipidemia in Mice by a Novel Underlying Mechanism Involving Trib1
547. Berberine attenuates hypoxia‐induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor‐β signaling
548. Berberine attenuates impairment of intestinal glutamine transport in sepsis
549. Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats
550. Berberine attenuates intestinal mucosal barrier dysfunction in type 2 diabetic rats
551. Berberine attenuates ischemia–reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation
552. Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5′-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat …
553. Berberine attenuates isoniazid-induced hepatotoxicity by modulating peroxisome proliferator-activated receptor gamma, oxidative stress and inflammation
554. Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway
555. Berberine attenuates lipopolysaccharide-induced impairments of intestinal glutamine transport and glutaminase activity in rat
556. Berberine attenuates macrophages infiltration in intracranial aneurysms potentially through FAK/Grp78/UPR axis
557. Berberine attenuates myocardial ischemia reperfusion injury by suppressing the activation of PI3K/AKT signaling
558. Berberine attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation response: role of silent information regulator 1
559. Berberine Attenuates NLRP3 Inflammasome Activation in Macrophages to Reduce the Secretion of Interleukin-1β
560. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway
561. Berberine attenuates oxidative stress and hepatocytes apoptosis via protecting mitochondria in blunt snout bream Megalobrama amblycephala fed high-fat diets
562. Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway
563. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells
564. Berberine attenuates pulmonary arterial hypertension via protein phosphatase 2A signaling pathway both in vivo and in vitro
565. Berberine attenuates sodium palmitate-induced lipid accumulation, oxidative stress and apoptosis in grass carp (Ctenopharyngodon idella) hepatocyte in vitro
566. Berberine attenuates the acute pancreatitis induced by Dibutyltin dichloride (DBTC) in albino Wistar rats
567. Berberine attenuates vascular remodeling and inflammation in a rat model of metabolic syndrome
568. Berberine attenuates XRCC1‐mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs
569. Berberine augments ATP-induced inflammasome activation in macrophages by enhancing AMPK signaling
570. Berberine augments for TRAIL-induced apoptosis of leukemic cells
571. Berberine Averts Formation of Azoxymethane Induced Colonic Preneoplastic Lesions in Rats
572. Berberine azoles as antimicrobial agents: synthesis, biological evaluation and their interactions with human serum albumin
573. Berberine behind the thriller of marked symptomatic bradycardia
574. Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells
575. Berberine bioisostere Q8 compound stimulates osteoblast differentiation and function in vitro
576. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment
577. Berberine bridge enzyme catalyzes the six electron oxidation of (S)-reticuline to dehydroscoulerine
578. Berberine bridge enzyme, a key branch-point enzyme in benzylisoquinoline alkaloid biosynthesis, contains a vacuolar sorting determinant
579. Berberine can reduce calyculin A-induced tau hyperphosphorylation by inhibiting GSK-3β in HEK293/tau cell
580. Berberine cation: A fluorescent chemosensor for alkanes and other low-polarity compounds. An explanation of this phenomenon
581. Berberine chloride ameliorated PI3K/Akt‐p/SIRT‐1/PTEN signaling pathway in insulin resistance syndrome induced in rats
582. Berberine chloride ameliorates oxidative stress, inflammation and apoptosis in the pancreas of Streptozotocin induced diabetic rats
583. Berberine chloride an isoquinoline alkaloid induces cytotoxicity in cultured HeLa Cells
584. Berberine Chloride and Hyperthermia Promote Osterix Expression and Suppress Cell Cycle Genes in Osteosarcoma Cells
585. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the …
586. Berberine chloride causes a caspase-independent, apoptotic-like death in Leishmania donovani promastigotes
587. Berberine chloride improved synaptic plasticity in STZ induced diabetic rats
588. Berberine chloride mediates its antileishmanial activity by inhibiting Leishmania mitochondria
589. Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages
590. Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat
591. Berberine coated mannosylated liposomes curtail RANKL stimulated osteoclastogenesis through the modulation of GSK3β pathway via upregulating miR-23a
592. Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response …
593. Berberine combined with atorvastatin downregulates LOX‑1 expression through the ET‑1 receptor in monocyte/macrophages
594. Berberine combined with stachyose induces better glycometabolism than Berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice
595. Berberine Combined with Triple Therapy versus Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials
596. Berberine complexes with DNA in the Berberine -induced apoptosis in human leukemic HL-60 cells
597. Berberine confers neuroprotection in coping with focal cerebral ischemia by targeting inflammatory cytokines
598. Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial.
599. Berberine content in Coscinium fenestratum (Gaertn.) Colebr grown in Sri Lanka
600. Berberine contents and alkaloid profile of Berberis species from different altitudes
601. Berberine Contents from Different Parts of five Barberry (Berberis L.)[J]
602. Berberine Contents in Coptis chinensis and Phellodenron chinense before and after Processing Tested with Capillary Zone Electrophoresis [J]
603. Berberine cooperates with adrenal androgen dehydroepiandrosterone sulfate to attenuate PDGF-induced proliferation of vascular smooth muscle cell A7r5 through …
604. Berberine could ameliorate cardiac dysfunction via interfering myocardial lipidomic profiles in the rat model of diabetic cardiomyopathy
605. Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK …
606. Berberine counteracts enhanced IL-8 expression of AGS cells induced by evodiamine
607. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells
608. Berberine decreased inducible nitric oxide synthase mRNA stability through negative regulation of human antigen R in lipopolysaccharide-induced macrophages
609. Berberine decreased iNOS mRNA stability through negative regulation of HuR in LPS-induced macrophages
610. Berberine decreased N-acetylation of 2-aminofluorene through inhibition of N-acetyltransferase gene expression in human leukemia HL-60 cells
611. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption
612. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K/AKT and MAPK pathways
613. Berberine decreases PCSK9 expression in HepG2 cells
614. Berberine Decreases Plasma Lipids and Liver Weight in Hypercholesterolemic Rats
615. Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice
616. Berberine delays onset of collagen induced arthritis through T cell suppression
617. Berberine demonstrates anti‐inflammatory properties in Helicobacter pylori‐infected mice with chronic gastritis by attenuating the Th17 response triggered by the B …
618. Berberine depresses contraction of smooth muscle via inhibiting myosin light-chain kinase
619. Berberine derivative, Q8, stimulates osteogenic differentiation
620. Berberine derivatives as antileishmanial drugs.
621. Berberine derivatives as cationic fluorescent probes for the investigation of the energized state of mitochondria
622. Berberine derivatives as heteroatom induced hydrophobic sensor: An analytical approach for the selective and sensitive fluorometric detection and discrimination of …
623. Berberine Derivatives as Multi-Kinase Inhibitors of MAP Kinase and PI3K Pathways: Molecular Modelling, Molecular Dynamics Simulations, and in vitro Evaluation
624. Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE−/− mice
625. Berberine derivatives with different pharmacological activities via structural modifications
626. Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase
627. Berberine detection based on a fluorescent conjugated polyelectrolyte
628. Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice
629. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2
630. Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells
631. Berberine directly affects the gut microbiota to promote intestinal farnesoid x receptor activation
632. Berberine displays antitumor activity in esophageal cancer cells in vitro
633. Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes
634. Berberine down-regulates cellular JNK and NF-κB activation and this may result in an inhibition of HSV replication
635. Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells
636. Berberine down-regulates the Th1/Th2 cytokine gene expression ratio in mouse primary splenocytes in the absence or presence of lipopolysaccharide in a preventive …
637. Berberine dyeing of acrylic fibers [J]
638. Berberine Effect of Anti-microbiota-Possibility and Clinical Significance on Gut Microbiota and Metabolism: A Review
639. Berberine Effects on NFΚB, HIF1A and NFE2L2/AP-1 Pathways in HeLa Cells
640. Berberine elicits anti‐arrhythmic effects via IK1/Kir2. 1 in the rat type 2 diabetic myocardial infarction model
641. Berberine encapsulated PLGA-PEG nanoparticles modulate PCSK-9 in HepG2 Cells
642. Berberine enhances antidiabetic effects and attenuates untoward effects of canagliflozin in streptozotocin-induced diabetic mice
643. Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK signaling in breast cancer
644. Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NF‑κB
645. Berberine enhances defects in the establishment of leaf polarity in asymmetric leaves1 and asymmetric leaves2 of Arabidopsis thaliana
646. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide
647. Berberine enhances mitomycin C-induced cell cycle arrest and apoptosis of T24 bladder cancer cells
648. Berberine enhances posttranslational protein stability of p21/cip1 in breast cancer cells via down-regulation of Akt
649. Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo
650. Berberine enhances the antibacterial activity of selected antibiotics against coagulase-negative Staphylococcus strains in vitro
651. Berberine enhances the anti‑tumor activity of tamoxifen in drug‑sensitive MCF‑7 and drug‑resistant MCF‑7/TAM cells
652. Berberine enhances the radiosensitivity of hepatoma cells by Nrf2 pathway.
653. Berberine enhances tumor necrosis factor‑related apoptosis‑inducing ligand‑mediated apoptosis in breast cancer
654. Berberine Exerts a Protective Effect on Gut-Vascular Barrier via the Modulation of the Wnt/Beta-Catenin Signaling Pathway During Sepsis
655. Berberine exerts an anticonvulsant effect and ameliorates memory impairment and oxidative stress in a pilocarpine-induced epilepsy model in the rat
656. Berberine exerts anti-adipogenic activity through up-regulation of C/EBP inhibitors, CHOP and DEC2
657. Berberine exerts antioxidant effects via protection of spiral ganglion cells against cytomegalovirus-induced apoptosis
658. Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and …
659. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of B-cell …
660. Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy
661. Berberine exhibits antioxidative effects and reduces apoptosis of the vaginal epithelium in bacterial vaginosis
662. Berberine exhibits antitumor effects in human ovarian cancer cells
663. Berberine exposure triggers developmental effects on planarian regeneration
664. Berberine EXTRACTION FROM BARBERRY ROOT: A COMPARISON STUDY BETWEEN SCW AND SCF EXTRACTION TECHNIQUES
665. Berberine Facilitates Angiogenesis Against Ischemic Stroke Through Modulating Microglial Polarization via AMPK Signaling
666. Berberine finishing for developing antimicrobial nylon 66 fibers:% exhaustion, colorimetric analysis, antimicrobial study, and empirical modeling
667. Berberine formate–succinic acid (1/1)
668. Berberine from Argemone mexicana L exhibits broadspectrum antibacterial activity
669. Berberine from roots of Berberis aristata prevents cataract formation in isolated goat eye lens: An In-vitro Study
670. Berberine gel in periodontal inflammation: clinical and histological effects
671. Berberine hydrochloride as a treatment of oriental sore (a preliminary report).
672. Berberine hydrochloride attenuates cyclooxygenase-2 expression in rat small intestinal mucosa during acute endotoxemia
673. Berberine hydrochloride attenuates lipopolysaccharide-induced endometritis in mice by suppressing activation of NF-κB signal pathway
674. Berberine hydrochloride counteracts enhanced IL-8 expression induced by SN 38 in AGS cells
675. Berberine Hydrochloride for the Prevention of Colorectal Adenomas: A Double-Blind, Randomised Controlled Multicenter Clinical Trial
676. Berberine hydrochloride IL-8 dependently inhibits invasion and IL-8-independently promotes cell apoptosis in MDA-MB-231 cells
677. Berberine hydrochloride impact on physiological processes and modulation of twist levels in nasopharyngeal carcinoma CNE-1 cells
678. Berberine hydrochloride improves symptoms in diarrhoea predominant irritable bowel syndrome
679. Berberine hydrochloride in inhibiting expression of proteome of Staphylococcus epidermidis
680. Berberine hydrochloride induces brown adipogenesis
681. Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax …
682. Berberine hydrochloride inhibits formation of Staphylococcus epidermidis biofilm: relative gene expressions
683. Berberine hydrochloride on G6PD enzyme defects in red blood cells of patients [J]
684. Berberine hydrochloride prevents postsurgery intestinal adhesion and inflammation in rats
685. Berberine hydrochloride protects against cytokine-induced inflammation through multiple pathways in undifferentiated C2C12 myoblast cells
686. Berberine hydrochloride protects C2C12 myoblast cells against oxidative stress‐induced damage via induction of Nrf‐2‐mediated HO‐1 expression
687. Berberine Hydrochloride Protects Cytokine-Induced Inflammation through Multiple Pathways
688. Berberine Hydrochloride Reference Standard (Control 001) of National Institute of Health Sciences
689. Berberine hydrochloride reference standard (Control 941) of the National Institute of Health Sciences
690. Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
691. Berberine Hydrochloride-chitosan Slow Releasing Microspheres
692. Berberine hydrochloride-loaded chitosan nanoparticles effectively targets and suppresses human nasopharyngeal carcinoma
693. Berberine impairs embryonic development in vitro and in vivo through oxidative stress‐mediated apoptotic processes
694. Berberine improved Aldo-induced podocyte injury via inhibiting oxidative stress and endoplasmic reticulum stress pathways both in vivo and in vitro
695. Berberine improved experimental chronic colitis by regulating interferon-γ-and IL-17A-producing lamina propria CD4+ T cells through AMPK activation
696. Berberine improves advanced glycation end products‑induced osteogenic differentiation responses in human periodontal ligament stem cells through the …
697. Berberine improves airway inflammation and inhibits NF-κB signaling pathway in an ovalbumin-induced rat model of asthma
698. Berberine improves benign prostatic hyperplasia via suppression of 5 alpha reductase and extracellular signal-regulated kinase in vivo and in vitro
699. Berberine improves cognitive deficiency and muscular dysfunction via activation of the AMPK/SIRT1/PGC-1a pathway in skeletal muscle from naturally aging rats
700. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer’s …
701. Berberine Improves Diabetic Encephalopathy Through the SIRT1/ER Stress Pathway in db/db Mice
702. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans
703. Berberine improves free-fatty-acid–induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator–activated receptor γ and fatty acid transferase …
704. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
705. Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance
706. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis
707. Berberine improves glucose metabolism through induction of glycolysis
708. Berberine Improves High Glucose-induced Damage to Vascular Endothelial Cells and Microvascular Endothelial Cells
709. Berberine improves insulin resistance in adipocyte models by regulating the methylation of hypoxia-inducible factor-3α
710. Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase
711. Berberine improves insulin resistance induced by high fat diet in rats
712. Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients
713. Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice
714. Berberine improves intestinal motility and visceral pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms in …
715. Berberine improves kidney function in diabetic mice via AMPK activation
716. Berberine Improves Kidney Injure Following Renal Ischemia Reperfusion in Rats
717. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
718. Berberine IMPROVES LIVER FAILURE INDUCED BY FERROUS SULFATE IN RAT
719. Berberine improves liver injury following renal ischemia reperfusion in rats
720. Berberine IMPROVES LIVER INJURY FOLLOWING RENAL ISCHEMIA/REPERFUSION IN RATS
721. Berberine improves mesenteric artery insulin sensitivity through up‐regulating insulin receptor‐mediated signalling in diabetic rats
722. Berberine improves metabolic syndrome insulin resistance by inducing macrophage M2 polarization
723. Berberine improves motor function recovery by inhibiting endoplasmic reticulum stress-induced neuronal apoptosis via AMPK activation in rats with spinal cord …
724. Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats
725. Berberine Improves Plasma Glucose Control and Lipid Profiles in Streptozotocin-Induced Diabetic Rats
726. Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy
727. Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity
728. Berberine improves the intestinal antioxidant status of laboratory mice, Mus musculus
729. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
730. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
731. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis
732. Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft
733. Berberine in combination with insulin has additive effects on titanium implants osseointegration in diabetes mellitus rats
734. Berberine in combination with yohimbine attenuates sepsis-induced neutrophil tissue infiltration and multiorgan dysfunction partly via IL-10-mediated inhibition of …
735. Berberine in Malaria. A Preliminary Note
736. Berberine in the treatment of childhood diarrhoea
737. Berberine in the Treatment of Malaria.
738. Berberine in the treatment of oriental sore
739. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis
740. Berberine in toxin-induced experimental cholera
741. Berberine in trachoma
742. Berberine in type 2 diabetes therapy: a new perspective for an old antidiarrheal drug?
743. Berberine increases adipose triglyceride lipase in 3T3-L1 adipocytes through the AMPK pathway
744. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation
745. Berberine increases glucose uptake and intracellular ROS levels by promoting Sirtuin 3 ubiquitination
746. Berberine increases glucose uptake in 3T3-L1 adipocytes by enhancing GLUT1 activity
747. Berberine Increases the Expression of ATP-Binding Cassette Transporter A1 and Cholesterol Efflux in THP-1 Macrophages via Deacetylation of Liver X Receptor-α
748. Berberine increases the expression of NHE3 and AQP4 in sennosideA-induced diarrhoea model
749. Berberine increasing the expression of adipophilin in macrophage
750. Berberine induced apoptosis of human osteosarcoma cells by inhibiting phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signal pathway activation
751. Berberine induced apoptosis via promoting the expression of caspase-8,-9 and-3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous …
752. Berberine induced down-regulation of matrix metalloproteinase-1,-2 and-9 in human gastric cancer cells (SNU-5) in vitro
753. Berberine induced down-regulation of matrix metalloproteinases-1-2 and-7 expressions were associated with levels of reactive oxygen species in human gastric …
754. Berberine INDUCED IMPROVEMENT IN HEPATIC STEATOSIS INDEX IN OVERWEIGHT DYSLIPIDAEMIC PATIENTS TREATED WITH LIPID-LOWERING …
755. Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death
756. Berberine induces apoptosis and DNA damage in MG‑63 human osteosarcoma cells
757. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma
758. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway
759. Berberine induces apoptosis in hormone refractory human prostate carcinoma DU145 cells through activation of caspase 3 accompanied with disruption of …
760. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway
761. Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter
762. Berberine induces apoptosis in non-small-cell lung cancer cells by upregulating miR-19a targeting tissue factor
763. Berberine induces apoptosis in p53-null leukemia cells by down-regulating XIAP at the post-transcriptional level
764. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL
765. Berberine induces apoptosis of breast cancer MCF-7 cells: Its related oxidative stress mechanism [J]
766. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells
767. Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells
768. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines
769. Berberine induces apoptosis via the mitochondrial pathway in liver cancer cells
770. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism
771. Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor
772. Berberine induces cell apoptosis through cytochrome C/apoptotic protease-activating factor 1/caspase-3 and apoptosis inducing factor pathway in mouse insulinoma …
773. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line
774. Berberine induces cell cycle arrest and apoptosis in human HSC-3 oral cancer cells
775. Berberine induces cell cycle arrest in cholangiocarcinoma cell lines via inhibition of NF-κB and STAT3 pathways
776. Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147
777. Berberine Induces CYP2J2 Expression in Human U251 Glioma Cells via Regulation of Peroxisome Proliferator-Activated Receptor Alpha
778. Berberine induces dedifferentiation by actin cytoskeleton reorganization via phosphoinositide 3-kinase/Akt and p38 kinase pathways in rabbit articular chondrocytes
779. Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis
780. Berberine induces double-strand DNA breaks in Rev3 deficient cells
781. Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells
782. Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway
783. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways
784. Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase/AKT and NF-E2-related factor-2 signaling pathway in astrocytes
785. Berberine induces hERG channel deficiency through trafficking inhibition
786. Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway
787. Berberine induces mitochondrial apoptosis of EBV-transformed B cells through p53-mediated regulation of XAF1 and GADD45α
788. Berberine induces mitochondrial‑mediated apoptosis and protective autophagy in human malignant pleural mesothelioma NCI‑H2452 cells
789. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells
790. Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP …
791. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage
792. Berberine induces pacemaker potential inhibition via cGMP-dependent ATP-sensitive K+ channels by stimulating mu/delta opioid receptors in cultured …
793. Berberine induces resistance against tobacco mosaic virus in tobacco
794. Berberine induces selective apoptosis through the AMPK‑mediated mitochondrial/caspase pathway in hepatocellular carcinoma
795. Berberine induces senescence of human glioblastoma cells by downregulating the EGFR–MEK–ERK signaling pathway
796. Berberine induces toxicity in HeLa cells through perturbation of microtubule polymerization by binding to tubulin at a unique site
797. Berberine induces ZIP14 expression and modulates zinc redistribution to protect intestinal mucosal barrier during polymicrobial sepsis
798. Berberine influences blood glucose via modulating the gut microbiome in grass carp
799. Berberine inhibited apoptosis of human umbilical vein endothelial cells induced by Staphylocoocus aureus: an experimental research
800. Berberine Inhibited Arylamine N-Acetyltransferase Activity and Gene Expression and DNA Adduct Formation in Human Malignant Astrocytoma (G9T/VGH) and Brain …
801. Berberine inhibited radioresistant effects and enhanced anti-tumor effects in the irradiated-human prostate cancer cells
802. Berberine inhibited the growth of thyroid cancer cell lines 8505C and TPC1
803. Berberine Inhibited the Proliferation of Cancer Cells by Suppressing the Activity of Tumor Pyruvate Kinase M2
804. Berberine inhibition of electrogenic ion transport in rat colon
805. Berberine Inhibition of Fibrogenesis in a Rat Model of Liver
806. Berberine inhibition of fibrogenesis in a rat model of liver fibrosis and in hepatic stellate cells
807. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
808. Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy
809. Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3
810. Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
811. Berberine Inhibits Adipogenesis in Porcine Adipocytes via AMP‐Activated Protein Kinase‐Dependent and ‐Independent Mechanisms
812. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose
813. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells
814. Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway
815. Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down‐regulation in vitro
816. Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells
817. Berberine Inhibits Arylamine N-Acetyltransferase Activity and Gene Expression in Salmonella Typhi
818. Berberine inhibits cardiac fibrosis of diabetic rats
819. Berberine inhibits cardiac remodeling of heart failure after myocardial infarction by reducing myocardial cell apoptosis in rats
820. Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells
821. Berberine inhibits cell growth via Wnt/beta-catenin signaling in glioma
822. Berberine inhibits Chlamydia pneumoniae infection-induced vascular smooth muscle cell migration through downregulating MMP3 and MMP9 via PI3K
823. Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth
824. Berberine inhibits cyclin D1 expression via suppressed binding of AP‐1 transcription factors to CCND1 AP‐1 motif1
825. Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the α2-adrenergic receptor in mice
826. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression
827. Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation
828. Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer
829. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy
830. Berberine inhibits epithelial-mesenchymal transition and promotes apoptosis of tumour-associated fibroblast-induced colonic epithelial cells through regulation of TGF …
831. Berberine inhibits experimental varicocele‐induced cell cycle arrest via regulating cyclin D1, cdk4 and p21 proteins expression in rat testicles
832. Berberine inhibits fluphenazine-induced up-regulation of CDR1 in Candida albicans
833. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages
834. Berberine inhibits glucose oxidation and insulin secretion in rat islets
835. Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells
836. Berberine inhibits growth and inflammatory invasive phenotypes of ectopic stromal cells: Imply the possible treatment of adenomyosis
837. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231
838. Berberine inhibits HEp-2 cell invasion induced by Chlamydophila pneumoniae infection
839. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats
840. Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis
841. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein
842. Berberine inhibits HIF-1α expression via enhanced proteolysis
843. Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages
844. Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling
845. Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes
846. Berberine inhibits human melanoma A375. S2 cell migration and invasion via affecting the FAK, uPA, and NF-κB signaling pathways and inhibits PLX4032 resistant …
847. Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis
848. Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model
849. Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and …
850. Berberine inhibits inflammatory activation of rat brain microglia*⋆
851. Berberine inhibits inflammatory mediators and attenuates acute pancreatitis through deactivation of JNK signaling pathways
852. Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes
853. Berberine Inhibits Intestinal Polyps Growth in Apc (min
854. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins.
855. Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway
856. Berberine inhibits ion transport in human colonic epithelia
857. Berberine inhibits lipopolysaccharide-and polyethylene particle-induced mouse calvarial osteolysis in vivo
858. Berberine inhibits low shear stress-induced glycocalyx degradation via modulating AMPK and p47phox/Hyal2 signal pathway
859. Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells
860. Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway to protect against DSS-induced colitis
861. Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567
862. Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic β-cell
863. Berberine inhibits myocardial inflammation in rat with chronic heart failure
864. Berberine Inhibits Myofibroblast Differentiation in Nasal Polyp‐Derived Fibroblasts via the p38 Pathway
865. Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages
866. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell
867. Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-α-caspase signaling pathway
868. Berberine inhibits oxygen consumption rate independent of alteration in cardiolipin levels in H9c2 cells
869. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells
870. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking Berberine to insulin …
871. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells
872. Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of Cbl in colon tumor cells
873. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78.
874. Berberine Inhibits Proliferative Ability of Breast Cancer Cells by Reducing Metadherin
875. Berberine inhibits PTP1B activity and mimics insulin action
876. Berberine inhibits pulmonary metastasis through down‐regulation of MMP in metastatic B16F‐10 melanoma cells
877. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-κB and Akt pathways
878. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo: Berberine improves …
879. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells
880. Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells
881. Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis
882. Berberine inhibits SREBP‐1‐related clozapine and risperidone induced adipogenesis in 3T3‐L1 cells
883. Berberine inhibits Staphylococcus Epidermidis adhesion and biofilm formation on the surface of titanium alloy
884. Berberine inhibits the chemotherapy‐induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer
885. Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer
886. Berberine inhibits the expression of TNFα, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARγ pathway
887. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo
888. Berberine inhibits the interleukin‐1 beta‐induced inflammatory response via MAPK downregulation in rat articular chondrocytes
889. Berberine inhibits the invasion and metastasis of nasopharyngeal carcinoma cells through Ezrin phosphorylation.
890. Berberine inhibits the ischemia-reperfusion induced testicular injury through decreasing oxidative stress
891. Berberine inhibits the ischemia‑reperfusion injury induced inflammatory response and apoptosis of myocardial cells through the phosphoinositide 3‑kinase/RAC‑α …
892. Berberine inhibits the LPS‑induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling …
893. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive …
894. Berberine inhibits the MexXY‑OprM efflux pump to reverse imipenem resistance in a clinical carbapenem‑resistant Pseudomonas aeruginosa isolate in a …
895. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase
896. Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells
897. Berberine inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cells
898. Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2
899. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling
900. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism
901. Berberine inhibits the proliferation of human uterine leiomyoma cells
902. Berberine inhibits the proliferation of prostate cancer cells and induces G0/G1 or G2/M phase arrest at different concentrations
903. Berberine inhibits the release of glutamate in nerve terminals from rat cerebral cortex
904. Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes
905. Berberine inhibits tumor necrosis factor‑α‑induced expression of inflammatory molecules and activation of nuclear factor‑κB via the activation of AMPK in …
906. Berberine inhibits tumor-associated macrophages in subcutaneous tumor of mice [J]
907. Berberine inhibits uterine leiomyoma cell proliferation via downregulation of cyclooxygenase 2 and pituitary tumor-transforming gene 1
908. Berberine Inhibits WEHI-3 Leukemia Cells in Balb/C Mice In Vivo
909. Berberine inhibits WEHI-3 leukemia cells in vivo
910. Berberine inhibits Wilms’ tumor cell progression through upregulation of Wilms’ tumor gene on the X chromosome
911. Berberine interfered with breast cancer cells metabolism, balancing energy homeostasis
912. Berberine is a dopamine D1-and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses
913. Berberine is a new mechanism drug against energy metabolic disorder
914. Berberine is a new medicine for energy-related metabolic disorders
915. Berberine is a new medicine for energy–related metabolic disorders
916. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
917. Berberine is a novel type efflux inhibitor which attenuates the MexXY-mediated aminoglycoside resistance in Pseudomonas aeruginosa
918. Berberine is a potent agonist of peroxisome proliferator activated receptor alpha
919. Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation
920. Berberine is multi-targets therapeutic weapon; medical biotechnology resolves the mystery
921. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
922. Berberine Maintains Gut Microbiota Homeostasis and Ameliorates Liver Inflammation in Experimental Non-alcoholic Fatty Liver Disease
923. Berberine may be a promising botanical for glycemic control
924. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells
925. Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells
926. Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines
927. Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity
928. Berberine mitigates IL-21/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17/Treg imbalance in rheumatoid arthritis
929. Berberine mitigates methotrexate-induced oxidative stress and inflammation in the cerebrum of rats
930. Berberine moderates glucose and lipid metabolism through multipathway mechanism
931. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine
932. Berberine modifies cysteine 179 of IκBα kinase, suppresses nuclear factor-κB–regulated antiapoptotic gene products, and potentiates apoptosis
933. Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase
934. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells
935. Berberine modulates ASK1 signaling mediated through TLR4/TRAF2 via upregulation of miR-23a
936. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203
937. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203 Animal
938. Berberine Modulates Epigenetics via Inhibition of Hypoxia‐Induced Histone Lysine Demethylases Expression
939. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel
940. Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signaling pathway
941. Berberine modulates insulin signaling transduction in insulin-resistant cells
942. Berberine Modulates LPA Function to Inhibit the Proliferation and Inflammation of FLS-RA via p38/ERK MAPK Pathway Mediated by LPA1
943. Berberine modulation on doxorubicin-induced cell death and auto phagy
944. Berberine nanoparticles for promising sonodynamic therapy of a HeLa xenograft tumour
945. Berberine nanoparticles protects tubular epithelial cells from renal ischemia-reperfusion injury
946. Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity
947. Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL/6 mice
948. Berberine on Inducing HL-60 Cells Differentiation and Cytostatic Effect
949. Berberine on LPS-induced COX-2 expression: p38 mitogen-activated protein kinase and extracellular signal-regulated kinase signaling pathway comparision
950. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials
951. Berberine Overcome the Drug Resistance of Leukemic K562/A02 Cells
952. Berberine Plus
953. Berberine possesses muscarinic agonist-like properties in cultured rodent cardiomyocytes
954. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling
955. Berberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validation
956. Berberine Preconditioning Protects Neurons Against Ischemia via Sphingosine-1-Phosphate and Hypoxia-Inducible Factor-1
957. Berberine Pretreatment Confers Cardioprotection Against Ischemia–Reperfusion Injury in a Rat Model of Type 2 Diabetes
958. Berberine Prevents Bone and Cartilage Destruction and Influences Cell Senescence in Experimental Arthritis
959. Berberine prevents cardiac dysfunction and myocardial neutrophil accumulation independent of α_2 adrenoceptor in endotoxemic mice
960. Berberine prevents damage to the intestinal mucosal barrier during early phase of sepsis in rat through mechanisms independent of the NOD-like receptors signaling …
961. Berberine prevents free fatty acid-induced lipid accumulation by activating ERK through sphingosine-1-phosphate receptor 2 in hepatocytes
962. Berberine prevents high glucose-induced cell viability inhibition and apoptosis in podocytes
963. Berberine prevents human nucleus pulposus cells from IL‑1β‑induced extracellular matrix degradation and apoptosis by inhibiting the NF‑κB pathway
964. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial …
965. Berberine prevents intestinal mucosal barrier damage during early phase of sepsis in rat through the toll-like receptors signaling pathway
966. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson’s disease
967. Berberine prevents nitric oxide-induced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling
968. Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice
969. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress
970. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats
971. Berberine prevents the apoptosis of mouse podocytes induced by TRAF5 overexpression by suppressing NF-κB activation
972. Berberine prevents UV-induced MMP-1 and reduction of type I procollagen expression in human dermal fibroblasts
973. Berberine produces antidepressant-like effects in ovariectomized mice
974. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice
975. Berberine production by batch and semi-continuous cultures of immobilized Thalictrum cells in an improved bioreactor
976. Berberine production by cultured Coptis japonica cells in a one-stage culture using medium with a high copper concentration
977. Berberine prolongs life span and stimulates locomotor activity of Drosophila melanogaster
978. Berberine promoted myocardial protection of postoperative patients through regulating myocardial autophagy
979. Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest
980. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU …
981. Berberine promotes axonal regeneration in injured nerves of the peripheral nervous system
982. Berberine Promotes Beige Adipogenic Signatures of 3T3-L1 Cells by Regulating Post-transcriptional Events
983. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway
984. Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats
985. Berberine promotes glucose consumption independently of AMP-activated protein kinase activation
986. Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3
987. Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b
988. Berberine promotes nerve regeneration through IGFR‑mediated JNK‑AKT signal pathway
989. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK
990. Berberine Promotes Osteogenic Differentiation of Human Dental Pulp Stem Cells Through Activating EGFR-MAPK-Runx2 Pathways
991. Berberine promotes osteogenic differentiation of mesenchymal stem cells with therapeutic potential in periodontal regeneration
992. Berberine promotes proliferation of sodium nitroprusside-stimulated rat chondrocytes and osteoarthritic rat cartilage via Wnt/β-catenin pathway
993. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice
994. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage
995. Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans
996. Berberine protected rats against adiposity induced by high-fat diets
997. Berberine protects 6-hydroxydopamine-induced human dopaminergic neuronal cell death through the induction of heme oxygenase-1
998. Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis
999. Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 …
1000. Berberine protects against chronic social defeat stress-induced depressive-like behaviors with upregulation of neuronal PAS domain protein 4/brain-derived …
1001. Berberine protects against cytokine-induced inflammation through multiple pathways in undifferentiated C2C12 myoblast cells
1002. Berberine protects against diabetic kidney disease via promoting PGC‐1α‐regulated mitochondrial energy homeostasis
1003. Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels
1004. Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines
1005. Berberine protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells
1006. Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis
1007. Berberine protects against ischemia/reperfusion injury after orthotopic liver transplantation via activating Sirt1/FoxO3α induced autophagy
1008. Berberine protects against ischemia-reperfusion injury: a review of evidence from animal models and clinical studies
1009. Berberine protects against light-induced photoreceptor degeneration in the mouse retina
1010. Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms
1011. Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer’s-like dementia: Involvement of …
1012. Berberine protects against metformin-associated lactic acidosis in induced diabetes mellitus
1013. Berberine Protects against NEFA-Induced Impairment of Mitochondrial Respiratory Chain Function and Insulin Signaling in Bovine Hepatocytes
1014. Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury
1015. Berberine protects against palmitate-induced apoptosis in tubular epithelial cells by promoting fatty acid oxidation
1016. Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4
1017. Berberine protects C17. 2 neural stem cells from oxidative damage followed by inducing neuronal differentiation
1018. Berberine protects C57BL/6J mice against ethanol withdrawal‐induced hyperexcitability
1019. Berberine PROTECTS CELLULAR INTEGRITY DURING 7, 12-DIMETHYLBENZ [A] ANTHRACENE-INDUCED ORAL CARCINOGENESIS IN GOLDEN SYRIAN …
1020. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway
1021. Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction
1022. Berberine protects HK-2 cells from hypoxia/reoxygenation induced apoptosis via inhibiting SPHK1 expression
1023. Berberine protects homocysteic acid-induced HT-22 cell death: involvement of Akt pathway
1024. Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress …
1025. Berberine protects human retinal pigment epithelial cells from hydrogen peroxide-induced oxidative damage through activation of AMPK
1026. Berberine protects human umbilical vein endothelial cells against LPS-induced apoptosis by blocking JNK-mediated signaling
1027. Berberine protects immortalized line of human melanocytes from H2O2-induced oxidative stress via activation of Nrf2 and Mitf signaling pathway
1028. Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice
1029. Berberine protects mesenchymal stem cells against hypoxia-induced apoptosis in vitro
1030. Berberine Protects Mice Against Dextran Sulfate Sodium-Induced Colitis by Activating mTORC1 Pathway
1031. Berberine protects myocardial cells against anoxia‑reoxygenation injury via p38 MAPK‑mediated NF‑κB signaling pathways
1032. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress
1033. Berberine protects renal tubular cells against hypoxia/reoxygenation injury via the Sirt1/p53 pathway
1034. Berberine protects secondary injury in mice with traumatic brain injury through anti-oxidative and anti-inflammatory modulation
1035. Berberine protects steatotic donor undergoing liver transplantation via inhibiting endoplasmic reticulum stress-mediated reticulophagy
1036. Berberine protects the liver and kidney against functional disorders and histological damages induced by ferrous sulfate
1037. Berberine protects vascular endothelial cells in hypertensive rats
1038. Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51
1039. Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expression
1040. Berberine reduce allergic inflammation in a house dust mite allergic rhinitis mouse model
1041. Berberine reduced blood pressure and improved vasodilation in diabetic rats
1042. Berberine Reduced Lipopolysaccharide-Mediated Macrophage Migration By Suppression Of Src Enhancement
1043. Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages
1044. Berberine reduces cAMP-induced chloride secretion in T84 human colonic carcinoma cells through inhibition of basolateral KCNQ1 channels
1045. Berberine reduces endoplasmic reticulum stress and improves insulin signal transduction in Hep G2 cells
1046. Berberine reduces endothelial injury and arterial stiffness in spontaneously hypertensive rats
1047. Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition
1048. Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models
1049. Berberine reduces inflammation of human dental pulp fibroblast via miR-21/KBTBD7 axis
1050. Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro
1051. Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
1052. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K–Akt signaling in diabetic rats
1053. Berberine Reduces Leukocyte Adhesion to Lps-Stimulated Endothelial Cells and Vcam-1 Expression Both In Vivo and In Vitro
1054. Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats
1055. Berberine reduces neuroglia activation and inflammation in streptozotocin-induced diabetic mice
1056. Berberine reduces neurotoxicity related to nonalcoholic steatohepatitis in rats
1057. Berberine reduces pyruvate-driven hepatic glucose production by limiting mitochondrial import of pyruvate through mitochondrial pyruvate carrier 1
1058. Berberine reduces rat intestinal tight junction injury induced by ischemia–reperfusion associated with the suppression of inducible nitric oxide synthesis
1059. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte
1060. Berberine reduces the hypoxic-ischemic insult in rat pup brain
1061. Berberine reduces the metastasis of chondrosarcoma by modulating the αvβ3 integrin and the PKCδ, c-Src, and AP-1 signaling pathways
1062. Berberine reduces the metastasis of chondrosarcoma by modulating the 𝛼v𝛽3 integrin and the PKC𝛿, c-Src, and AP-1 signaling pathways
1063. Berberine reduces the occurrence of neonatal necrotizing enterocolitis by reducing the inflammatory response
1064. Berberine reduces Toll-like receptor-mediated macrophage migration by suppression of Src enhancement
1065. Berberine reduces uremia-associated intestinal mucosal barrier damage
1066. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver
1067. Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes
1068. Berberine regulated lipid metabolism in the presence of C75, compound C, and TOFA in breast cancer cell line MCF-7
1069. Berberine regulates AMP‐activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice
1070. Berberine regulates glycemia via local inhibition of intestinal dipeptidyl peptidase-Ⅳ
1071. Berberine regulates melanin synthesis by activating PI3K/AKT, ERK and GSK3β in B16F10 melanoma cells
1072. Berberine regulates neurite outgrowth through AMPK-dependent pathways by lowering energy status
1073. Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes
1074. Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway
1075. Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy
1076. Berberine regulates the microRNA‑21‑ITGΒ4‑PDCD4 axis and inhibits colon cancer viability
1077. Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines
1078. Berberine regulates Treg/Th17 balance to treat ulcerative colitis through modulating the gut microbiota in the colon
1079. Berberine regulates type 2 diabetes mellitus related with insulin resistance
1080. Berberine reinforces Sertoli cells niche and accelerates spermatogonial stem cells renewal in experimentally-induced varicocele condition in rats
1081. Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells
1082. Berberine represses DAXX gene transcription and induces cancer cell apoptosis
1083. Berberine rescues D-galactose-induced synaptic/memory impairment by regulating the levels of Arc
1084. Berberine restored nitrergic and adrenergic function in mesenteric and iliac arteries from streptozotocin-induced diabetic rats
1085. Berberine restricts coxsackievirus B type 3 replication via inhibition of c-Jun N-Terminal Kinase (JNK) and p38 MAPK Activation in vitro
1086. Berberine reversed the epithelial‐mesenchymal transition of normal colonic epithelial cells induced by SW480 cells through regulating the important components in …
1087. Berberine reverses abnormal expression of L-type pyruvate kinase by DNA demethylation and histone acetylation in the livers of the non-alcoholic fatty …
1088. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells
1089. Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKβ
1090. Berberine reverses hypoxia-induced chemoresistance in breast cancer through the inhibition of AMPK-HIF-1α
1091. Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS
1092. Berberine reverses LPS-induced repression of CYP7A1 through an anti-inflammatory effect
1093. Berberine Reverses the Chemoresistance of Breast Cancer to 5-Fluorouracil by Downregulating Metadherin
1094. Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation
1095. Berberine salts on the basis of some aminoacids
1096. Berberine salts on the basis of some aminoacids; Soli berberina na osnove nekotorikh aminokislot
1097. Berberine selectively inhibits human monoamine oxidase B: kinetics and mechanism of inhibition
1098. Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.
1099. Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93/PTEN/Akt signaling pathway
1100. Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro
1101. Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis
1102. Berberine sensitizes rapamycin‑mediated human hepatoma cell death in vitro
1103. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins
1104. Berberine significantly reduces plasma total cholesterol and nonhigh density lipoprotein cholesterol levels in Golden Syrian hamsters
1105. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells
1106. Berberine stimulates fibroblast growth factor 21 by modulating the molecular clock component brain and muscle Arnt-like 1 in brown adipose tissue
1107. Berberine stimulates glucose transport through a mechanism distinct from insulin
1108. Berberine substance groups obtained from HPLC have affects on the content of IL-1β, IL-6, IL-8 and TNF-α of the excessive heat syndrome model rats
1109. Berberine sulfate attenuates osteoclast differentiation through RANKL induced NF-κB and NFAT pathways
1110. Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane.
1111. Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin
1112. Berberine sulfate: antimicrobial activity, bioassay, and mode of action
1113. Berberine sulphate binding to mast cell polyanions: a cytofluorometric method for the quantitation of heparin
1114. Berberine sulphate in chronic trachoma
1115. Berberine sulphate in oriental sore
1116. Berberine suppress the colon cancer proliferation through activating AMPK.
1117. Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells
1118. Berberine suppresses adipocyte differentiation via decreasing CREB transcriptional activity
1119. Berberine suppresses amyloid‐beta‐induced inflammatory response in microglia by inhibiting nuclear factor‐kappaB and mitogen‐activated protein kinase signalling …
1120. Berberine suppresses androgen receptor signaling in prostate cancer
1121. Berberine SUPPRESSES ANDROGEN RECEPTOR SIGNALING IN PROSTATE CANCER CELLS.
1122. Berberine suppresses apoptosis and extracellular matrix (ECM) degradation in nucleus pulposus cells and ameliorates disc degeneration in a rodent model
1123. Berberine suppresses cell motility through downregulation of TGF-β1 in triple negative breast cancer cells
1124. Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP/SREBP-1 signaling pathway-mediated lipogenesis
1125. Berberine suppresses fibronectin expression through inhibition of c-Jun phosphorylation in breast cancer cells
1126. Berberine suppresses gero-conversion from cell cycle arrest to senescence
1127. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2
1128. Berberine Suppresses Hepatic Glucose Output and Improves Insulin Signaling in Hepatocytes.
1129. Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway
1130. Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling
1131. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-κB, u-PA and MMP-2 and …
1132. Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB
1133. Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells
1134. Berberine Suppresses Interleukin-1β-Induced MUC5AC Gene Expression in Human Airway Epithelial Cells
1135. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study
1136. Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264. 7 cells
1137. Berberine suppresses mast cell-mediated allergic responses via regulating FcɛRI-mediated and MAPK signaling
1138. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury
1139. Berberine suppresses migration of MCF-7 breast cancer cells through down-regulation of chemokine receptors
1140. Berberine suppresses neuroinflammatory responses through AMP‐activated protein kinase activation in BV‐2 microglia
1141. Berberine suppresses osteoclastogenesis and osteolysis in a mouse model
1142. Berberine suppresses proinflammatory responses through AMPK activation in macrophages
1143. Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression
1144. Berberine suppresses Th17 and dendritic cell responses
1145. Berberine suppresses the ectopic expression of miR-133a in endothelial cells to improve vascular dementia in diabetic rats
1146. Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells
1147. Berberine suppresses TNF-α-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells
1148. Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells
1149. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts
1150. Berberine synergy with amphotericin B against disseminated candidiasis in mice
1151. Berberine synthase, the methylenedioxy group forming enzyme inBerberine synthesis
1152. Berberine synthesis by callus and cell suspension cultures of Coscinium fenestratum
1153. Berberine target key enzymes and amino acid inibitiors in AD treatment—–creation from Berberine -based structure screening
1154. Berberine targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and cytochrome-c/caspase signaling to suppress human cancer cell growth
1155. Berberine targets assembly of Escherichia coli cell division protein FtsZ
1156. Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro
1157. Berberine therapy of hypertyraminemia in patients with liver cirrhosis.
1158. Berberine treatment attenuates the palmitate-mediated inhibition of glucose uptake and consumption through increased 1, 2, 3-triacyl-sn-glycerol synthesis and …
1159. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe−/− mice
1160. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5′-adenosine monophosphate-activated protein kinase in type 2 diabetic rats …
1161. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/-mice
1162. Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis
1163. Berberine upregulates hepatic low-density lipoprotein receptor through ras-independent but AMP-activated protein kinase-dependent Raf-1 activation
1164. Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1
1165. Berberine upregulates P-glycoprotein in human Caco-2 cells and in an experimental model of colitis in the rat via activation of Nrf2-dependent mechanisms
1166. Berberine up-regulates the BDNF expression in hippocampus and attenuates corticosterone-induced depressive-like behavior in mice
1167. Berberine Uptake in HepG2 Cells
1168. Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice
1169. Berberine vs. nifedipine in treating essential hypertension
1170. Berberine was neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved
1171. Berberine wastewater treatment test using Fenton oxidation.
1172. Berberine , a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells
1173. Berberine , a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth
1174. Berberine , a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway
1175. Berberine , a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth
1176. Berberine , a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells
1177. Berberine , a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells
1178. Berberine , a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib
1179. Berberine , a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
1180. Berberine , a natural plant product, activates AMPK with beneficial metabolic effects in diabetic and insulin resistant states
1181. Berberine , a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells
1182. Berberine , a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells
1183. Berberine , a natural product, inhibits growth and induces G1 arrest and caspase-3-dependent apoptosis accompanied with loss of mitochondrial membrane potential …
1184. Berberine , a plant alkaloid with lipid-and glucose-lowering properties: from in vitro evidence to clinical studies
1185. Berberine , a potential drug for trachoma.
1186. Berberine , a strong polyriboadenylic acid binding plant alkaloid: spectroscopic, viscometric, and thermodynamic study
1187. Berberine , a Traditional Chinese Medicine, Reduces Inflammation in Adipose Tissue, Polarizes M2 Macrophages, and Increases Energy Expenditure in Mice …
1188. Berberine , an epiphany against cancer
1189. Berberine , an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice
1190. Berberine , an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the …
1191. Berberine , an isoquinoline alkaloid, inhibits streptozotocin-induced apoptosis in mouse pancreatic islets through down-regulating Bax/Bcl-2 gene expression ratio
1192. Berberine , an isoquinoline alkaloid, inhibits the metastatic potential of breast cancer cells via Akt pathway modulation
1193. Berberine , and quina in large doses. Lime juice was also given
1194. Berberine , COPTIDIS RHIZOMA AND DIOSPYRIN AS NOVEL ANTINEOPLASTIC AGENTS: A REVIEW ON TRADITIONAL USE AND BIOMEDICAL …
1195. Berberine , Quercetin and O-Coumaric Acid Phytochemicals Ameliorate the Impact of Experimentally Fed High-Fat/High-Sucrose Diet on Pancreas Β-Cells and …
1196. Berberine /tacrolimus interaction
1197. Berberine /γ‐Cyclodextrin Inclusion Structure Studied by 1H‐NMR Spectroscopy and Molecular‐Dynamics Calculations
1198. Berberine : a fluorescent alkaloid with a variety of applications from medicine to chemistry
1199. Berberine : A multipotent remedy with unknown cellular target?
1200. Berberine : a naturally occurring phototoxic alkaloid
1201. Berberine : A pioneer remedy for various Ailments
1202. Berberine : a plant alkaloid with therapeutic potential for central nervous system disorders
1203. Berberine : A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease
1204. Berberine : A potential adjunct for the treatment of gastrointestinal cancers?
1205. Berberine : a potential multipotent natural product to combat Alzheimer’s disease
1206. Berberine : a potential phytochemical with multispectrum therapeutic activities
1207. Berberine : A Traditional Natural Product With Novel Biological Activities.
1208. Berberine : alkaloid with wide spectrum of pharmacological activities.
1209. Berberine : An Antihypoglycemic Alkaloid
1210. Berberine : an indigenous drug in experimental herpetic uveitis
1211. Berberine : An old drug but new use for liver diseases
1212. Berberine : As a therapeutic target for treating obese diabetes
1213. Berberine : Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders
1214. Berberine : Chemistry and biological activity
1215. Berberine : complex with DNA
1216. Berberine : metabolic and cardiovascular effects in preclinical and clinical trials
1217. Berberine : new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders
1218. Berberine : new perspectives for old remedies
1219. Berberine : Pathways to protect neurons
1220. Berberine : Production Through Plant (Thalictrum spp.) Cell Cultures
1221. Berberine 8998, a new derivative of Berberine , improves hyperlipidemia through additional mechanisms
1222. Berberine -A Neuropsychiatric Pharmacotherapy
1223. Berberine —antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells
1224. Berberine ‑attenuated monocyte adhesion to endothelial cells induced by oxidized low‑density lipoprotein via inhibition of adhesion molecule expression
1225. Berberine -based carbon dots for selective and safe cancer theranostics
1226. Berberine -containing herbs and pregnancy
1227. Berberine –DNA complexation: New insights into the cooperative binding and energetic aspects
1228. Berberine -electrochemical detector for the determination of Berberine -type alkaloids in various Chinese patent medicines by flow injection analysis
1229. Berberine -improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver X receptors, and …
1230. Berberine -incorporated shape memory fiber applied as a novel surgical suture
1231. Berberine -induced activation of 5′-adenosine monophosphate–activated protein kinase and glucose transport in rat skeletal muscles
1232. Berberine -induced activation of AMPK increases hepatic FGF21 expression via NUR77
1233. Berberine -Induced Amelioration of the Pathological Changes in Nutrients Homeostasis During Murine Intestinal Eimeria papillata Infection
1234. Berberine -induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression
1235. Berberine -induced anticancer activities in FaDu head and neck squamous cell carcinoma cells
1236. Berberine -induced apoptosis in human breast cancer cells is mediated by reactive oxygen species generation and mitochondrial-related apoptotic pathway
1237. Berberine -induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and …
1238. Berberine -induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation
1239. Berberine -induced apoptosis in leukemia Molt-4 cell line and expression of NF-κB/p65 and Caspase-3
1240. Berberine ‐induced apoptosis of human leukemia HL‐60 cells is associated with down‐regulation of nucleophosmin/B23 and telomerase activity
1241. Berberine -induced apoptosis via decreasing the survivin protein in K562 cell line
1242. Berberine -induced apoptotic and autophagic death of HepG2 cells requires AMPK activation
1243. Berberine -induced autophagic cell death by elevating GRP78 levels in cancer cells
1244. Berberine -induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts
1245. Berberine -induced changes in protein expression and antioxidant enzymes in melanoma cells
1246. Berberine -induced changes of mitochondria membrane potential and free intracellular calcium of HaCaT cells
1247. Berberine -induced decline in circulating CD31+/CD42− microparticles is associated with improvement of endothelial function in humans
1248. Berberine ‐induced growth inhibition of epithelial ovarian carcinoma cell lines
1249. Berberine ‐induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases
1250. Berberine -induced Inactivation of signal transducer and activator of transcription 5 signaling promotes male-specific expression of a bile acid uptake transporter
1251. Berberine -induced inhibition of adipocyte enhancer-binding protein 1 attenuates oxidized low-density lipoprotein accumulation and foam cell formation in phorbol 12 …
1252. Berberine -induced LDLR up-regulation involves JNK pathway
1253. Berberine -induced mobilization of circulating endothelial progenitor cells improves human small artery elasticity
1254. Berberine -induced morphologic differentiation and down-regulation of c-Ki-ras2 protooncogene expression in human teratocarcinoma cells
1255. Berberine -induced pigment dispersion in Bufo melanostictus melanophores by stimulation of beta-2 adrenergic receptors
1256. Berberine -induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma
1257. Berberine -induced upregulation of circulating endothelial progenitor cells is related to nitric oxide production in healthy subjects
1258. Berberine -INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the Berberine and INF55 components
1259. Berberine –INF55 Hybrid Antimicrobials: Effects of Varying the Relative Orientation of the Berberine and INF55 Components
1260. Berberine -loaded Janus gold mesoporous silica nanocarriers for chemo/radio/photothermal therapy of liver cancer and radiation-induced injury inhibition
1261. Berberine ‐loaded Janus nanocarriers for magnetic field‐enhanced therapy against hepatocellular carcinoma
1262. Berberine -loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice
1263. Berberine -loaded solid proliposomes prepared using solution enhanced dispersion by supercritical CO2: Sustained release and bioavailability enhancement
1264. Berberine -loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study
1265. Berberine -piperazine conjugates as potent influenza neuraminidase blocker
1266. Berberine -Promoted CXCR4 Expression Accelerates Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Persons with Prehypertension
1267. Berberine -sonodynamic therapy induces autophagy and lipid unloading in macrophage
1268. Berberine -stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK
1269. Berberine -targeted miR-21 chemosensitizes oral carcinomas stem cells
1270. Berberis ceylanica Schneider Stems: A Rich Source of Berberine with Antimicrobial Properties
1271. Berberis Vulgaris and Berberine : An Update Review
1272. Berberis vulgaris and its constituent Berberine as antidotes and protective agents against natural or chemical toxicities
1273. Bidirectional regulation of adenosine 5′‐monophosphate–activated protein kinase activity by Berberine and metformin in response to changes in ambient glucose …
1274. Biliverdin/Phycocyanobilin, Glycine, High-Dose Folate, and Metformin/Berberine as Antidotes to Endotoxin
1275. Binding of 9-O-(ω-amino) alkyl ether analogues of the plant alkaloid Berberine to poly (A): Insights into self-structure induction
1276. Binding of alkaloids Berberine , palmatine and coralyne to lysozyme: a combined structural and thermodynamic study
1277. Binding of Berberine to a membrane fraction from Coptis cells
1278. Binding of Berberine to bovine serum albumin: spectroscopic approach
1279. Binding of Berberine to human telomeric quadruplex–spectroscopic, calorimetric and molecular modeling studies
1280. Binding of DNA-binding alkaloids Berberine and palmatine to tRNA and comparison to ethidium: spectroscopic and molecular modeling studies
1281. Binding of isoquinoline alkaloids Berberine , palmatine and coralyne to hemoglobin: structural and thermodynamic characterization studies
1282. Binding of novel 9-O–N-aryl/arylalkyl amino carbonyl methyl Berberine analogs to poly(U)-poly(A)·poly(U) triplex and comparison to the duplex poly(A)-poly(U)
1283. Binding of plant alkaloids Berberine and palmatine to serum albumins: a thermodynamic investigation
1284. Binding of the 9-ON-aryl/arylalkyl amino carbonyl methyl substituted Berberine analogs to tRNAphe
1285. Binding parameters of alkaloids Berberine and sanguinarine with DNA
1286. Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models
1287. Bioactivities of Berberine metabolites after transformation through CYP450 isoenzymes
1288. Bioactivities of Berberine , palmatine, and jatrorrhizine isolated from food allergy herbal formula 2 (FAHF-2)
1289. Bioactivity evaluation of Berberine Sulfate on Microcystis aeruginosa
1290. Bioactivity of Berberine hydrochloride to brevicoryne brassicae (L.)
1291. BIOACTIVITY OF Berberine HYDROCHLORIDE TO BREVICORYNE BRASSICAE (L.)[J]
1292. Bioavailability of Berberine and monacolin after oral administration of a proprietary nutraceutical combination in healthy male volunteers
1293. Bioavailability study of Berberine and the enhancing effects of TPGS on intestinal absorption in rats
1294. Biocatalytic Oxidative C C Bond Formation Catalysed by the Berberine Bridge Enzyme: Optimal Reaction Conditions
1295. Biochemical activities of Berberine , palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores
1296. Biochemical characterisation of Berberine bridge enzyme (BBE), a covalently flavinylated oxidase involved in benzophenanthridine alkaloid biosynthesis
1297. Biochemical effects of Berberine
1298. Biochemical evidence that Berberine bridge enzyme belongs to a novel family of flavoproteins containing a bi-covalently attached FAD cofactor
1299. Biochemical pathways in the antiatherosclerotic effect of Berberine
1300. Bioformulation of silver nanoparticles as Berberine carrier cum anticancer agent against breast cancer
1301. Biogenic gold nanoparticles as fotillas to fire Berberine hydrochloride using folic acid as molecular road map
1302. Bioinformatics Analysis of Berberine Bridge Enzyme in Papaver somniferum L.[J]
1303. Bioinformatics analysis of endophytic bacteria related to Berberine in the Chinese medicinal plant Coptis teeta Wall.
1304. Biological and molecular evaluation of accessions of Coscinium fenestratum Gaertn Colebr in vitro synthesis of Berberine and its antibacterial and cytotoxic evaluation
1305. Biological function of Berberine and its effects on growth and immune functions of broilers.
1306. Biomass and Berberine Content in Mixed Forest of Phellodendron amurense and Cunninghamia lanceolata [J]
1307. Biopharmaceutics classification system of Chinese materia medica of Berberine in Gegen Qinlian decoction
1308. Biophysical characterization of the strong stabilization of the RNA triplex poly (U)• poly (A)* poly (U) by 9-O-(ω-amino) alkyl ether Berberine analogs
1309. Biophysical studies on the effect of the 13 position substitution of the anticancer alkaloid Berberine on its DNA binding
1310. Bioreactor operating strategy inThalictrum rugosum plant cell culture for the production of Berberine
1311. Biosynthesis of a Tricyclo[6.2.2.02,7]dodecane System by a Berberine Bridge Enzyme‐Like Aldolase
1312. BIOSYNTHESIS OF Berberine AND BERBERASTINE INCORPORATION OF CATECHOLAMINES
1313. Biosynthetic Incorporation of One-Carbon Units into Berberine and Hydrastine
1314. Biotechnology; Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes
1315. Biotransformation of tetrahydroBerberine to Berberine by enzymes prepared from cultured Coptis japonica cells
1316. Bitterness intensity prediction of Berberine hydrochloride using an electronic tongue and a GA‑BP neural network
1317. Block of HERG channels by Berberine : mechanisms of voltage-and state-dependence probed with site-directed mutant channels
1318. Blocking action of Berberine on various receptors in rat anococcygeus muscle
1319. Blocking action of Berberine on various receptors in the rat anococoygeus muscle
1320. Blocking action of Berberine on α2- and α1-adrenoceptors in rat vas deferens and anococcygeus muscle
1321. BMD-TLC—the useful technique for quantitative analysis of chelidonine, chelerithrine and Berberine in herbal drugs
1322. Butanol fraction containing Berberine or related compound from Nexrutine® inhibits NFκB signaling and induces apoptosis in prostate cancer cells
1323. C34 INSIGHTS INTO COPD PATHOGENESIS FROM PRE-CLINICAL STUDIES: Berberine Attenuates Airway Inflammation And Mucus Production Induced By …
1324. C60 Fullerene as an Effective Nanoplatform of Alkaloid Berberine Delivery into Leukemic Cells
1325. Calmodulin as a Potential Target by Which Berberine Induces Cell Cycle Arrest in Human Hepatoma B el7402 Cells
1326. Calorimetric study and thermal analysis of Berberine sulphate
1327. Canadine synthase from Thalictrum tuberosum cell cultures catalyses the formation of the methylenedioxy bridge in Berberine synthesis
1328. Cancer cell membrane-modified biodegradable mesoporous silica nanocarriers for Berberine therapy of liver cancer
1329. Capillary Electrophoresis Determination of Berberine in Pharmaceuticals with End‐Column Electrochemiluminescence Detection
1330. Capsaicin and Berberine inhibit the production of TNF-α, IL-1β and nitric oxide on LPS-stimulated mice
1331. Cardiometabolic Efficacy and Mechanisms of Berberine in Experimentally Induced Changes in Diabetes and Metabolic Syndrome Rats
1332. Cardiovascular actions of Berberine
1333. Cardiovascular and metabolic effects of Berberine
1334. Cardiovascular aspects of pharmacology of Berberine : I. α-adrenoceptor blocking action of Berberine in isolated rat anococcygeus muscle and rabbit aortic strip
1335. Cardiovascular Effects Circular Training (Resistance-Interval) Combined with Berberine in Overweight Elderly Men
1336. Cardiovascular effects of Berberine in patients with severe congestive heart failure
1337. Cardiovascular effects of Berberine : a review of the literature
1338. Catalytic and structural role of a conserved active site histidine in Berberine bridge enzyme
1339. Cause Analysis of Low Diversion Rate of Berberine Hydrochloride in Caulis Mahoniae of Xiaojie’an Capsule [J]
1340. CCXIX.—ψ-Berberine
1341. Cell-specific pattern of Berberine pleiotropic effects on different human cell lines
1342. Cellular delivery and enhanced anticancer activity of Berberine complexed with a cationic derivative of γ–cyclodextrin
1343. Cetyltrimethylammonium assay using fluorescence probe Berberine and a competitive host–guest complexation with butylated β-cyclodextrin
1344. Changes in Fingerprint Pattern of Compound Granatum Berberine Capsules before and after Irradiation
1345. Changes of the Physiological and Berberine Content in Phellodendron amurense Seedlings under Drought Stress
1346. Characterisation of the selectivity and binding interactions of Berberine derivatives with G-quadruplex DNA and a DNA/RNA hybrid
1347. Characteristics of the Combination of Hesperidin-Berberine , and Hesperidin-synephrine on Myosin Activities [J]
1348. Characterization and assessment of antifungal activity of chemically modified Berberine
1349. Characterization and mechanism of the Berberine bridge enzyme, a covalently flavinylated oxidase of benzophenanthridine alkaloid biosynthesis in plants
1350. Characterization of bacterial communities in hybrid upflow anaerobic sludge blanket (UASB)–membrane bioreactor (MBR) process for Berberine antibiotic wastewater treatment
1351. Characterization of Berberine transport into Coptis japonica cells and the involvement of ABC protein
1352. CHARACTERIZATION OF CdS-TiO_2 COMPOSITE PHOTOCATALYST AND PHOTOCATALYTIC ACTIVITY FOR Berberine UNDER VISIBLE LIGHT [J]
1353. Characterization of encapsulated Berberine in yeast cells of Saccharomyces cerevisiae
1354. Characterization of the promoter region of biosynthetic enzyme genes involved in Berberine biosynthesis in Coptis japonica
1355. Characterization of the transient species generated by the photoionization of Berberine : A laser flash photolysis study
1356. Characterization of the transportation of Berberine in Coptidis rhizoma extract through rat primary cultured cortical neurons
1357. Characterization of tinospora cordifolia willd miers germplasm using molecular marker and Berberine content
1358. Characterization of vacuolar transport of the endogenous alkaloid Berberine in Coptis japonica
1359. Characterization, pharmacokinetics, and hypoglycemic effect of Berberine loaded solid lipid nanoparticles
1360. Chemical Transformation of ProtoBerberine s. III. Convenient Synthesis of 8-MethoxyBerberine phenolbetaine by Photooxygenation of Berberine . A Novel Conversion of Berberine into (±)-Ophiocarpine, (±)-Epiophiocarpine, (±)-α-Hydrastine, and (±)-β-Hydrastine
1361. Chemical Transformation of ProtoBerberine s. IV. A Novel, Simple Synthesis of (±)-Canadaline and a Retroproto-Berberine from TetrahydroBerberine
1362. Chemical transformation of protoBerberine s. Part 9. A biomimetic synthesis of oxychelerythrine, dihydrochelerythrine, and chelerythrine from Berberine
1363. Chemical Transformation of ProtoBerberine s. VI. Ring D Inversion of ProtoBerberine Alkaloids. Conversion of Berberine into Non-naturally Occurring 11, 12 …
1364. Chemical transformation of protoBerberine s. VI. Ring D inversion of protoBerberine alkaloids. Conversion of Berberine into non-naturally occurring 11, 12-oxygenated …
1365. Chemiluminescence flow sensor for Berberine with immobilized reagents
1366. Chemiluminescence recognition of Berberine triggered by biomimetically synthesized silver nanoparticles
1367. Chemopreventive effects of Berberine on intestinal tumor development in Apc min/+ mice
1368. Chemopreventive efficacy of Berberine in 7, 12-dimethylbenz [a] anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice
1369. Chitosan hydrogel as a base for transdermal delivery of Berberine and its evaluation in rat skin
1370. Chitosan sponge matrices with β-cyclodextrin for Berberine loadinging
1371. Chitosan-coated nano-liposomes for the oral delivery of Berberine hydrochloride
1372. Chronic administration of Berberine inhibits Aβ production, plaque formation, gliosis and cognitive deterioration in a transgenic mouse model of alzheimer’s
1373. Chronic effects of Berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats
1374. Chronic infusion of Berberine into the hypothalamic paraventricular nucleus attenuates hypertension and sympathoexcitation via the ROS/Erk1/2/iNOS pathway
1375. Circadian Pharmacological Effects of Berberine on Chronic Colitis in Mice: Role of the Clock Component Rev-erbα
1376. Circular dichroism studies of the structure of DNA complex with Berberine
1377. CL.—The constitution of Berberine
1378. Claudin-1-and-2-based cytokine-induced paracellular barrier impairment: prevention by the plant alkaloide, Berberine
1379. Clinic and pharmacological effect of Berberine on cardiovascular system [J]
1380. Clinic observation of Metronidazole and Berberine clyster therapy for chronic colitis 26 cases [J]
1381. CLINICAL ACTIVITY OF ISOFLAVONES+ Berberine IN MENOPAUSAL PATIENTS WITH BORDERLINE DYSLIPIDAEMIA: PREVENTION IN THE MENOPAUSE.
1382. Clinical Application of Berberine in the Treatment of Diabetes
1383. Clinical Curative Effect of all kinds of Arrhythmia Treated with the Combination of Berberine Hydrochtoride. Oryzanol and Coenzyme Q_10
1384. Clinical Curative effect of Compound Berberine Hydrochloride Soluble Power on Colibacillosis of Chickling [J]
1385. Clinical Effects of Sucralfate and Berberine in Treating 94 Cases of Chronic Refractory Gastritis
1386. Clinical evidence of efficacy of red yeast rice and Berberine in a large controlled study versus diet
1387. Clinical observation about wash and drainage of deep abscess by Berberine [J]
1388. Clinical Observation of Adjuvant Therapy of Berberine on Type 2 Diabetes plus Peptic Ulcer with HP Infection [J]
1389. Clinical Observation of Berberine Combined With Nitrendipine on Essential Hypertension and Cardia Insufficiency
1390. Clinical Observation of Berberine in Intervening Insulin Resistance of Polycystic Ovary Syndrome
1391. Clinical Observation of Berberine in Treatment of Non-Gonococcal Urethritis and Cervicitis Due to Chlamydia Trachomatis
1392. Clinical observation on Berberine treating non-alcoholic fatty liver disease.
1393. Clinical Observation on Compound Berberine in Treatment of Irritable Bowel Syndrome
1394. Clinical observation on the therapeutic effect of Berberine in thetreatment of type 2 diabetes [J]
1395. Clinical Observation on the Therapeutic Effect of Berberine plus Ciprofloxacin Hydrochloride on Bedsore
1396. Clinical observe of effect of regulating hyperlipidemia and weight reduction by Berberine and oryzanol [J]
1397. Clinical pharmacokinetics and metabolism of Berberine and hydrastine following an oral dose of goldenseal supplement
1398. Clinical Research on Combining Berberine and Bifico of Diarrhea in Patients after Esophageal Cancer Surgery
1399. Clinical Research on the Changes in Activation, Release and Ultrastructure of Platelet and the Protective Function of Berberine on Platelet During Cardiopulmonary …
1400. Clinical study on Berberine , amoxicillin, lansoprazole, bismuth quadruple therapy for Helicobacter pylori eradication in 283 patients
1401. Clinical study on improvement of typeⅡdiabetes mellitus complicated with fatty liver treated by Berberine
1402. Clinical Study: Berberine Treats the Insulin Resistance in Patients with Polycystic Ovarian Syndrome (PCOS)
1403. Clinical trial of Berberine in acute watery diarrhoea
1404. Clinical trial of Berberine in acute watery diarrhoea.
1405. Clinical trial of high-dose Berberine and tetracycline in cholera
1406. Cloning, expression and immunological characterization of full‐length timothy grass pollen allergen Phl p 4, a Berberine bridge enzyme‐like protein with homology to …
1407. CLVIII.—The constitution of sinactine (1-tetrahydro epi Berberine )
1408. Co-administration of Berberine and plant stanols synergistically reduces plasma cholesterol in rats
1409. Co-Existent Biphasic Region of Nematic and Columnar Smectic Phases in Binary Mixture of Berberine and Alizarin Dye
1410. CO-EXTRACTION-SPECTROPHOTOMETRIC DETERMINATION OF Berberine WITH QUININE AND BROMOPHENOL BLUE
1411. Cognitive impairments induced by severe acute pancreatitis are attenuated by Berberine treatment in rats
1412. Combating drug resistance-Comparison of the antibiotic effect of Hydrastis canadensis extract and pure Berberine via Minimum Inhibitory Concentration assay
1413. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine : Molecular Mechanisms and Therapeutic Potential
1414. Combination of Berberine and ciprofloxacin reduces multi-resistant Salmonella strain biofilm formation by depressing mRNA expressions of luxS, rpoE, and …
1415. Combination of Berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats
1416. Combination of Berberine and Plant Stanols Significantly Reduce Plasma Cholesterol and Triacylglyceride Concentrations in Golden Syrian Hamsters
1417. Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy
1418. Combination of simvastatin with Berberine improves the lipid-lowering efficacy
1419. Combination of upflow anaerobic sludge blanket (UASB) and membrane bioreactor (MBR) for Berberine reduction from wastewater and the effects of Berberine on bacterial community dynamics
1420. Combination Therapy of Amlodipine with Berberine for Hypertensive with Arthrolithiasis [J]
1421. Combination treatment of Berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured …
1422. Combined analytical approaches to define biodistribution and biological activity of semi-synthetic berberrubine, the active metabolite of natural Berberine
1423. Combined use of astragalus polysaccharide and Berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway
1424. Combining effects of probiotics, oligosaccharides and Berberine on production performance of pigs
1425. Combining effects of probiotics, oligosaccharides and Berberine on production performance of pigs.
1426. Comment on “Berberine and its emerging benefits in psychiatric conditions especially Alzheimer’s disease”
1427. Comparation of the Berberine Content in the Roots of Thalictrum from Gansu
1428. Comparative effect of Berberine and its derivative 8-cetylBerberine on attenuating atherosclerosis in ApoE−/− mice
1429. Comparative inhibitory effects of sanhuang, Berberine and gentamicin against E. coli
1430. Comparative pharmacokinetics and safety assessment of transdermal Berberine and dihydroBerberine
1431. Comparative pharmacokinetics of Berberine after oral administration of pure Berberine , coptidis rhizoma extract, and decoctions of two different complex herbal …
1432. Comparative pharmacokinetics of Berberine and salvianolic acid B in single herb and traditional herbal medicine
1433. Comparative pharmacokinetics of Berberine , palmatine and jatrorrhizine in rat plasma after oral administration of Rhizoma coptidis and Zuojinwan using liquid …
1434. Comparative pharmacokinetics of puerarin, daidzin, baicalin, glycyrrhizic acid, liquiritin, Berberine , palmatine and jateorhizine by liquid chromatography–mass …
1435. Comparative studies on concentration of Berberine in plasma after oral administration of coptidis rhizoma extract, its cultured cells extract, and combined use of these …
1436. Comparative study of Berberine in various organs of three kinds of Berberis in different areas of Qinghai province.
1437. Comparative study of Berberis vulgaris fruit extract and Berberine chloride effects on acetic acid-induced colitis in rats
1438. Comparative study of pharmacokinetics and tissue distribution of 8-cetylBerberine and Berberine in rats
1439. Comparative study of single/combination use of Huang-Lian-Jie-Du decoction and Berberine on their protection on sepsis induced acute liver injury by NMR metabolic …
1440. Comparative study of transport character of jatrorrhizine, coptisine, palmatine and Berberine in Zuojin Wan and its similar formulae in Caco-2 cells
1441. Comparative study on purification of Berberine in rhizoma of Coptis chinensis Franch by different ways
1442. Comparative study on the ACTH-releasing activities of Berberine , palmatine and tetrahydropalmatine (Corydalis B) in the rat
1443. Comparative study on the antimicrobial activity of Berberis aristata from different regions and Berberine in vitro
1444. Comparative Study on the Dissolution Character between Berberine and 8-hydroxy DihydroBerberine
1445. Comparative study on the effects of huanglianjiedu decoction and Berberine on glucose and lipid metabolisms in type 2 diabetic rats
1446. Comparative study on the treatment of Berberine wastewater by chemical-and electro-coagulation processes: zeta potential analysis
1447. Comparing effects of Berberine on the growth and photosynthetic activities of Microcystis aeruginosa and Chlorella pyrenoidosa
1448. Comparision of Dissolution Rates of Berberine Hydrochloride in Sanhuang Tablets Produced by Different Factories
1449. Comparison of anti-inflammatory effects of Berberine , and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo
1450. Comparison of Antimicrobial Effect of Berberine as an Endodontic Irrigant with that of Other Common Root Canal Irrigants on Three Microorganisms Involved in …
1451. Comparison of Antimicrobial Potency between Berberine Hydrochloride and Drug Material Coptis Chinensis on Staphyloccocus Aureus by Cup-Plate Method [J]
1452. Comparison of Berberine Hydrochloride Content in Single Medicine Decoction and Mixed Medicine Decoction of Sanhuangxiexin Decoction [J]
1453. Comparison of Berberine hydrochloride, palmtine hydrochloride and jatrorrhizinehydrochloride in dispensing granule of Coptis produced by different factories [J]
1454. Comparison of Changes of Content of Berberine Hydrochloride and Yield of Dry Extract from Pieces and Powder of Phellodendri chinense in Different Boiling Time [J]
1455. Comparison of Content of Berberine Hydrochloride in Dispensing Granules and Slice Decoctions of Rhizoma Coptidis and Cortex Phellodendri [J]
1456. Comparison of Contents of Berberine Hydrochloride, Jatrorrhizine Hydrochloride and Palmatine Hydrochloride in Phellodendri Chinensis Cortex of Different Extract by …
1457. Comparison of Contents of Kakonein, Baicalin and Berberine Hydrochloride by HPLC in Gegen Qinlian Decoctions with Different Compatibility [J]
1458. Comparison of extraction rate of Berberine with ultrasonic extraction and alkaline immersion method
1459. Comparison of Helicobacter pylori urease inhibition by Rhizoma Coptidis, cortex phellodendri and Berberine : mechanisms of interaction with the sulfhydryl group
1460. Comparison of the antidiabetic activity of Berberis lyceum root extract and Berberine in alloxan‐induced diabetic rats
1461. Comparison of the contents of Berberine and baicalin in three preparation methods for San huang Xiexin decoction.
1462. Comparison of the Contents of Berberine Hydrochloride in Traditional Decoctions vs. TCM Formula Granules of Lianpu Drink
1463. Comparison of the Contents of Ferulic Acid, Berberine , Baicalin in Single Medicine Decoction and Mixed Medicine Decoction of Dangguiliuhang Decoction [J]
1464. Comparison of Three Traditional Methods to Extract Berberine from Coptis chinensis in Laboratory
1465. Comparison of total alkaloids from Coptis Root and Berberine for ulcerative colitis treatment [J]
1466. Comparison on the Content of Berberine between Granule and Traditional Decoction of Traditional Chinese Medicine of TangKuei Six Yellow Decoction
1467. Comparison on the dissolution rate of Berberine between granule and traditional decoction of traditional Chinese medicine of Jiaotai pill [J]
1468. Competition of Berberine with pyridoxal phosphate in the tryptophanase system of Escherichia coli
1469. Competitive supramolecular interaction of carbachol and Berberine with cucurbit [7] uril and its analytical application
1470. Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by Berberine using gas-chromatography combined with polymerase chain reaction
1471. Comprehensive study in the inhibitory effect of Berberine on gene transcription, including TATA box
1472. Computational and experimental prediction of molecules involved in the anti-melanoma action of Berberine
1473. Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in Berberine -treated HepG2 cells
1474. Conformation-activity studies on the interaction of Berberine with acetylcholinesterase: Physical chemistry approach
1475. Conformational aspects of poly (dI-dC). poly (dI-dC) and poly (dG-dC). poly (dG-dC) on binding of the alkaloid, Berberine chloride.
1476. Conjugating Berberine to a multidrug resistance pump inhibitor creates an effective antimicrobial
1477. Considerable fluorescence enhancement upon supramolecular complex formation between Berberine and p-sulfonated calixarenes
1478. Construction and expression of a single-chain Fv fragment against Berberine in Escherichia coli
1479. Content and Dissolution Determination of Berberine Hydrochloride in Fengshi Qutong Capsule by HPLC
1480. Content comparison of Berberine hydrochloride in ultramicro and conventional Wuji Pills
1481. Content Determinate of Berberine Hydrochloride in Sifangwei Capsules by HPLC
1482. Content determination of Berberine hydrochloride and palmatine hydrochloride in Haemorrhoid Lotion by HPLC.
1483. Content Determination of Berberine Hydrochloride in Bai Qing Gel by HPLC
1484. Content Determination of Berberine Hydrochloride in Biantong Pills by RP-HPLC
1485. Content Determination of Berberine Hydrochloride in Canghuang Tablet by High Performance Liquid Chromatography
1486. Content determination of Berberine hydrochloride in Chunyu Burn Ointment by HPLC [J]
1487. Content determination of Berberine hydrochloride in coptis chinensis franch by RP-HPLC with the quantification of Triethylamine
1488. Content determination of Berberine Hydrochloride in Duodongning Capsules by HPLC [J]
1489. Content determination of Berberine hydrochloride in Fuke Zhidai tablets by HPLC
1490. Content Determination of Berberine Hydrochloride in Huanglian Shangqing Water Pills by HPLC [J]
1491. Content Determination of Berberine Hydrochloride in Jiawei Xianglian Water Pills by HPLC [J]
1492. Content Determination of Berberine Hydrochloride in Kangfu Films by HPLC [J]
1493. Content Determination of Berberine Hydrochloride in Lianzhen Pill by HPLC [J]
1494. Content determination of Berberine hydrochloride in Li’ermian Tablets by HPLC
1495. Content Determination of Berberine Hydrochloride in Prossing Calamina by Sanhuang Tang [J]
1496. Content Determination of Berberine Hydrochloride in Qianlietong Soft Capsules by High Performance Liquid Chromatography
1497. Content Determination of Berberine Hydrochloride in Qingrejiedu Granule by HPLC
1498. Content determination of Berberine Hydrochloride in Shirebi Granules by HPLC [J]
1499. Content Determination of Berberine Hydrochloride in Sifangwei Capsule
1500. Content determination of Berberine hydrochloride in Wubaishen Cleaning Solution by HPLC
1501. Content Determination of Berberine in Compound Sophorae Raidix Lotion
1502. Content Determination of Berberine in Double Yellow Antiinflammatory Tablets
1503. Content Determination of Berberine in Fujie Lotion by RP-HPLC
1504. Content determination of Berberine in Huangju Detoxication Tablets.
1505. Content Determination of Berberine in Lomatogonium rotatum Soup-4 by HPLC [J]
1506. Content Determination of Berberine in Rhizoma Coptidis and Zuojin Pills by Macroporous Adsorptive Resin-RP-HPLC [J]
1507. Content determination of Berberine in Yiqing soft capsule by HPCE
1508. Content Determination of Oryzanol and Berberine in Sanhe Pingzhi Capsules by Microemulsion Liquid Chromatography [J]
1509. Contents determination of Berberine , palmatine and jatrorrhizine of Phellodendren amurense bark by HPLC
1510. Contractile effect of Berberine on isolated antral smooth muscle-cells in rat stomach
1511. Contribution to the study on quantitation dosage of Berberine hydrochloride by potentio-titration method in dry medium
1512. Control Effectiveness of 95% Berberine on Two Pepper Anthracnose Fungi [J]
1513. Controlled release of Berberine hydrochloride from alginate microspheres embedded within carboxymethyl chitosan hydrogels
1514. Controlling effect of Berberine on in vitro synthesis and metabolism of steroid hormones in insulin resistant ovary
1515. Conversion of Berberine into berberrubine by selective demethylation under microwave irradiation
1516. Conversion of Berberine into phthalideisoquinolines
1517. Conversion of Hydrastine into Berberine , and an Instance of the Asymmetrical Quaternization of a Tertiary Base
1518. Coptis rhizome and Phellodendron bark extracts and Berberine inhibit the development of mouse embryos
1519. Coptis: In Vitro Regeneration of Plants and the Production of Berberine
1520. Correction: A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered Berberine
1521. Correction: Berberine attenuates axonal transport impairment and axonopathy induced by calyculin a in N2a cells
1522. Correction: Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models
1523. Correction: Berberine -targeted miR-21 chemosensitizes oral carcinomas stem cells
1524. Correction: Design, synthesis and anti-inflammatory effects of novel 9-O-substituted-Berberine derivatives electronic supplementary information
1525. Correlation between antitumor activity of Berberine and the inhibition of Wnt/?-catenin signal pathway
1526. Correlation between the amelioration of insulin resistance and protein expression of PI-3K and GLUT4 in type 2 diabetic rats treated with Berberine
1527. Corrigendum to” Activation of AMPK by Berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice”[Toxicol. Appl. Pharmacol …
1528. Corrigendum to” Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice”[Biomed. Pharmacother. 118 (2019) 109206].
1529. Corrigendum: Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
1530. Cortex Phellodendron (huang bai) but not its major ingredient Berberine blocks anaphylactic reactions in a murine model of peanut allergy
1531. COX-2 and survivin reduction may play a role in Berberine -induced apoptosis in human ductal breast epithelial tumor cell line
1532. CPU86017, a Berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting …
1533. Croatian barberry (Berberis croatica Horvat): a new source of Berberine —analysis and antimicrobial activity
1534. Cryptic stereochemistry of Berberine alkaloid biosynthesis
1535. Curing Elderly Person’s Chronic Bacterial Dysentery with Transnormal Dosages of Berberine Associated with TMP
1536. Current knowledge and pharmacological profile of Berberine : an update
1537. Cyclizing-Berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127)
1538. CYP2D plays a major role in Berberine metabolism in liver of mice and humans
1539. CYP450 enzyme inhibition of Berberine in pooled human liver microsomes by cocktail probe drugs
1540. Cytological effects of Berberine sulphate onChironomus salivary gland nuclei
1541. Cytotoxic and Proapoptotic Activity of Sanguinarine, Berberine , and Extracts of Chelidonium majus L. and Berberis thunbergii DC. toward Hematopoietic Cancer Cell …
1542. Cytotoxic Benzophenanthridine and Berberine Alkaloids from Argemone mexicana
1543. Cytotoxic Effect of Coscinium Fenestratrum (Gaertn.) Colebr. and its Active Principle Berberine on L929 Cells
1544. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (Berberine , coptisine and icariin) on hepatoma and leukaemia …
1545. Cytotoxicity enhancement in MDA-MB-231 cells by the combination treatment of tetrahydropalmatine and Berberine derived from Corydalis yanhusuo WT …
1546. Cytotoxicity evaluation of natural coptisine and synthesis of coptisine from Berberine
1547. Cytotoxicity of Berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction
1548. Cytotoxicity of the natural herbicidal chemical, Berberine , on Nicotiana tabacum Bright yellow-2 cells
1549. Cytotoxicity testing of a polyurethane nanofiber membrane modified with chitosan/β-cyclodextrin/Berberine suitable for wound dressing application: evaluation of …
1550. D and BP. Antibacterial Activity of Berberine against Methicillin-Resistant Staphylococcus Aureus Planktonic and Biofilm Cells
1551. Deciphering the positional impact of chlorine in new series of Berberine analogues towards superb-selective “turn-on” hydrophobic signaling of bovine serum albumin …
1552. Decrease in the production of beta-amyloid by Berberine inhibition of the expression of beta-secretase in HEK293 cells
1553. Decreased Levels of Spleen Tissue CD4+ CD25+ Foxp3+ Regulatory T Lymphocytes in Mice Exposed to Berberine
1554. Degradation of Berberine in Fe (Ⅲ)-fumarate system under ultraviolet radiation
1555. Degradation of MDM2 by the interaction between Berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells
1556. Degradative study in the Berberine series—I
1557. Delivery of Berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier
1558. Delivery system for Berberine chloride based on the nanocarrier ZnAl-layered double hydroxide: physicochemical characterization, release behavior and evaluation of …
1559. Dendrimer encapsulated and conjugated delivery of Berberine : A novel approach mitigating toxicity and improving in vivo pharmacokinetics
1560. Dendritic effect of ligand-coated nanoparticles: enhanced apoptotic activity of silica− Berberine nanoconjugates
1561. Dentin Matrix Metalloprotease Inhibition by Berberine
1562. Derivatives of the cationic plant alkaloids Berberine and palmatine amplify protonophorous activity of fatty acids in model membranes and mitochondria
1563. Derivatization of Berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans
1564. Design and Evalution of Liposomal Formulation for Topical Delivery of Curcumin and Berberine
1565. Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery
1566. Design and Synthesis of a Berberine Dimer: A Fluorescent Ligand with High Affinity towards G‐Quadruplexes
1567. Design of experiments for the optimization and statistical analysis of Berberine finishing of polyamide substrates
1568. Design, synthesis and anti-inflammatory effects of novel 9-O-substituted-Berberine derivatives
1569. Design, synthesis and biological evaluation of a hybrid compound of Berberine and magnolol for improvement of glucose and lipid metabolism
1570. Design, synthesis, and anticancer activity of novel Berberine derivatives prepared via CuAAC “click” chemistry as potential anticancer agents
1571. Design-of-experiment approach for the development and validation of a high-performance thin-layer chromatography method for the simultaneous estimation of Berberine chloride and galangin in Tinospora cordifolia M. and Alpinia galanga L. and their herbal formulations
1572. Detection of antibacterial activity of Berberine hydrochloride by multiwalled carbon nanotubes
1573. Detection of Berberine Hydrochloride in Jin Weng Zhili Particle Using TLC and HPLC.
1574. DETECTION OF Berberine , HYDRASTINE AND OXYACANTHINE.
1575. Detection of DNA in agarose gels using Berberine and mordant yellow 3R
1576. Determinatin of Berberine hydrochloride in Mongolia Medicine Huchun Pill by HPLC
1577. Determination and correlation of the solubility for Berberine chloride in pure imidazolium-based ionic liquids
1578. Determination and preliminary studies of metabolism of Berberine in human urine after oral administration
1579. Determination Berberine in Coptis Chinensis Franch by High Performance Liquid Chromatography-tandem Mass Spectrometry [J]
1580. Determination for Berberine in Huanglian Jiedu Decoction by HPLC [J]
1581. Determination of (+)-catechin and (-)-epicatechin and Berberine hydrochloride in Wangying Capsule by RP-HPLC
1582. Determination of Aesculin and Berberine Hydrochloride in Enema of Pulsatillae Decoction by HPLC [J]
1583. Determination of Baicalin and Berberine Hydrochloride in Angong Niuhuang Capsules by HPLC
1584. Determination of baicalin and Berberine hydrochloride in Xiaoyanshuan by HPLC.
1585. Determination of Baicalin and Berberine Hydrochloride in Yigan Jiedu Capsules by HPLC [J]
1586. Determination of baicalin and Berberine in Ganmao Yixiaoshi Capsule by HPLC [J]
1587. Determination of Baicalin and Berberine in Lianmeiyin preparation
1588. Determination of Baicalin, Berberine Hydrochloride, Prim-o-glucosylcimifugin and Liquiritin in Mingmu Jili Pill by HPLC at the Same Time
1589. Determination of baicalin, rhein and Berberine in Yiqing Capsule by HPLC
1590. Determination of Berberine and berberrubine in rabbit plasma by capillary electrophoresis with amperometric detection and its application to pharmacokinetic study
1591. Determination of Berberine and palmatine in Cortex phellodendron and Chinese patent medicines by HPLC
1592. Determination of Berberine and palmatine in Phellodendri Cortex using ion-pair supercritical fluid chromatography on-line coupled with ion-pair supercritical fluid …
1593. Determination of Berberine and phellodendrine in Cortex Phellodendri by HPLC
1594. Determination of Berberine and Phellodendrine in Cortex Phellodendri of Enshi by HPLC
1595. Determination of Berberine and Scutellarin in Yankening Tablets by RP-HPLC [J]
1596. Determination of Berberine and strychnine in medicinal plants and herbal preparations by pressurized liquid extraction with capillary zone electrophoresis
1597. Determination of Berberine and the study of fluorescence quenching mechanism between Berberine and enzyme-catalyzed product
1598. Determination of Berberine and trimethoprim in compound Berberine in-jection by HPLC [J]
1599. Determination of Berberine by Its Polarographic Catalytic Wave [J]
1600. Determination of Berberine by measuring the enhanced total internal reflected fluorescence at water/tetrachloromethane interface in the presence of sodium dodecyl …
1601. Determination of Berberine by RP-HPLC-FLDC [J]
1602. Determination of Berberine bydrochloride in sanbuan tablets by selective electrode method
1603. Determination of Berberine chloride in mouse plasma after intragastric administration of Lianxiang microemulsion
1604. Determination of Berberine content in the stem extracts of Coscinium fenestratum by TLC densitometry
1605. Determination of Berberine from Daochi pills by HPCE and HPLC
1606. Determination of Berberine hydrochlodride in Rupi Anxiao Granules by HPLC
1607. Determination of Berberine hydrochlodride in Rupi’anxiao soft capsule by HPLC
1608. Determination of Berberine hydrochlorde in Shirebi Tablets by HPLC [J]
1609. Determination of Berberine hydrochlorid in Kangli ointment by TLC-scanning
1610. Determination of Berberine hydrochloride and ammonium glycyrrhizinate in ganhuan zaoshi lotion by HPLC
1611. Determination of Berberine hydrochloride and baicalin in Compound Kushen Lotions by HPLC [J]
1612. Determination of Berberine Hydrochloride and Baicalin in Qingxinling Pellets by HPLC [J]
1613. Determination of Berberine hydrochloride and baicalin in the Gegen Qinlian mini-pill by second order derivative spectrophotometry [J]
1614. Determination of Berberine hydrochloride and Baicalin in Wefushu Capsules by HPLC [J]
1615. Determination of Berberine Hydrochloride and Baicalin in Yankening Tablet by HPLC [J]
1616. Determination of Berberine hydrochloride and Baicalin in Yiqing Granules by HPLC [J]
1617. Determination of Berberine Hydrochloride and Chlorogenic Acid in Zhizi Jinhuawan by Capillary Electrophoresis [J]
1618. Determination of Berberine Hydrochloride and Curcumine in Shangke Dieda Paste by HPLC
1619. Determination of Berberine hydrochloride and gallic acid in Suxiao Zhixie capsules by HPLC [J]
1620. Determination of Berberine hydrochloride and jatrorrhizine hydrochlo ride in different parts of Cortex Phellodendri Chinensis by HPLC
1621. Determination of Berberine Hydrochloride and Palmatine Hydrochloride in Coptis omeiensis and Coptis deltoidea
1622. Determination of Berberine hydrochloride and palmatine hydrochloride in different processing products of phellodendri amurensis cortex
1623. Determination of Berberine Hydrochloride and Phellodendrine in Lishukang Capsules by HPLC
1624. Determination of Berberine hydrochloride and total alkaloids in compound Er-xian decoction
1625. Determination of Berberine Hydrochloride and Total Alkaloids in Thalictrum [J]
1626. Determination of Berberine hydrochloride based on the interaction of perfluorooctanesulfonate with Berberine hydrochlo-ride by the resonance light scattering method.
1627. Determination of Berberine Hydrochloride by Fluorescent Spectrometry with Sodium Dodecyl Sulfate as Sensitizer
1628. Determination of Berberine hydrochloride by light-emitting diode induced fluorescence microplate analyzer with surfactant sensitization
1629. Determination of Berberine hydrochloride content in Phellodendri Chinensis Cortex decoction of different comminution degree by HPLC
1630. Determination of Berberine Hydrochloride Content in Qingwen Baidu Granule by HPLC
1631. Determination of Berberine hydrochloride contents in its tablets by HPLC
1632. Determination of Berberine hydrochloride contents of RU AN membrane by HPLC
1633. Determination of Berberine hydrochloride contents of RU AN membrane with thin layer scanning
1634. Determination of Berberine hydrochloride from Cortex Phellodendri in Sichuan and its genuineness
1635. Determination of Berberine Hydrochloride in Berberine Prickly-heat Powder by UV Spectrophotometry [J]
1636. Determination of Berberine Hydrochloride in Berberis Nummularia Bge. By HPLC [J]
1637. Determination of Berberine hydrochloride in Changershu Capsules by RP-HPLC
1638. Determination of Berberine Hydrochloride in Changkang Tablets by HPLC
1639. Determination of Berberine hydrochloride in Changshuling Capsules by HPLC [J]
1640. Determination of Berberine hydrochloride in changyan enema by UV spectrophotometry [J]
1641. Determination of Berberine Hydrochloride in Child Changweikang Granules by HPLC
1642. Determination of Berberine Hydrochloride in Ciprofloxacin Hydrochloride and Berberine Hydrochloride Premix by UV Spectrophotometry [J]
1643. Determination of Berberine hydrochloride in compound huang lian granules by TLCS [J]
1644. Determination of Berberine Hydrochloride in Compound Huangsong Lotion by HPLC
1645. Determination of Berberine Hydrochloride in Compound Jinhuang Hemorrhoids Ointment by RP-HPLC [J]
1646. Determination of Berberine Hydrochloride in Compound Kushenzi Lotion by HPLC
1647. Determination of Berberine hydrochloride in compound mingmu soap by HPLC
1648. Determination of Berberine Hydrochloride in Compound Zinc Sulfate Eye Drops by HPLC
1649. Determination of Berberine hydrochloride in Coptis deltoidea CY Cheng et Hsiao in Sichuan by HPLC
1650. Determination of Berberine hydrochloride in Cortex Phellodendri Chinensis with direct potential method based on molecularly imprinted polymers
1651. Determination of Berberine Hydrochloride in Danwei Capsules by HPLC
1652. Determination of Berberine hydrochloride in Diyu Pills by HPLC
1653. Determination of Berberine Hydrochloride in Duxiekang Granules by HPLC [J]
1654. Determination of Berberine hydrochloride in Erlongtongqiao Pills by RP-HPLC
1655. Determination of Berberine Hydrochloride in Ermiao Wan by HPLC [J]
1656. Determination of Berberine Hydrochloride in Fat-Soluble Qianlie’an Suppositories by HPLC
1657. Determination of Berberine Hydrochloride in Fluorescent Spectrophotometry
1658. Determination of Berberine Hydrochloride in Fukang Xiji by TLCF [J]
1659. Determination of Berberine Hydrochloride in Fulexiaoyan Wan by HPLC [J]
1660. Determination of Berberine Hydrochloride in Fuyanpin Paoteng Pian by HPLC [J]
1661. Determination of Berberine hydrochloride in fuyanpin powder by HPLC
1662. Determination of Berberine Hydrochloride in Fuyanping Effervescent Tablets Using Reversed-Phase High Performance Liquid Chromatography
1663. Determination of Berberine Hydrochloride in Gandouling Tablets by TLC-scanning
1664. Determination of Berberine hydrochloride in Gangtai suppositories by HPLC [J]
1665. Determination of Berberine Hydrochloride in Ge Gen Qin Lian Capsules By RP-HPLC
1666. Determination of Berberine Hydrochloride in Gegen Qinlian Tablets by HPLC
1667. Determination of Berberine Hydrochloride in Gegen Qinlian Tablets by RP-HPLC [J]
1668. Determination of Berberine Hydrochloride in Gengnian ningxin tablets by HPLC
1669. Determination of Berberine hydrochloride in Habudari-16 pill by HPLC
1670. Determination of Berberine hydrochloride in Huangbai capsules by HPLC
1671. Determination of Berberine Hydrochloride in Huangbaidiy (?) Capsules by HPLC [J]
1672. Determination of Berberine hydrochloride in huangbo qingye oral solution by high performance liquid chromatography.
1673. Determination of Berberine Hydrochloride in Huanglian Jiangtang Pill by HPLC
1674. Determination of Berberine hydrochloride in Huanglian Shangqing pills by HPLC
1675. Determination of Berberine Hydrochloride in Huanglian Shangqing Tablets by RP-HPLC [J]
1676. Determination of Berberine hydrochloride in Huanglian Zhixie Pills by HPLC [J]
1677. Determination of Berberine hydrochloride in Huanglianshangqing Tablets by HPLC
1678. Determination of Berberine hydrochloride in Huanglianshangqing Tablets by HPLC [J]
1679. Determination of Berberine Hydrochloride in Huangzhulishi Granules by HPLC [J]
1680. Determination of Berberine Hydrochloride in Huashe Jieyang Tablets by HPLC [J]
1681. Determination of Berberine Hydrochloride in Jianglianzhixie Tablets by HPLC [J]
1682. Determination of Berberine hydrochloride in Jianpi Zengshi Pill by HPLC
1683. Determination of Berberine hydrochloride in Jiaotongxinshen capsules by HPLC
1684. Determination of Berberine hydrochloride in Jieyinjing suppositories by HPLC [J]
1685. Determination of Berberine Hydrochloride in Jieze Lotion by HPLC [J]
1686. Determination of Berberine Hydrochloride in Jin Ji Capsule by RP-HPLC [J]
1687. Determination of Berberine Hydrochloride in Jinhuaxiaocuo Pills by HPLC
1688. Determination of Berberine hydrochloride in JinYuan Capsules by HPLC
1689. Determination of Berberine hydrochloride in Kangfuling dropping pills by HPLC [J]
1690. Determination of Berberine Hydrochloride in Kanji Xiaoke Tablets by HPLC
1691. Determination of Berberine Hydrochloride in Keyangmin Tincture by RP-HPLC
1692. Determination of Berberine Hydrochloride in Liangan granules by HPLC [J]
1693. Determination of Berberine Hydrochloride in Lianpu Shuangqing Tablets by HPLC
1694. Determination of Berberine Hydrochloride in Lishukang Capsules by HPLC [J]
1695. Determination of Berberine Hydrochloride in Mixture for Burn and Scald by HPLC
1696. Determination of Berberine hydrochloride in Mongolia Medicine Maidong-18 Powder by HPLC
1697. Determination of Berberine hydrochloride in Naotongling Granules by TLCS [J]
1698. Determination of Berberine hydrochloride in Niantongwan by HPLC [J]
1699. Determination of Berberine Hydrochloride in Ninbitai Capsules by HPLC
1700. Determination of Berberine hydrochloride in Ningxinanshen Capsules by HPLC [J]
1701. Determination of Berberine Hydrochloride in Phellodendron amurense Rupr by RRLC
1702. Determination of Berberine hydrochloride in Pifu pills by HPLC
1703. Determination of Berberine Hydrochloride in Qianlie Shutong Tablets by RP-HPLC
1704. Determination of Berberine Hydrochloride in Qianlieshutong Tablets by HPLC [J]
1705. Determination of Berberine Hydrochloride in Qianlieshutong Troche by RP-HPLC [J]
1706. Determination of Berberine Hydrochloride in Qingfei Yihuowan by HPLC [J]
1707. Determination of Berberine Hydrochloride in Qinggan Granules by HPLC
1708. Determination of Berberine hydrochloride in Qingre Huadu Pill by HPLC [J]
1709. Determination of Berberine hydrochloride in Quyou ointment by RP-HPLC [J]
1710. Determination of Berberine Hydrochloride in Rhizoma Coptidis and its Concentrated Granule for Prescription by HPLC
1711. Determination of Berberine hydrochloride in Ruyi Jinhuang Powder with scanning method of two-wavelengths thin layer chramography [J]
1712. Determination of Berberine hydrochloride in Sambucus williamsti Hance by RP-HPLC.
1713. Determination of Berberine Hydrochloride in San Yu Ointment by HPLC
1714. Determination of Berberine Hydrochloride in Sanhao Shedan Chuanbei Tablets by HPLC [J]
1715. Determination of Berberine hydrochloride in Sanhuang decoction for purging stomach-fire by HPLC
1716. Determination of Berberine Hydrochloride in Sanhuang Sanyu Cataplasm by HPLC [J]
1717. Determination of Berberine Hydrochloride in Sanhuang series by HPLC
1718. Determination of Berberine hydrochloride in sanhuang tablets by HPLC
1719. Determination of Berberine Hydrochloride in Sanhuang Tablets by HPLC [J]
1720. Determination of Berberine hydrochloride in sanhuangpian by HPLC
1721. Determination of Berberine Hydrochloride in Sanmiao Pills by HPLC
1722. Determination of Berberine Hydrochloride in Sanmiao Pills by HPLC [J]
1723. Determination of Berberine hydrochloride in Shangqing pills by HPLC
1724. Determination of Berberine Hydrochloride in Shangtongning plaster by HPLC
1725. Determination of Berberine Hydrochloride in Shaoshang Ⅱ Tincture by HPLC [J]
1726. Determination of Berberine hydrochloride in Shaoyao decoction by HPLC.
1727. Determination of Berberine Hydrochloride in Shenshe Ointments by HPLC
1728. Determination of Berberine hydrochloride in Shihu Yeguang pills by HPLC.
1729. Determination of Berberine hydrochloride in Shuanghuang Xiaoyan capsule by HPLC.
1730. DETERMINATION OF Berberine HYDROCHLORIDE IN SHUANGHUANGBUSUSTAINED RELEASE MEDICINAL STRIPS BY RP-HPLC [J]
1731. Determination of Berberine Hydrochloride in Shuanghuangxiaoyan Tablets by HPLC [J]
1732. Determination of Berberine Hydrochloride in Shuiniujiao Detoxicating Pill by HPLC
1733. Determination of Berberine Hydrochloride in Sifangwei Capsule by HPLC
1734. Determination of Berberine Hydrochloride in Siji Sanhuang Capsules
1735. Determination of Berberine Hydrochloride in Sijisanhuang Capsules by TLC-Scanning
1736. Determination of Berberine Hydrochloride in Smilax Glabra Roxby Capsules by RP-HPLC [J]
1737. Determination of Berberine hydrochloride in Suniaozhixie Capsules by HPLC
1738. Determination of Berberine Hydrochloride in the Changzhong Capusules by RP-HPLC [J]
1739. Determination of Berberine Hydrochloride in the Fufanglingxiao Capusules by RP-HPLC
1740. Determination of Berberine hydrochloride in the Miniaoning tablets by HPLC [J]
1741. Determination of Berberine Hydrochloride in Three fellows Lotion co. by RP-HPLC
1742. Determination of Berberine hydrochloride in Tibetan medicine Bangbei Kangyan suppository by RP-HPLC
1743. Determination of Berberine hydrochloride in Tongluo Jiedu liniment with Thin Layer Chromatography-Ultraviolet Spectrophotometry [J]
1744. Determination of Berberine hydrochloride in Tongmai Jiangtang granules by HPLC [J]
1745. Determination of Berberine hydrochloride in traditional Chinese medicines containing Coptis chinensis Franch by reversed phase high performance liquid …
1746. Determination of Berberine Hydrochloride in Weian Capsule by HPLC
1747. Determination of Berberine Hydrochloride in Weichangning Granules by HPLC
1748. Determination of Berberine hydrochloride in weidean capsule [J]
1749. Determination of Berberine hydrochloride in Weitai capsule by RP-HPLC [J]
1750. Determination of Berberine Hydrochloride in Weiwei Granules by TLC-Fluorometry
1751. Determination of Berberine hydrochloride in Weiyankang Capsule by RP-HPLC
1752. Determination of Berberine hydrochloride in Wuji Pills by HPLC
1753. Determination of Berberine Hydrochloride in Wuji Pills by HPLC [J]
1754. Determination of Berberine Hydrochloride in Xianglian Capsules by HPLC [J]
1755. Determination of Berberine Hydrochloride in Xianglian Pills by TLC scanning [J]
1756. Determination of Berberine Hydrochloride in Xiao A Lotion by HPLC
1757. Determination of Berberine Hydrochloride in Xiaoerxiaoke Tablets by HPLC
1758. Determination of Berberine Hydrochloride in Xiaokeling Tablets by HPLC [J]
1759. Determination of Berberine Hydrochloride in Xiaomi Effervescent Tablets by RP-HPLC
1760. Determination of Berberine Hydrochloride in Xiaotangling Capsule by HPLC
1761. Determination of Berberine Hydrochloride in XiaoYan Paste by HPLC
1762. Determination of Berberine Hydrochloride in Xiaoyan Pills by HPLC
1763. Determination of Berberine Hydrochloride in Xiaoyanjing Capsules by HPLC [J]
1764. Determination of Berberine Hydrochloride in Xiaoyanliniao Mixture by RP-HPLC
1765. Determination of Berberine Hydrochloride in Xiaozhi Granule by HPLC
1766. Determination of Berberine Hydrochloride in Xingnao Zaizao Jiaonang Capsule by HPLC [J]
1767. Determination of Berberine Hydrochloride in Xueqing Two Number Granule by HPLC [J]
1768. Determination of Berberine Hydrochloride in Yangxianfeng Wan by HPLC
1769. Determination of Berberine Hydrochloride in Yinghuang Capsule by HPLC
1770. Determination of Berberine Hydrochloride in Zhikang Jiaonang by RP-HPLC
1771. Determination of Berberine hydrochloride in Zhike complex granules by RP-HPLC [J]
1772. Determination of Berberine Hydrochloride in Zhimei Miedi Capsules by RP-HPLC
1773. Determination of Berberine Hydrochloride in Zhimiling Effervescent Tablets by HPLC
1774. Determination of Berberine Hydrochloride in Zhixiebaotong Granule by HPLC
1775. Determination of Berberine hydrochloride in Zhongweikang capsules by convolution spectrometry method
1776. Determination of Berberine Hydrochloride in Zuning Granules by HPLC
1777. Determination of Berberine Hydrochloride in Zuojin Dispersible Tablets by HPLC
1778. Determination of Berberine Hydrochloride of Fuke Zhidai Tablets [J]
1779. Determination of Berberine hydrochloride of Yankening tablets by HPLC
1780. Determination of Berberine Hydrochloride Premix Content by HPLC
1781. Determination of Berberine hydrochloride using a fluorimetric method with silica nanoparticles as a probe
1782. Determination of Berberine Hydrochloride Using Flow Injection Chemiluminescence
1783. Determination of Berberine Hydrochloride with Reverse Flow Injection Chemiluminescence [J]
1784. Determination of Berberine Hydrochloride, Baicalin and Wogonin in Yankening Pian by HPLC
1785. Determination of Berberine hydrochloride, chlorogenic acid and phillyrin in Compound prescription cortex phellodendri chinensis fluid by RP-HPLC [J]
1786. Determination of Berberine hydrochloride, palmatine hydrochloride and jatrorrhizine hydrochloride in Cortex Phellodendri Chinensis by HPLC
1787. Determination of Berberine Hydrochloridein Compound Fuxikang Lotion by HPLC [J]
1788. Determination of Berberine hydrochlorie in Bozhiqianlietong Granules by HPLC [J]
1789. Determination of Berberine in Angong Niuhuang Wan by HPLC
1790. Determination of Berberine in Baidai Wan by HPLC
1791. Determination of Berberine in Bianyan Oral Solution by HPLC
1792. DETERMINATION OF Berberine IN BIOLOGICAL SPECIMEN BY HIGH PERFORMANCE TLC AND [J]
1793. Determination of Berberine in biological specimen by high performance TLC and fluoro-densitometric method
1794. Determination of Berberine in Changyanxiao Solution by HPLC
1795. Determination of Berberine in Compound Huangbai Tincture by RP-HPLC [J]
1796. DETERMINATION OF Berberine IN COPTIS [J]
1797. Determination of Berberine in Cortex Phellodendri with Different Processing Methods by HPLC
1798. Determination of Berberine in decocted liquid from shenshu granules with water by reversed-phase liquid chromatography
1799. Determination of Berberine in Guilinxiguashuang Spray by HPLC [J]
1800. Determination of Berberine in Guzhining Liniment by RP-HPLC
1801. Determination of Berberine in human plasma by liquid chromatography–electrospray ionization–mass spectrometry
1802. Determination of Berberine in Human Serum by Reversed Phase High Performance Liquid Chromatography [J]
1803. Determination of Berberine in human serum by reversed-phase high performance liquid chromatography
1804. Determination of Berberine in kangjixiaoke tablet by HPLC [J]
1805. Determination of Berberine in lianpushuangqing tablets by HPLC [J]
1806. Determination of Berberine in pharmaceutical preparations using acidic hydrogen peroxide–nitrite chemiluminescence system
1807. Determination of Berberine in Phellodendron amurense from different sites of Changbai Mountain
1808. Determination of Berberine in Phellodendron chinense Schneid and its processed products by TLC (thin layer chromatography) densitometry
1809. Determination of Berberine in plasma, urine and bile by high-performance liquid chromatography
1810. Determination of Berberine in Processed Amur Corktree (Phellodendron amurense) by HPLC [J]
1811. DETERMINATION OF Berberine IN QINGJING CAPSULES BY HPLC [J]
1812. Determination of Berberine in Rhizoma coptidis and its preparations by non‐aqueous capillary electrophoresis
1813. Determination of Berberine in Shanhuang Tablets by HPLC
1814. Determination of Berberine in shuanghuangxiaoyan tablets by HPLC [J]
1815. Determination of Berberine in Siji Sanhuang Soft Capsules by HPLC [J]
1816. Determination of Berberine in Taxilli Herba and Its Host Plants-Clausena lansium by RP-HPLC
1817. Determination of Berberine in the callus of the Berberis lycium.
1818. Determination of Berberine in Tongdadibiji by TLC-scanning
1819. Determination of Berberine in xiancaihuangliansu Capsule by HPLC [J]
1820. Determination of Berberine in Xiaotangling Capsules by HPLC [J]
1821. Determination of Berberine in yankening tablets by HPLC [J]
1822. Determination of Berberine Sulfate Injection by HPLC
1823. Determination of Berberine sulphate in sompound solanum lyratum injection by UV
1824. Determination of Berberine , palmatine and jatrorrhizine in rabbit plasma by liquid chromatography–electrospray ionization-mass spectrometry
1825. Determination of Berberine , Palmatine and Jatrorrhizine in Tangkeqing Tablet
1826. Determination of Berberine -type Alkaloids in Wanshi Niuhuang Qingxin Wan by HPLC [J]
1827. Determination of Berberine -upregulated endogenous short-chain fatty acids through derivatization by 2-bromoacetophenone
1828. Determination of Caffeic Acid and Berberine Hydrochlcride in Lianpu Shuangqing Pian by HPLC [J]
1829. Determination of Chlorogenic Acid and Berberine Hydrochloride in Yiqi Decoction by HPLC [J]
1830. Determination of content of Berberine chloride in Dabaidu capsule by HPLC
1831. Determination of Content of Berberine Hydrochloride and Phellodendrine in Manpenyihao Power by RP-HPLC [J]
1832. Determination of Content of Berberine Hydrochloride in Coptis chinensis Franch. by RP-HPLC [J]
1833. Determination of Content of Berberine Hydrochloride in Sanhuang Qinghuo Capsules by HPLC [J]
1834. Determination of Content of Berberine Hydrochloride in Shuitiao Powders by HPLC [J]
1835. Determination of Content of Berberine Hydrochloride in the Mongolian Medicine Leizhuhua by RP-HPLC
1836. Determination of Content of Berberine Hydrochloride in the Mongolian Medicine Tufuling Qiwei Powder by RP-HPLC
1837. Determination of contents of Berberine type alkaloids in Huanglian Shangqing Pills (Tablets)
1838. Determination of coptisine, Berberine and palmatine in traditional Chinese medicinal preparations by capillary electrophoresis
1839. Determination of Dehydrocavidine, Palmatine Hydrochloride and Berberine Hydrochloride in Total Alkaloids of Corydalis saxicola Bunting [J]
1840. Determination of emodin and Berberine hydrochloride in Wangshibaochi Pills by HPLC
1841. Determination of furazolidone, carbenoxolone sodium and Berberine hydrochloride in wei kang tablets by reversed-phase high performance liquid chromatography …
1842. Determination of Gallic Acid and Berberine Hydrochloride in Fukang Vaginal Effervescent Tablets by HPLC [J]
1843. Determination of genpioside, baicalin and Berberine hydrochloride in Gonglao Quhuo Tablets simultaneously by RP-HPLC [J]
1844. Determination of gentiopicroside, mangiferin, palmatine, Berberine , baicalin, wogonin and glycyrrhizin in the traditional Chinese medicinal preparation Sann-Joong …
1845. Determination of Glycyrrhizic Acid and Berberine in Xiancaihuangliansu Capsules by HPLC
1846. Determination of hydrastine and Berberine in goldenseal raw materials, extracts, and dietary supplements by high-performance liquid chromatography with UV …
1847. Determination of hydrochloric acid Berberine in kangfuyan capsules by high performance liquid chromatography
1848. Determination of Hydrochloric Berberine in Burn Ⅱ Medicine by RP-HPLC [J]
1849. Determination of hydrochloric Berberine in Quban powder by HPLC [J]
1850. Determination of jatrorrhizine hydrochloride, palmatine hydrochloride and Berberine hydrochloride in compound Kushen lotion by HPLC
1851. Determination of jatrorrhizine, palmatine and Berberine in Cortex phellodendron by HPLC
1852. Determination of mangiferin, jateorrhizine, palmatine, Berberine , cinnamic acid, and cinnamaldehyde in the traditional Chinese medicinal preparation Zi-Shen pill by …
1853. Determination of muriatic acid Berberine by microscale chemical experiment [J]
1854. Determination of Norfloxacin and Berberine Hydrochloride by HPLC [J]
1855. Determination of paeoniflorin, palmatine hydrochloride and Berberine hydrochloride in Changji’an Preparation by HPLC [J]
1856. Determination of Palmatine and Berberine in the Coptis chinensisFranch by High Performance Liquid Chromatography [J]
1857. Determination of Palmatine Hydrochloride and Berberine Hydrochloride in Baishi Shuitiao Powder by HPLC
1858. Determination of palmatine hydrochloride and Berberine hydrochloride in Jinji capsules by RP-HPLC [J]
1859. Determination of palmatine hydrochloride and Berberine hydrochloride in phellodendron and gypsum powder by HPLC
1860. Determination of palmatine hydrochloride and Berberine hydrochloride in traditional Chinese patent medicine Qinlian tablets by HPLC [J]
1861. Determination of Palmatine Hydrochloride and Berberine Hydrochloride in Zhizi Huangbai Oral Solutions by HPLC
1862. Determination of Penicillamine Using Fluorescence Probe of Complexation Between Berberine and Cucurbit [7] uril [J]
1863. Determination of Plasma Protein Binding Rate of Berberine Hydrochloride
1864. Determination of propafenone and Berberine in serum by HPLC [J]
1865. Determination of rhein, baicalin and Berberine in traditional Chinese medicinal preparations by capillary electrophoresis with two‐marker technique
1866. Determination of Scutellarin and Berberine Hydrochloride in Jiawei Weiyanxiao Tablets by HPLC [J]
1867. Determination of the Antineoplastic Activivity of Berberine Isolated from Tinospora cordifolia in Swiss Albino Mice Transplanted with Ehrlich Ascites Carcinoma
1868. Determination of the Berberine Hydrochloride and Jatrorrhizine Hydrochlorid in Huanglian by HPLC
1869. Determination of the concentration of Berberine in rats plasma by HPLC
1870. Determination of the content of Berberine Hydrochloride by HPLC in Zuojin Capsule
1871. Determination of the Content of Berberine Hydrochloride in Baitouweng Powder by HPLC
1872. Determination of the content of Berberine hydrochloride in Fengtongding Capsules by HPLC [J]
1873. Determination of the Content of Berberine Hydrochloride in Fukezhidai Capsules by HPLC
1874. Determination of the Content of Berberine Hydrochloride in Fukezhidai Tablets by HPLC
1875. Determination of the content of Berberine Hydrochloride in Nanyanxiao Granu by TLC-Scanning
1876. Determination of the Content of Berberine Hydrochloride in Qinhuang Houzheng Capsule by HPLC
1877. Determination of the content of Berberine hydrochloride in Sanmiao Pills by HPLC
1878. Determination of the Content of Berberine Hydrochloride in Shentekang Capsule by HPLC
1879. Determination of the Content of Berberine Hydrochloride in the Fukezhidai Tablets by RP-HPLC
1880. Determination of the Content of Berberine Hydrochloride in Tibetan Medicine Bawei Zhangyacai Pills by HPLC
1881. Determination of the Content of Berberine Hydrochloride in Weining capsule by HPLC
1882. Determination of the content of Berberine hydrochloride of lianpu shuangqing tablets by UV Spectrophotometry [J]
1883. Determination of the content of Berberine hydrochloride of weikangning tablets by UV spectrophotometry
1884. Determination of the content of Berberine hydrochloride tablets by potassium dichromate colormetric method
1885. Determination of the contents of Berberine hydrochloride in Biyan Jiedu capsules by HPLC [J]
1886. Determination of the Contents of Berberine Hydrochloride in Spring Rain Burns Gels
1887. Determination of the Contents of Berberine in Huanglian Shangqing Pills [J]
1888. Determination of three kinds of Berberine type alkaloids in Rhizoma coptidis and Jinqi Jiangtang Tablet by RP-HPLC
1889. Determination of Trimethoprim in Berberine Hydrochloride and Trimethoprim Capsules by HPLC [J]
1890. Determination of Two Active Constituents in Enrofloxacin and Berberine Hydrochloride Powder by HPLC
1891. Determination of ZhangYe FangJijian Hydrochloride and Berberine Hydrochloride by HPLC
1892. Determination on Berberine of Huangbo in Shenkang oral liquid by RP—HPLC [J]
1893. Determination on the Content of Berberine Bydrochloride in Rhizoma Coptidis by HPLC [J]
1894. Determination the Content of Berberine Hydrochloride in Fuke Zhidai Tablets by HPLC [J]
1895. Determination the Content of Berberine Hydrochloride in Lianpushuangqing Tablets by HPLC [J]
1896. DETERMINATION THE CONTENT OF COSTUNOLIDE AND DEHYDROCOSTUSLACTONE IN THE Berberine COMPOUND TABLETS BY UPLC
1897. Determination the Contents of Berberine Hydrochloride in Jieyinshu Lotions by HPLC [J]
1898. Determination the contents of hydrochloric Berberine in Ermiao capsule by HPLC [J]
1899. Determinaton of Berberine hydrochloride in Linghuangbaoer Pellets by HPLC
1900. Determine of Berberine hydrochloride in luji kechuan keli by HPLC [J]
1901. Determining the Content of Berberine Hydrochloride in Weiyan kang Capsule by High Pressure Liquid Chromatography (HPLC)
1902. Determining the interaction behavior of calf thymus DNA with Berberine hydrochloride in the presence of linker histone: a biophysical study
1903. Deternination of Berberine in Shujing Tongluo Pill by HPLC
1904. Development and application of a UPLC‐MS/MS method for simultaneous determination of fenofibric acid and Berberine in rat plasma: application to the drug–drug pharmacokinetic interaction study of fenofibrate combined with Berberine after oral administration in rats
1905. Development and Application of Berberine Chemical Sensor [J]
1906. Development and Application of Silicotungstic Acid-Berberine Field Effect Transistor [J]
1907. Development and factorial design of glyceryl tristearate based solid lipid nanoparticles (SLNs) containing Berberine
1908. Development and in vitro evaluation of linear PEI-shelled heparin/Berberine nanoparticles in human osteosarcoma U-2 OS cells
1909. Development and Percutaneous Permeation Study of Escinosomes, Escin-Based Nanovesicles Loaded with Berberine Chloride
1910. Development and validation of a method for densitometric analysis of Berberine in herbal extract and polyherbal formulation
1911. DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD OF Berberine AND ITS QUANTIFICATION IN MULTICOMPONENT HOMEOPATHIC …
1912. Development and Validation of High-Performance Thin-layer Chromatographic Method for Quantification of Berberine in Rhizomes of Coptis teeta Wall, an …
1913. Development and Validation of RP-HPLC Method for Quantification of Berberine in Ethanol Fraction of Methanol Extract and Developed Formulation of …
1914. Development and Validation of UV-Spectrophotometric Methods for the Determination of Berberine in Polymeric Nanoparticles
1915. Development of a Berberine Loaded Multifunctional Design for the Treatment of Helicobacter pylori Induced Gastric Ulcer
1916. Development of a High Sensitive Assay for Determination of Berberine in Rat Plasma by LC-MS and its Application to a Pharmacokinetic Study
1917. Development of a new, rapid, and sensitive validated high-performance thin-layer chromatographic method for the estimation of Berberine in Tinospora cordifolia
1918. Development of a novel Berberine -mediated mitochondria-targeting nano-platform for drug-resistant cancer therapy
1919. Development of a novel quality control method for estimation of Berberine in Tinospora cordifolia by HPTLC fingerprint approach
1920. DEVELOPMENT OF ANTIBACTERIAL AND ANTIFUNGAL Berberine -PVA GEL PATCH AND ITS IN-VIVO ASSAY AGAINST STAPHYLOCOCCUS AUREUS …
1921. Development of Berberine attraction sites onto cellulosic substrates modified by reactive bridging agent: statistical optimization and analysis
1922. Development of Berberine -based derivatives as novel antimicrobial agents
1923. Development of bioadhesive microspheres for oral bioavailability enhancement of Berberine hydrochloride
1924. Development of botanical fungicide on japanese apple canker. 2. Synthesis and antifungal activity of Berberine derivatives.
1925. Development of botanical fungicide on japanese apple canker. 3. Control effect of Berberine derivatives on japanese apple canker
1926. Development of BSA gel/Pectin/Chitosan polyelectrolyte complex microcapsules for Berberine delivery and evaluation of their inhibitory effect on Cutibacterium acnes
1927. Development of Capsules Filled with Phenytoin and Berberine Loaded Nanoparticles-A New Approach to Improve Anticonvulsant Efficacy
1928. Development of escin-based nanovesicles loaded with Berberine chloride and percutaneous permeation study
1929. Development of formaldehyde-free agar/gelatin microcapsules containing Berberine HCl and gallic acid and their topical and oral applications
1930. Development of Nanoformulations for Enhancement in the Bioavailability of P-gp Substrate–Berberine Chloride
1931. Development of nano-scaled Silibinin and Berberine formulations to enhance their bioavailability for hepatoprotective and anticancer activities
1932. Development of novel nanoparticles shelled with heparin for Berberine delivery to treat Helicobacter pylori
1933. Development of poly(N-isopropylacrylamide)/alginate copolymer hydrogel-grafted fabrics embedding of Berberine nanosuspension for the infected wound treatment
1934. Development of process strategies for Berberine production in plant cell suspension cultures
1935. Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of Berberine hydrochloride
1936. Developmental toxicity evaluation of Berberine in rats and mice
1937. Dexamethasone combined with Berberine is an effective therapy for bleomycin‑induced pulmonary fibrosis in rats
1938. Dietary administration of Berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis
1939. Differences Between the Concentrations in Rabbit Body Fluid of Berberine Hydrochloride, Chlorogenic Acid, Baicalin, and Their Minimal Inhibitory Concentrations
1940. Differences of the Contents of Berberine for Three Preparation Methods in Sanhuang Xiexin Decoction by High Performance Capillary Electrophoresis with Internal …
1941. Differences of the contents of Berberine hydrochloride by three preparation methods in Sanhuang Xiexin decoction by HPCE Internal Standard Method.
1942. Different concentrations of Berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line
1943. Different mechanisms involved in the Berberine ‐induced antiproliferation effects in triple‐negative breast cancer cell lines
1944. Different regulation of Berberine via regulation of adenosine-5′-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart
1945. Different salinity influenced the percutaneous absorption of Berberine in washout application of traditional Chinese medicine in vitro [J]
1946. Different structures of Berberine and five other protoBerberine alkaloids that affect P-glycoprotein-mediated efflux capacity
1947. Differential effect of Rhizoma coptidis and its main alkaloid compound Berberine on TNF-α induced NFκB translocation in human keratinocytes
1948. Differential effects of Berberine , baicalein, and triptolide on cytokine production from IL-1β-activated mast cells (95.28)
1949. Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by Berberine and its oxidative metabolites
1950. Differential interaction behaviors of an alkaloid drug Berberine with various bile salts
1951. Differential modes of photosensitisation in cancer cells by Berberine and coralyne
1952. Differential pulse anodic stripping voltammetric determination of Berberine using nano-Na-montmorillonite clay modifiedcarbon paste electrode
1953. Differentiated hypoglycemic effects of baicalin, Berberine and puerarin on insulin-resistance HepG2 cells
1954. Differentiation of B16 Melanoma Induced by Berberine Hydrochloride
1955. Digital gene expression analysis of Microsporum canis exposed to Berberine chloride
1956. DihydroBerberine , a hydrogenated derivative of Berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB …
1957. Direct fluorometric determination of liver alcohol dehydrogenase with Berberine
1958. Discovery and characterization of Berberine derivatives as stimulators of osteoblast differentiation
1959. Discovery of 2-aminothiazolyl Berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii
1960. Discovery of Berberine based derivatives as anti-influenza agent through blocking of neuraminidase
1961. Discovery of Berberine , abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
1962. Discovery of mitochondria-targeting Berberine derivatives as the inhibitors of proliferation, invasion and migration against rat C6 and human U87 glioma cells
1963. Discovery of natural Berberine -derived nitroimidazoles as potentially multi-targeting agents against drug-resistant Escherichia coli
1964. Discovery of novel Berberine imidazoles as safe antimicrobial agents by down regulating ROS generation
1965. Discussion about Determination of Berberine Hydrochloride Tablets by HPLC [J]
1966. Discussion on Methods of Content Determination in Berberine Hydrocloride Tablets
1967. Displacement of bilirubin from albumin by Berberine
1968. Dissolution Determination of Berberine Hydrochloride in Compound Berberine Tablets by HPLC
1969. Dissolution of Baicalin and Berberine Hydrochloride in Sanhuang Tablets from Different Pharmaceutical Factories
1970. Dissolution properties of salt forms of Berberine
1971. Dissolution rate of Berberine in ermiao pills
1972. Dissolution Test in Vitro of Weiyoujing Tablets of Hydrodynamic Balance System (HBS (Berberine Hydrochloride)[J]
1973. Distribution in vivo of colon-oriented Berberine hydrochloride-carboxymethyl konjac glucomannan pellets in rats
1974. Diversity of the Gut Microbiota in Dihydrotestosterone-induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine
1975. DNA Binding Mode of the Isoquinoline Alkaloid Berberine with the Deoxyoligonucleotide d(GCCGTCGTTTTACA)2
1976. DNA Damage and Oxidation Damage of Berberine Hydrochloride on Spleen of Mice
1977. DNA Logic Gate Based on the Competitive Reaction Between Hemin and G-Quadruplex/Berberine Composite
1978. DNA-binding cytotoxic alkaloids: comparative study of the energetics of binding of Berberine , palmatine, and coralyne
1979. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine )
1980. Dose-dependent effects of Berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells
1981. Dose-dependent effects of Berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells.
1982. Dose-effect relationship of Berberine and analogues on antibacterial metabolism of Bacillus shigae by microcalorimetry
1983. Dose-effect relationship of Berberine and analogues on antibacterial metabolism of Bacillus shigae by microcalorimetry.
1984. Dose-response effect of Berberine on bile acid profile and gut microbiota in mice
1985. Dose–response of Berberine on hepatic cytochromes P450 mRNA expression and activities in mice
1986. Downregulation of cellular c-Jun N-terminal protein kinase and NF-κB activation by Berberine may result in inhibition of herpes simplex virus replication
1987. Down-regulation of c-Ki-ras2 gene expression associated with morphologic differentiation in human embryonal carcinoma cells treated with Berberine .
1988. Down-regulation of cyclin B1 and up-regulation of Wee1 by Berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle
1989. Down-regulation of cyclin B1 expression by Berberine promotes leukemia cells entry into G2/M phase of cell cycle
1990. Downregulation of inflammatory cytokines by Berberine attenuates Riemerella anatipestifer infection in ducks
1991. Drug-carrying capacity and anticancer effect of the folic acid-and Berberine -loaded silver nanomaterial to regulate the AKT-ERK pathway in breast cancer
1992. Drug–drug interactions between Ketoconazole and Berberine in rats: pharmacokinetic effects benefit pharmacodynamic synergism
1993. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of Berberine
1994. Dual-functionalised shellac nanocarriers give a super-boost of the antimicrobial action of Berberine
1995. Dual‐Stimuli‐Responsive Gut Microbiota‐Targeting Berberine ‐CS/PT‐NPs Improved Metabolic Status in Obese Hamsters
1996. Dual-Targeting of AR and Akt Pathways by Berberine in Castration-Resistant Prostate Cancer
1997. Dyed fabrics modified via assembly with phytic acid/Berberine for antibacterial, UV resistance, and self-cleaning applications
1998. Dyeing behaviors of Berberine , palmatine, and dye extracted from Phellodendron bark on silk fabric
1999. Dyeing of anionic modified cotton fabric with natural dye Berberine
2000. Dyeing of anionic modified cotton fabric with natural dyes extracted from Berberine
2001. Dyeing of soybean protein fibers with Berberine [J]
2002. Dyeing Properties of Berberine on Cationic Dyeable Polyester
2003. Dynamic intracellular localization of natural alkaloids in different human tumor cell lines: a case study with Berberine
2004. E. coli QS inhibition by TCM Inhibitory effect of two traditional Chinese medicine monomers, Berberine and matrine, on the quorum sensing system of antimicrobial …
2005. Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product Berberine
2006. Effect and mechanism of Berberine inhibiting cardiac fibroblasts proliferation and collagen protein synthesis induced by AngⅡ [J]
2007. Effect and mechanism of EGFR expression in macrophages on the anti-cancer effect of Berberine on colorectal cancer
2008. Effect and mechanisms of Berberine on hyperlipidemic and insulin resistant rats
2009. Effect and Mechanisms of Berberine on Proliferation of Ehrlich Ascites Tumor Cell in Mice [J]
2010. Effect of a combination of Berberine and monacolin on CYP enzymes: an oral cocktail interaction study in healthy volunteers
2011. Effect of a food supplement containing Berberine , monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo …
2012. Effect of Alstonia scholaris in Enhancing the Anticancer Activity of Berberine in the Ehrlich Ascites Carcinoma-Bearing Mice
2013. Effect of anemonin and Berberine on E-selectin expression in rat intestinal microvascular endothelial cells
2014. Effect of Antibacterial Activities of Berberine by Introduction of Lipophilic Aryl in its 9-position [J]
2015. Effect of Astragalus polysaccharides and Berberine on carbohydrate metabolism and cell differentiation in 3T3-L1 adipocytes
2016. Effect of auxins on Berberine synthesis in cell suspension culture of Coscinium fenestratum (Gaertn.) Colebr—A critically endangered medicinal liana of Western …
2017. Effect of Baicalin and Berberine Against Ureaplasma Urealyticum in Vitro
2018. Effect of baicalin and Berberine on transport of nimodipine on primary‐cultured, rat brain microvascular endothelial cells1
2019. Effect of benzyl alcohol on Berberine dyeing of acrylic fibers
2020. Effect of Berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion
2021. Effect of Berberine alkaloid on cholera vibrio and its endotoxin.
2022. Effect of Berberine alkaloids on Bifidobacterium adolescentis growth by microcalorimetry
2023. EFFECT OF Berberine ALONE OR IN COMBINATION WITH ARGON ION LASER TREATMENT ON 9L RAT GLIOMA CELL LINE
2024. Effect of Berberine alone or in combination with argon ion laser treatment on 9L rat glioma cell line.
2025. Effect of Berberine and (±)-bicuculline isolated fromCorydalis chaerophylla on spore germination of some fungi
2026. Effect of Berberine and Berberis aetnensis C. Presl. alkaloid extract on glutamate‐evoked tissue transglutaminase up‐regulation in astroglial cell cultures
2027. Effect of Berberine and Berberis aetnensis C. Presl. alkaloid extract on tissue transglutaminase in primary astroglial cell cultures
2028. Effect of Berberine and Dioscin on Expression of Saccharometabolism Disorders Trophocyte MLN64 mRNA and Placental Hormone Secretion
2029. Effect of Berberine and some antibiotics on the growth of microorganisms
2030. Effect of Berberine bisulfate on platelet hemostasis in thrombocytopenia patients
2031. Effect of Berberine Chloride on Absorption Rate of Cyclosporin A by Small Intestine in Rat
2032. Effect of Berberine chloride on caspase-3 dependent apoptosis and antioxidant capacity in the hippocampus of the chronic cerebral hypoperfusion rat model
2033. Effect of Berberine chloride on long term potentiation (ltp) at dentate gyrus in streptozotocin-induced diabetic rats
2034. Effect of Berberine combined with bone marrow mesenchymal stem cells on energy metabolism of HUVECs damaged by high glucose
2035. Effect of Berberine combined with risperidone therapy on endocrine hormones and oxidative stress in patients with schizophrenia
2036. Effect of Berberine derivative HB-13 on IFN-γ secretion in cultured HaCaT cells
2037. Effect of Berberine HCl on pharmacokinetics of cyclosporine A in human
2038. Effect of Berberine Hydrochloride and Vitamin E on Learning and Memory in Streptozotocin-Induced Diabetes in Rats
2039. Effect of Berberine hydrochloride from coptis Chinensis franch on the proliferation of three kinds of carcinoma cell lines [J]
2040. Effect of Berberine hydrochloride on grass carp Ctenopharyngodon idella serum bactericidal activity against Edwardsiella ictaluri
2041. Effect of Berberine Hydrochloride on Lipid Metabolism, Endocrine and Antioxidan Function of Meat Rabbit
2042. Effect of Berberine hydrochloride on muscarinic receptors
2043. Effect of Berberine Hydrochloride on Ornithine Decarboxylase Expression in Colon Cancer HT29 cells
2044. Effect of Berberine Hydrochloride on Slaughter Performance and Meat Quality of Rabbit
2045. Effect of Berberine Hydrochloride on the Expression of Bone Gla Protein and Interleukin-6 in the Periodontal Tissues of Rats
2046. Effect of Berberine hydrochloride on the expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissues in rats
2047. Effect of Berberine hydrochloride on the proliferation, apoptosis and cytokine secretion of splenocytes in mice
2048. Effect of Berberine hydrochloride on the secretion of monocyte chemoattractant protein-1 from human periodontal ligament cells in vitro
2049. Effect of Berberine hydrochloride-functionalized gold nanoparticles on calf thymus DNA: a biophysical study
2050. Effect of Berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms
2051. Effect of Berberine in Tumor Necrosis Factor-α Induced Inflammation
2052. Effect of Berberine on a cellular model of non-alcoholic fatty liver disease
2053. Effect of Berberine on acetylcholine-induced atrial fibrillation in rabbit
2054. Effect of Berberine on adhesion characteristic of PG cell line from highly metastatic human giant cell lung carcinoma
2055. Effect of Berberine on airway inflammation and mucus hypersecretion in mice with chronic obstructive pulmonary disease and its molecular mechanism
2056. Effect of Berberine on Angiogenesis and HIF-1α/VEGF Signal Transduction Pathway in Rats with Cerebral Ischemia-Reperfusion Injury
2057. Effect of Berberine on apoptosis and expression of Bax and Bcl-2 proteins in HeLa cells
2058. Effect of Berberine on AQP4 Expression in Focal Cerebral Ischemia Area in Diabetic Rats
2059. Effect of Berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells
2060. Effect of Berberine on barrier function in a human retinal pigment epithelial cell line
2061. Effect of Berberine on Blood Glucose and Peripheral Neuropathy in Type 2 Diabetes Patients
2062. Effect of Berberine on bone mineral density in SAMP6 as a senile osteoporosis model
2063. Effect of Berberine on cardiac arrhythmia following coronary artery occlusion and its mechanism
2064. Effect of Berberine on Cardiac Function and Plasma Inflammatory Factors in Chronic Heart Failure
2065. Effect of Berberine on cardiac hypertrophy induced by isoproterenol in rats [J]
2066. Effect of Berberine on catecholamine levels in rats with experimental cardiac hypertrophy
2067. Effect of Berberine on CDK9 and cyclin T1 expression in skeletal muscle of diabetic rats induced by streptozotocin and a high-carbohydrate/high-fat diet
2068. Effect of Berberine on Cdk9 and cyclin T1 expressions in myocardium of diabetic rats
2069. Effect of Berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53/cyclin D1 and PI3K/Akt
2070. Effect of Berberine on cell survival in the developing rat brain damaged by MK-801
2071. Effect of Berberine on Cerebral Pial Microcirculation in Cerebral Ischemic Rats [J]
2072. Effect of Berberine on Cognitive Impairment and Hippocampal Lesion in Diabetic Rats
2073. Effect of Berberine on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials
2074. Effect of Berberine on cytosolic free Ca~(2+) concentration in cultured myocardial cells of neonatal rat
2075. Effect of Berberine on cytosolic free calcium concentration in isolated ventricular myocytes of adult rats
2076. Effect of Berberine on cytosolic free calcium of rat myocardial cells in vitro
2077. Effect of Berberine on D-dimer, fibrinogen and interleukin-6 in peripheral blood of ovarian cancer patients
2078. Effect of Berberine on depression-and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in …
2079. Effect of Berberine on Electrolyte in Renal Transplanted Recipients Taking Cyclosporin A
2080. Effect of Berberine on enterotoxin-induced intestinal fluid accumulation in rats
2081. Effect Of Berberine On Epigenetic Regulation Mediated By Histone Deacetylases Targeted Chromatin Remodeling In A549 Human Nonsmall Cell Lung Cancer …
2082. Effect of Berberine on Escherichia coli, Bacillus subtilis, and their mixtures as determined by isothermal microcalorimetry
2083. Effect of Berberine on expression of Bcl-2, Caspase-3 in cerebral ischemia reperfusion in rats
2084. Effect of Berberine on expression of fibronectin and connective tissue growth factor in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats [J]
2085. Effect of Berberine on expression of hepatocyte nuclear factor-4α in rats with fructose-induced insulin resistance
2086. Effect of Berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy
2087. Effect of Berberine on Expressions of Cell Adhesion Molecules in Rats with Middle Cerebral Artery Occlusion [J]
2088. Effect of Berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats
2089. Effect of Berberine on extracellular release of HMGB1.
2090. Effect of Berberine on fructose-induced insulin resistance and expression of tumor necrosis factor-alpha in liver of rats
2091. EFFECT OF Berberine ON FUNCTION OF MEMORY AND LEARN IN MICE [J]
2092. Effect of Berberine on gastric precancerous lesions in rats and its mechanism
2093. Effect of Berberine on Gene Expression of Adiponectin by IL-6 Induced Insulin Resistance in 3T3-L1 Adipocyte
2094. Effect of Berberine on gene expression of adiponectin in type 2 diabetic mellitus rats
2095. Effect of Berberine on glucokinase and its related glucose metabolism in rats with insulin-secretion deficiency [J]
2096. EFFECT OF Berberine ON GLUTAMATE-INDUCED CYTOTOXICITY IN PC12 AND N2A CELLS
2097. Effect of Berberine on growth of the callus cultures of several species
2098. Effect of Berberine on Helicobacter pylori-induced human gastric epithe-lial cells injury
2099. Effect of Berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine-and …
2100. Effect of Berberine on Hepatocytes of Obstructive Jaundice Rats
2101. Effect of Berberine on hippocampal tissue oxidative stress levels and BDNF expression in diabetic encephalopathy rats
2102. Effect of Berberine on HL-60 cell proliferation, apoptosis and vascular endothelial growth factor receptor 2 expression
2103. Effect of Berberine on HMGB1 Release from Macrophages and its Mechanism
2104. Effect of Berberine on human endometrial carcinoma cell line Ishikawa co-cultured with TAM [J]
2105. Effect of Berberine on human lung carcinoma cell line A549 and experimental lung cancer
2106. Effect of Berberine on HuR accumulation in necleus in macrophages.
2107. EFFECT OF Berberine ON HYDROGEN PEROXIDE INDUCED ALTERATIONS OF ELECTRICAL ACTIVITY OF GUINEA PIG PAPILARY MUSCLES
2108. Effect of Berberine on In Vitro Metabolism of Sulfonylureas: A herb‐drug interactions study
2109. Effect of Berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial
2110. Effect of Berberine on insulin secretion and glucokinase activity of NIT-1 cells
2111. Effect of Berberine on Insulin, GLP-1R and DPP4 Gene Expression Levels in Streptozotocin Induced Diabetic Rats
2112. Effect of Berberine on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line
2113. Effect of Berberine on intestinal secretion mediated by Escherichia coli heat-stable enterotoxin in jejunum of pigs.
2114. Effect of Berberine on Intimal Hyperplasia and Vascular Remodeling After Balloon Withdrawal Injury of Rabbit Carotid artery
2115. Effect of Berberine on intracellular free CA2+ concentration in cultured brain cells
2116. Effect of Berberine on invasion and migration of PG cells from a high metastatic human giant lung carcinoma cell line
2117. Effect of Berberine on islet β-cell function in type 2 diabetes mellitus (damp-heat type)
2118. Effect of Berberine on Islet?-cell Function in Type 2 Diabetes Mellitus (Damp-Heat Type)
2119. Effect of Berberine on left ventricular remodeling in renovascular hypertensive rats
2120. Effect of Berberine on lipid metabolism and atherosclerosis of atherosclerotic rabbits
2121. Effect of Berberine on lipid metabolism and expressions of low density lipoprotein receptor and scavenger receptor class‐B type 1 genes in livers of hyperlipidemic …
2122. Effect of Berberine on lipopolysaccharide-induced monocyte chemotactic protein-1 and interleukin-8 expression in a human retinal pigment epithelial cell line
2123. Effect of Berberine on Liver Fibrosis in Mice
2124. Effect of Berberine on LPS-induced tranendothelial migration of leukocytes [J]
2125. Effect of Berberine on membrane fluidity and membrane protein fluorescence of rabbit red-blood cells.
2126. Effect of Berberine on monocyte chemotactic protein-1 and cytokine-induced neutrophil chemoattractant-1 expression in rat lipopolysaccharide-induced uveitis
2127. Effect of Berberine on mRNA expression levels of hepatic glucokinase, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase in type 2 diabetic Chinese …
2128. Effect of Berberine on MUC5AC Mucin Gene Expression and Mucin Production from Human Airway Epithelial Cells
2129. Effect of Berberine on myoelectric activity and transit of the small intestine in rats
2130. Effect of Berberine on Nasal Polyp-derived Fibroblast
2131. Effect of Berberine on nitric oxide production during oxygen-glucose deprivation/reperfusion in OLN-93 oligodendrocytes.
2132. Effect of Berberine on nitric oxide release of rat intestinal mucous microvascular endothelial cells
2133. Effect of Berberine on p53 expression by TPA in breast cancer cells
2134. Effect of Berberine on pentylenetetrazol-induced seizures in rats
2135. Effect of Berberine on peripheral neuropathy of type 2 diabetic model rats
2136. Effect of Berberine on pharmacokinetics of digoxin after oral administration to rats
2137. Effect of Berberine on positive transcription elongation factor b expression in diabetic rat retinas [J]
2138. Effect of Berberine on PPARalpha/delta/gamma expression in type 2 diabetic rat retinae.
2139. Effect of Berberine on PPARs expression in myocardium of diabetic rats
2140. Effect of Berberine on PPARα/NO activation in high glucose-and insulin-induced cardiomyocyte hypertrophy
2141. Effect of Berberine on PPARα/δ/γexpression in type 2 diabetic rat kidney
2142. Effect of Berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV
2143. Effect of Berberine on Prevention of 7, 12 Dimethylbenz (α) Anthracene Induced Mammary Carcinogenesis in Rats
2144. Effect of Berberine on proinflammatory cytokine production by ARPE-19 cells following stimulation with tumor necrosis factor-α
2145. Effect of Berberine on proliferation and apoptosis of gastric adenocarcinoma cells AGS
2146. Effect of Berberine on proliferation and apoptosis of MCF-7 cells
2147. Effect of Berberine on proliferation and secretion of transforming growth factor-β_1 of glomerular mesangial cells from diabetic nephropathy rats
2148. Effect of Berberine on Proliferation of Pulmonary Artery Smooth Muscle Cells in Rats [J]
2149. Effect of Berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich …
2150. Effect of Berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells
2151. Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters
2152. Effect of Berberine on proto-oncogene c-fos expression inducedby focal cerebral ischemia in rats
2153. Effect of Berberine on radiosensitivity of cervical cancer cells
2154. Effect of Berberine on regression of pressure-overload induced cardiac hypertrophy in rats
2155. Effect of Berberine on Restenosis after Percutaneous Transluminal Angioplasty of carotid artery in rabbits [J]
2156. Effect of Berberine on Sensitivity Enhances of K562/DOX Cells to Doxorubicin [J]
2157. Effect of Berberine on serum C-reactive protein in obese patients
2158. Effect of Berberine on serum inflammatory mediators and patho-morphology of beta cells in rats with type 2 diabetes [J]
2159. Effect of Berberine on serum retinol-binding protein4 contents in patients with type 2 diabetes mellitus [J]
2160. Effect of Berberine on serum superoxide dismutase activity, MDA content and neural function in rats after cerebral ischemia reperfusion [J]
2161. Effect of Berberine on slow inward ionic current in guinea pig ventricular papillary muscle
2162. Effect of Berberine on spatial learning and memory impairment in Alzheimer’s disease model rats with okadaic acid and its mechanism
2163. Effect of Berberine on Staphylococcus epidermidis biofilm formation
2164. Effect of Berberine on Testosterone secretion from Testicular TM3 cell lines in hypoxia condition.
2165. Effect of Berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats
2166. Effect of Berberine on the atrial natriuretic peptide secretion in cardiac atria (1150.9)
2167. Effect of Berberine on the autolytic enzyme system of methicillin-resistant Staphylococcus aureus [J]
2168. Effect of Berberine on the blood concentration of cyclosporine A in the renal transplant recipients
2169. Effect of Berberine on the brain damage of glycated rats induced by D-galactose
2170. Effect of Berberine on the cytosolic calcium concentration in the single ventricular cell of guinea pig
2171. Effect of Berberine on the cytosolic calcium concentration in the single ventricular cell of guinea pig [J]
2172. Effect of Berberine on the diaphragm in rabbits
2173. Effect of Berberine on the differentiation and apoptosis of K562 cell line
2174. Effect of Berberine on the differentiation of adipocyte
2175. Effect of Berberine on the endoplasmic reticulum stress-related apoptosis in pancreatic β cells
2176. Effect of Berberine on the expression of lipid metabolism-associated gene PPARα and CPTIA
2177. Effect of Berberine on the expression of nephrin, podocin and intergrin α3β1 in diabetic nephropathy rats
2178. Effect of Berberine on the Expression of Nuclear Factor Kappa B, Vascular Cell Adhesion Molecule-1 and Monocyte Chemoattractant Protein-1 in Carotid Artery …
2179. Effect of Berberine on the expression of P-glycoprotein in the epileptic rat’s brain tissue
2180. Effect of Berberine on the expression of phosphorylation tau proteins in frontal cortex of rats with Alzheimer’s disease induced by okadaic acid [J]
2181. Effect of Berberine on the fatty acid composition of Vibrio cholerae and Vibrio cholerae biotype eltor.
2182. Effect of Berberine on the function of myosin and on the contractility of intestinal and gastric smooth muscle [J]
2183. Effect of Berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats
2184. Effect of Berberine on the insulin resistance and TLR4/IKKbeta/NF-kappaB signaling pathways in skeletal muscle of obese rats with insulin resistance
2185. Effect of Berberine on the levels of endothelium-1, nitric oxide, platelet derived growth factor and transfer growth factor-β1 in rabbit carotid artery injured by balloon
2186. Effect of Berberine on the Levels of Nitric Oxide and Endothelin-1 after Balloon Withdrawal Injury of Rabbit Carotid Artery
2187. Effect of Berberine on the MMP-9 and TIMP-1 gene expression of alveolar and peritoneal macrophages from diabetic rats [J]
2188. Effect of Berberine on the mRNA expression of nitric oxide synthase (NOS) in rat corpus cavernosum
2189. Effect of Berberine on the mRNA expression of phosphodiesterase type 5 (PDE5) in rat corpus cavernosum</li
2190. Effect of Berberine on the osteogenic differentiation of bone marrow mesenchymal cells [J]
2191. Effect of Berberine on the peristalsis of cavy small intestine [J]
2192. Effect of Berberine on the pharmacokinetics of carbamazepine and its metabolism in rats [J]
2193. Effect of Berberine on the pharmacokinetics of substrates of CYP3A and P‐gp
2194. Effect of Berberine on the proinflammatory cytokines production in mice
2195. Effect of Berberine on the proliferation and apoptosis of a human skin squamous cell carcinoma cell line A431
2196. Effect of Berberine on the proliferation and apoptosis of lung cancer stem cells and the possible mechanism
2197. Effect of Berberine on the ratio of high-molecular weight adiponectin to total adiponectin and adiponectin receptors expressions in high-fat diet fed rats
2198. Effect of Berberine on the viability of adipose tissue-derived mesenchymal stem cells in nutrients deficient condition
2199. Effect of Berberine on the yield of pyrimidine dimers in uv-irradiated DNA
2200. Effect of Berberine on TNF-α-induced VEGF Expression via NF-κB Signaling Pathway
2201. Effect of Berberine on Toll-like Receptor 2 Signaling Pathway and Inflammatory Cytokines
2202. Effect of Berberine on transit time of human small intestine
2203. Effect of Berberine on Transit Time of Human Small Intestine [J]
2204. Effect of Berberine on Tyrosine Decarboxylase Activity of Streptococcus faeclis
2205. Effect of Berberine on visfatin expression in 3T3-L1 adipocytes
2206. Effect of Berberine preconditioning on intestinal injury caused by liver cold ischemia/reperfusion in rats
2207. Effect of Berberine pretreatment on hypoxia/reoxygenation-induced apoptosis in human renal tubular epithelial cells
2208. Effect of Berberine sulphate on Entamoeba histolytica
2209. Effect of Berberine treatment on the expressions of oxLDL, CD36 and PPAR? of macrophages from diabetic rats
2210. Effect of Berberine , glaucine, stephaglabrine and sanguiritrine on neuromuscular transmission
2211. Effect of Berberine , liensinine and neferine on HERG channel expression
2212. Effect of Berberine , liensinine and neferine on HERG channel expression [J]
2213. Effect of carbon dioxide and ethylene on Berberine production and cell browning in Thalictrum minus cell cultures
2214. Effect of catalpol, Berberine , and their combination on expression of Glut4 protein and C-Cb1 associated protein in insulin resistant 3T3-L1 adipocytes [J]
2215. Effect of catapol, Berberine , and their combination on insulin resistant 3T3-L1 adipocytes
2216. Effect of Compatible Compound Metformin and Berberine on Neural System of Diabetic Rats
2217. Effect of curcumin, Berberine and its compatibility on glucose and lipid metabolism in db/db mice
2218. Effect of Denuding and Undenuding the Sugarcoat on The Determination of Berberine in Sanhuang Tablets
2219. Effect of Different Extracting Methods on the Content of Berberine Hydrochloride in Rhizoma Coptis
2220. Effect of different nitrogen concentrations on the growth and contents of Berberine in rhizome of Coptis chinensis Franch
2221. Effect of Different Ultrasonic Frequencies on Extraction Rate of Berberine Chloride from Phellodendron chinese Schneid [J]
2222. Effect of enhanced UV-B radiation on metabolism and Berberine content of Coptis chinensis
2223. Effect of environmental factors on allelopathic inhibition of Microcystis aeruginosa by Berberine
2224. Effect of evodiamine and Berberine on miR-429 as an oncogene in human colorectal cancer
2225. Effect of evodiamine and Berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-β1
2226. Effect of extract method on pharmacokinetics of baicalin and Berberine in dogs
2227. Effect of Extracting Temperature to Microwave Irradiation of Berberine
2228. Effect of Extraction on Berberine Hydrochloride Transfer Rate for Lianxie Capsules Decomposed Recipes
2229. Effect of food on the oral bioavailability of Berberine and monacolin administered in combination in healthy male volunteers
2230. Effect of gibberellic acid on Berberine and tyrosine accumulation in Coptis japonica
2231. Effect of Glucosidorum Tripterygll Totorum, Berberine and Daunorubicin on Acute Lymphocyte Leukemia Cells and Comparison of Different Tetrazolium Salt Assays
2232. Effect of growth regulators, carbon source and cell aggregate size on Berberine production from cell cultures of Tinospora cordifolia Miers
2233. Effect of Host Trees on Berberine Content in Stem of Tinospora cordifolia Climber: A Preliminary Study
2234. Effect of Hydrochloric Acid-methyl Alcohol on Extraction Rate of Berberine Chloride from Berberis tsienii Ying
2235. Effect of inhibitor Berberine of the morphology on Human tongue cancer Tca8113 cell pine
2236. Effect of ion pairing on the fluorescence of Berberine , a natural isoquinoline alkaloid
2237. Effect of ion-pair formation with bile salts on the in vitro cellular transport of Berberine
2238. Effect of jatrorrhizine, Berberine , Huanglian Decoction and compound-mimic prescription on blood glucose in mice
2239. Effect of long-term administration of Berberine on scopolamine-induced amnesia in rats
2240. EFFECT OF L-TYROSINE ON Berberine SYNTHESIS IN COPT1S CHINENSIS CELLS CULTURED
2241. Effect of metal ions on the interaction between bovine serum albumin and Berberine chloride extracted from a traditional Chinese Herb coptis chinensis franch
2242. Effect of new Berberine derivatives on colon cancer cells
2243. Effect of new nutraceutical formulation with policosanol, Berberine , red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate …
2244. Effect of nitrogen, phosphorus and potassium on the growth of rhizome of Coptis chinensis Franch and its contents of Berberine
2245. Effect of oxygen supply on Berberine production in cell suspension cultures and immobilized cells ofThalictrum minus
2246. Effect of Puerarin, Baicalin and Berberine Hydrochloride on the Regulation of IPEC-J2 Cells Infected with Enterotoxigenic Escherichia coli
2247. Effect of reactive anionic agent on dyeing of cellulosic fibers with a Berberine colorant
2248. Effect of reactive anionic agent on dyeing of cellulosic fibers with a Berberine colorant—part 2: anionic agent treatment and antimicrobial activity of a Berberine dyeing
2249. Effect of Resistance Training and Berberine Chloride Supplementation on IGF-1, PDGF, and VEGF Gene Expression in Hippocampal Tissue of Diazinon …
2250. Effect of Rhizoma Coptidis and Radix Rehmanniae with different ratio on pharmacokinetics of Berberine in rats
2251. Effect of Rhizoma Coptidis coadministration with Cortex Cinnamomi on tissue distribution of Berberine in rats
2252. Effect of traditional Chinese medicine Berberine on type 2 diabetes based on comprehensive metabonomics
2253. Effect of ultrasonic extraction on extraction rate of Berberine
2254. Effectiveness and safety of bifidobacteria and Berberine in people with hyperglycemia: study protocol for a randomized controlled trial
2255. Effectiveness Evaluation Analysis on Berberine Tablets Combination with Metformin Treating Type 2 Diabetes
2256. Effects and action mechanisms of Berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice
2257. Effects and interaction of icariin, curculigoside, and Berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption
2258. Effects and mechanism of Berberine on the hypertensive renal injury rats induced by enriched high fat-salt-fructose diet
2259. Effects and mechanisms of Berberine in diabetes treatment
2260. Effects and underlying mechanism of Berberine on renal tubulointerstitial injury in diabetic rats
2261. Effects of 13-alkyl-substituted Berberine alkaloids on the expression of COX-II, TNF-α, iNOS, and IL-12 production in LPS-stimulated macrophages
2262. Effects of 13-hexyl-Berberine hydrochloride and 13-hexyl-palmatine hydrochloride on the activation of nuclear factor-kappa B and phosphorylation of p38 mitogen …
2263. Effects of a combination of puerarin, baicalin and Berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of …
2264. Effects of a new nutraceutical formulation (Berberine , red yeast rice and chitosan) on non-HDL cholesterol levels in individuals with dyslipidemia: results from a …
2265. Effects of a nutraceutical combination (Berberine , red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo …
2266. Effects of a nutraceutical combination containing Berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: a meta …
2267. Effects of a nutraceutical combination of Berberine , policosanol, red yeast rice and antioxidants, on lipid profile in hypercholesterolemic patients: A meta-analysis
2268. Effects of a nutraceutical combination of fermented red rice, liposomal Berberine , and curcumin on lipid and inflammatory parameters in patients with mild-to …
2269. Effects of AM fungi on the Berberine content in Phellodendron chinense seedlings [J]
2270. Effects of Andrographis Paniculata and Berberine Injected to Houhai Point on Anti-diarrhea of Mice
2271. Effects of baicalein, Berberine , curcumin and hesperidin on mucin release from airway goblet cells
2272. Effects of Berberine against radiation-induced intestinal injury in mice
2273. Effects of Berberine and 8-hydroxy dihydroBerberine on vascular endothelial function in type 2 diabetic rats
2274. Effects of Berberine and Atorvastatin on Circulating Endothelial Progenitor Cells in Patients with Acute Coronary Syndrome
2275. Effects of Berberine and cinnamic acid on palmitic acid-induced intracellular triglyceride accumulation in NIT-1 pancreatic β cells
2276. Effects of Berberine and Cortex Moutan Compatible with Dachengqi Decoction on IL-6 and NO of Rats with Intestine-heat and Fu-organ Excess Syndrome
2277. Effects of Berberine and hwangryunhaedok-tang on oral bioavailability and pharmacokinetics of ciprofloxacin in rats
2278. Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
2279. Effects of Berberine and its derivatives on the expression of PTP1B protein in skeletal tissues of type 2 diabetic rats
2280. Effects of Berberine and mangiferin and their combination on glucose uptake in L6 myotubes and the mechanism
2281. Effects of Berberine and Matrine against Formation of Mixed Biofilms of Vulvovaginal Candidiasis [J]
2282. Effects of Berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice
2283. Effects of Berberine and pioglitazone on type 2 diabetes acute insulin secretion and adiponectin [J]
2284. Effects of Berberine and pomegranate seed oil on plasma phospholipid metabolites associated with risks of type 2 diabetes mellitus by U-HPLC/Q-TOF-MS
2285. Effects of Berberine and red yeast on proinflammatory cytokines IL-6 and TNF-α in peripheral blood mononuclear cells (PBMCs) of human subjects
2286. Effects of Berberine and yohimbine on splenocyte apoptosis in septic mice
2287. Effects of Berberine chloride and coadministration with cyclo sporin on liver and small intestine microsomal cytochrome P450 isoenzyme in rat [J]
2288. Effects of Berberine chloride on secondary brain injury in contralateral parietal lobe cortex of TBI model mice
2289. Effects of Berberine chloride on the liver of streptozotocin-induced diabetes in albino Wistar rats
2290. Effects of Berberine Chloride or Bifendate and Coadministration with Cyclosporin on the Movement of Small Intestine in Mice
2291. Effects of Berberine combined with evodiamine on liver HMG-CoA reductase and L-FABP mRNA expression levels in a rat model of hyperlipidemia
2292. Effects of Berberine Combined with Magnolol and Honokiol on the Formation of THP-1 Macrophage-derived Foam Cells
2293. Effects of Berberine derivate CPU 86017 on IKur currents and experimental atrial fibrillation
2294. Effects of Berberine from Cortex Phellodendri Chinensis on osteoporosis in ovariectomized rats
2295. Effects of Berberine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort
2296. Effects of Berberine Hydrochloride and 8-hydroxy DihydroBerberine on the Activity of Acetylcholinesterase (AChE) in the Cerebral Tissue and Serum of Rats
2297. Effects of Berberine hydrochloride on alphar_1-adrenoceptor and voltage dependent calcium channel in vas-cular smooth muscle
2298. Effects of Berberine hydrochloride on nonalcoholic fatty liver disease in rats [J]
2299. Effects of Berberine hydrochloride on periodontal tissues and cytokine expression in rats with experimental periodontitis☆
2300. Effects of Berberine hydrochloride on secretion of interleukin-6 from human periodontal ligament cells cultured in vitro
2301. Effects of Berberine in the gastrointestinal tract—a review of actions and therapeutic implications
2302. Effects of Berberine of L-and T-type calcium channels in guinea pig ventricular myocytes.
2303. Effects of Berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson’s disease
2304. Effects of Berberine on a rat model of chronic stress and depression via gastrointestinal tract pathology and gastrointestinal flora profile assays
2305. Effects of Berberine on acquisition and reinstatement of morphine-induced conditioned place preference
2306. Effects of Berberine on acquisition and reinstatement of morphine-induced conditioned place preference in mice
2307. Effects of Berberine on adiponectin mRNA expression in 3T3-L1 adipocyte
2308. Effects of Berberine on adipose tissues and kidney function in 3T3-L1 cells and spontaneously hypertensive rats
2309. Effects of Berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo
2310. Effects of Berberine on amelioration of renal artery damage caused by atherosclerosis [J]
2311. Effects of Berberine on angiotensin-converting enzyme and NO/cGMP system in vessels
2312. EFFECTS OF Berberine ON APOPTOSIS AND SURVIVIN GENE IN EXPERIMENTALLY INDUCED DYSPHASIA OF GASTRIC EPITHELIA CELL [J]
2313. Effects of Berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells
2314. Effects of Berberine on arylamine N-acetyltransferase activity in human bladder tumour cells
2315. Effects of Berberine on arylamine N-acetyltransferase activity in human colon tumor cells
2316. Effects of Berberine on Atherosclerosis and vulnerable plaque and Serum Levels of Lipid in Atherosclerotic Rabbits [J]
2317. Effects of Berberine on basal and secretagogue-modified ion transport in the rabbit ileum in vitro.
2318. Effects of Berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis
2319. Effects of Berberine on blood glucose regulation of normal mice
2320. Effects of Berberine on cell cycle, DNA, reactive oxygen species, and apoptosis in L929 murine fibroblast cells
2321. Effects of Berberine on cell proliferation, peroxisome proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and protein expression in 3T3-L1 …
2322. Effects of Berberine on cholesterol efflux in THP-1 macrophage derived foam cells
2323. Effects of Berberine on cholesterol metabolism and Insig-2 gene expression of hyperlipidemic rats
2324. Effects of Berberine on conductivity of heart
2325. Effects of Berberine on Contractile Activity of Circular Muscle in Rat Gastric Body Under High Glucose and Insulin Conditions [J]
2326. Effects of Berberine on C-reactive protein expression in diabetic nephropathy rats
2327. Effects of Berberine on C-type inactivation of Kv1. 4 channel using Xenopus oocytes as carriers
2328. Effects of Berberine on cyclic GMP and cyclic AMP levels in rabbit corpus cavernosum in vitro
2329. Effects of Berberine on Cytoskeleton and Permeability of HUVEC Cells Infected with Influenza Virus
2330. Effects of Berberine on Cytosolic cAMP and Calcium Influx of Rabbit Platelets
2331. Effects of Berberine on delayed afterdepolarizations in ventricular muscles in vitro and in vivo.
2332. Effects of Berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats
2333. Effects of Berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
2334. Effects of Berberine on Digestion and Metabolism of Meat Rabbits
2335. Effects of Berberine on digestion and metabolism of meat rabbits.
2336. Effects of Berberine on DNFB-induced delayed type hypersensitivity in mice
2337. Effects of Berberine on EEG and EEG power spectrum recorded in conscious rabbits
2338. Effects of Berberine on EEG and EEG power spectrum recorded in conscious rabbits [J]
2339. Effects of Berberine on epithelial endoplasmic reticulum stress in a mouse model of dextran sulfate sodium-induced colitis
2340. Effects of Berberine on expression of hepatic sterol regulatory element-binding protein, its control and target genes in type 2 diabetic Chinese hamsters
2341. Effects of Berberine on expression of hepatocyte nuclear factor 4alpha and glucokinase activity in mouse primary hepatocytes
2342. Effects of Berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDL
2343. Effects of Berberine on fibronectin and p38MAPK signal pathway in rat glomerular mesangial cells cultured under high glucose condition
2344. Effects of Berberine on glucose and lipid metabolism in animal experiment
2345. Effects of Berberine on glucose metabolism in vitro
2346. Effects of Berberine on Glucose Stimulated Glucokinase Translation in NIT-1 Cells
2347. Effects of Berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome
2348. Effects of Berberine on Growth Development and Blood Parameters of Meat Rabbits
2349. Effects of Berberine on growth development and blood parameters of meat rabbits.
2350. Effects of Berberine on growth, liver histology, and expression of lipid-related genes in blunt snout bream (Megalobrama amblycephala) fed high-fat diets
2351. Effects of Berberine on Hemodynamics in Guinea Pigs
2352. Effects of Berberine on Hepatic Sirtuin 1-uncoupling Protein 2 Pathway in Non-alcoholic Fatty Liver Disease Rats Induced by High-fat Diet
2353. Effects of Berberine on Hepatocarcinoma Cell Lines
2354. Effects of Berberine on hippocampal neuronal damage and matrix metalloproteinase‐9 activity following transient global cerebral ischemia
2355. Effects of Berberine on human omental preadipocyte proliferation and differentiation
2356. Effects of Berberine on human rheumatoid arthritis fibroblast-like synoviocytes
2357. Effects of Berberine on IL-1 or tumour necrosis factor induced polymorphonuclear leucocyte-endothelium adhesion
2358. Effects of Berberine on In Vivo Pharmacokinetics of Midazolam and Its Metabolite in Rats
2359. Effects of Berberine on Induced Resistance and Development of Wheat and Preparation of Mixture
2360. Effects of Berberine on Insig-2 and VDR gene expression of HepG2 cell line
2361. Effects of Berberine on intracellular calcium concentration in smooth muscle cells of guinea pig colon
2362. Effects of Berberine on intracellular free calcium in smooth muscle cells of Guinea pig colon
2363. Effects of Berberine on ischemic ventricular arrhythmia
2364. Effects of Berberine on L-DOPA Therapy in 6-Hydroxydopamine-induced Rat Models of Parkinsonism
2365. Effects of Berberine on learning and memory ability in vascular cognitive impairment rats
2366. Effects of Berberine on Learning and Memory of Mice
2367. Effects of Berberine on left atria and trachea in guinea pigs
2368. Effects of Berberine on lipid and glucose metabolism in rats [J]
2369. Effects of Berberine on lipid metabolism and atherosclerosis in hyperlipidemic rabbits and its mechanism
2370. Effects of Berberine on lipid metabolism and PPARγ, INSIG-2 gene expression in adipose tissue of hyperlipidemic rabbits.
2371. Effects of Berberine on lipid metabolism in rats
2372. Effects of Berberine on lipid profile in subjects with low cardiovascular risk
2373. Effects of Berberine on Lymphocyte Proliferation and GM-CSF Production in Mice.
2374. Effects of Berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury
2375. EFFECTS OF Berberine ON MEMBRANE POTENTIAL AND CONTRACTION ACTIVITY OF SMOOTH MUSCLE IN GUINEA PIG PORTAL VEIN [J]
2376. Effects of Berberine on morphological changes of mesenteric vessels in diabetic rats
2377. Effects of Berberine on mRNA expression levels of PPARγ and adipocytokines in insulin-resistant adipocytes
2378. Effects of Berberine on mRNA expression of 11β-Hydroxysteroid dehydrogenase type Ⅰ in insulin-resistant HepG2 cells
2379. Effects of Berberine on Myoelectric Activity and Contractility of Rat Colonic Smooth Muscle
2380. Effects of Berberine on neurological effect and inflammatory factor in diabetes rats
2381. Effects of Berberine on neuronal apoptosis after global cerebral ischemia in mice [J]
2382. Effects of Berberine on neuronal apoptosis related gene after global cerebral ischemia in mice
2383. Effects of Berberine on neurotransmitter induced intracellular free Ca 2+ elevation in isolated brain cells of neonatal rat 1
2384. Effects of Berberine on neurotransmitter-induced intracellular free Ca~(2+) elevation in isolated brain cells of neonatal rat
2385. Effects of Berberine on NLRP3 and IL-1β expressions in monocytic THP-1 cells with monosodium urate crystals-induced inflammation
2386. Effects of Berberine on ovalbumin sensitized ileum smooth muscle strips of guinea pig
2387. Effects of Berberine on oxidative stress and endoplasmic reticulum stress in insulin resistance rats [J]
2388. Effects of Berberine on peripheral nerve function and neuropathic pain in diabetes rats
2389. Effects of Berberine on pharmacokinetics of amlodipine in rats and its potential mechanism
2390. Effects of Berberine on pharmacokinetics of midazolam and rhodamine 123 in rats in vivo
2391. Effects of Berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion
2392. EFFECTS OF Berberine ON PLATELET AGGREGATION AND PLASMA LEVELS OF TXB2 AND6-KETO-PGFla IN RATS WITH REVEKSIBLE MIDDLE CEREBRAL …
2393. Effects of Berberine on platelet aggregation and release
2394. Effects of Berberine on Potassium Current in Myocardial Cells of Cardiomyopathic Rats Induced by Abdominal Aorta Constriction
2395. Effects of Berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus
2396. Effects of Berberine on proliferation and apoptosis of human hepatoma Bel-7402 cell line
2397. Effects of Berberine on proliferation and apoptosis of human ovarian cancer cell line SKOV-3 in vitro
2398. Effects of Berberine on Proliferation and Metastasis of Human Endometrial Carcinoma Cell Line Ishikawa [J]
2399. Effects of Berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines
2400. Effects of Berberine on proliferation, migration and adhesion of lung adenocarcinoma cell line A549
2401. Effects of Berberine on Proto-oncogene c-fos Expression Induced by Global Cerebral Ischemia in Rats
2402. Effects of Berberine on rat jejunal motility
2403. Effects of Berberine on renal function, oxidative stress and renal aldose reductase in rats with diabetic nephropathy [J]
2404. Effects of Berberine on renal tubular of type 2 diabetic rats [J]
2405. Effects of Berberine on serum inflammatory factors and carotid atherosclerotic plaques in patients with acute cerebral ischemic stroke
2406. Effects of Berberine on serum levels of inflammatory factors and inflammatory signaling pathway in obese mice induced by high fat diet
2407. Effects of Berberine on single Ca2+ channel current in cultured embryonic chick ventricular myocytes
2408. Effects of Berberine on skeletal muscle protein metabolism in db/db mice and study of its mechanism
2409. Effects of Berberine on synthesis of platelet TXA2 and plasma PGI2 in rabbits
2410. Effects of Berberine on the activity of glucokinase and the gene expression in cultured hepG2 cells
2411. Effects of Berberine on the apoptosis of NIT-1 cells induced by high glucose and saturated fatty acids [J]
2412. Effects of Berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study
2413. Effects of Berberine on the clinical, metabolic and reproductive features of obese polycystic ovary syndrome women
2414. Effects of Berberine on the Expression of Caspase-3 Gene in Human Cervical Cancer Hela Cell
2415. Effects of Berberine on the Expression of GPVI on Platelets of Diabetes Rats [J]
2416. Effects of Berberine on the expression of hepatocyte nuclear factors mRNA in HepG2 cells [J]
2417. Effects of Berberine on the expression of LDLR in human liver cell strain Bel-7402
2418. Effects of Berberine on the expression of vascular endothelial growth factor in HepG2 cells
2419. Effects of Berberine on the growth and immune performance in response to ammonia stress and high-fat dietary in blunt snout bream Megalobrama amblycephala
2420. Effects of Berberine on the growth performance, antioxidative capacity and immune response to lipopolysaccharide challenge in broilers
2421. Effects of Berberine on the Intractable Heart Failure [J]
2422. Effects of Berberine on the levels of DTH and several important cytokines in the mice induced by DNFB
2423. Effects of Berberine on the pancreatic beta cell apoptosis in rats with insulin resistance
2424. Effects of Berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism
2425. Effects of Berberine on the photosynthetic pigments compositions and ultrastructure of Cyanobacterium Microcystis aeruginosa
2426. Effects of Berberine on the prevention of left ventricular remodeling after acute myocardial infarction
2427. Effects of Berberine on the proliferation and differentiation of HL-60 cells
2428. Effects of Berberine on the proliferation and the protein expression of Bcl-2, Bax on human gastric carcinoma SGC-7901 cells
2429. Effects of Berberine on the proliferation of diabetes mellitus rats vascular smooth muscle cells
2430. Effects of Berberine on the secretion of cytokines and expression of genes involved in cell cycle regulation in THP-1 monocytic cell line
2431. Effects of Berberine on the serum cystatin C levels and urine albumin/creatine ratio in patients with type 2 diabetes mellitus
2432. Effects of Berberine on the transport of P-gp substrates across Caco-2 and L-MDR1 cell monolayers
2433. Effects of Berberine on the vascular smooth muscle cell proliferation, rat carotid artery balloon-injury model and PTEN expression
2434. Effects of Berberine on tumor growth and intestinal permeability in HCT116 tumor-bearing mice using polyamines as targets
2435. Effects of Berberine on ventricular fibrillation threshold and action potentials in rabbit myocardium in vivo
2436. Effects of Berberine on β-secretase activity in a rabbit model of Alzheimer’s disease
2437. Effects of Berberine pretreatment on degree and incubation period of epileptic seizure in mice with penicillin-induced epilepsy
2438. Effects of Berberine , a plant alkaloid, on the growth of anaerobic protozoa in axenic culture.
2439. Effects of Berberine , Chelerythrine, and Sanguinarine on Proliferation in Four Human Immortalized Cell Lines
2440. Effects of Berberine , curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells—Power of …
2441. Effects of Berberine , glaucine, stephaglabrine, and sanguirythrine on neuromuscular transmission
2442. Effects of Berberine , palmatine and total alkaloids from Rhizoma coptidis on cholinergic nerve
2443. Effects of Berberine -evodiamine compatibility on expressions of intestinal ACAT2, ApoB48 and NPC1L1 in hypercholesterolemic rat
2444. Effects of berberis vulgaris fruit extracts and its active component Berberine on morphine dependence hypnosis and locomotor activity in mice
2445. Effects of Berberis vulgaris fruit extracts and its active component, Berberine , on morphine dependence, hypnosis and locomotor activity in mice
2446. Effects of chemical enhancers on the in vitro percutaneous absorption and amount retained in skin of baicalin and Berberine hydrochloride in compound Jiaoxuanling …
2447. Effects of chlorpromazine, Berberine and verapamil on Escherichia coli heat-labile enterotoxin-induced intestinal hypersecretion in rabbit ileal loops
2448. Effects of Cinnamon and Coptis in different compatibility proportion on content of Berberine in Jiaotai Bolus
2449. Effects of cinnamon granules on pharmacokinetics of Berberine in Rhizoma Coptidis granules in healthy male volunteers
2450. Effects of coadministration of Berberine chloride with cyclosporin on liver microsomal cytochrome P450 isoenzyme and mdr1 in rats
2451. Effects of Coadministration of Berberine Hydrochloride with Cyclosporine A on Liver Microsomal Drug Metabolizing Enzymes in Mice
2452. Effects of Complex of Astragalus Polysaccharids and Berberine on Egg Quality
2453. Effects of crude drugs and Berberine hydrochloride on the activities of fungi
2454. Effects of curcumin, Berberine and its compatibility on mRNA expression of glucose and lipid metabolismrelated genes in db/db mice
2455. Effects of decoction on transferring rate of Berberine hydrochloride in Jiawei Ermiaofang [J]
2456. Effects of different concentrations of Berberine on 3T3-L1 adipocyte glycometabolism and inflammatory cytokine expression
2457. Effects of different dose Berberine on hemodynamic parameters and [Ca2+] i of cardiac myocytes of diastolic heart failure rat model
2458. Effects of Different Processing Methods on Berberine Hydrochloride Content of Rhizoma Coptidis [J]
2459. Effects of emodin and Berberine on insulin resistance HepG2 cells [J]
2460. Effects of Evodiae Fructus on targeted distribution of Berberine in rats
2461. Effects of evodiamine and Berberine hydrochloride on cell apoptosis and expression of hTERT-mRNA of human colorectal cancer cell line HT-29 [J]
2462. Effects of evodiamine and Berberine hydrochloride on telomerase activity of human colorectal cancer cell line HT29
2463. Effects of Exenatide combinated with Berberine therapy on early phase insulin secretion in the patients with new onset type 2 diabetes mellitus
2464. Effects of ginseng total saponins with Berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure
2465. Effects of ginseng total saponins with Berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure.
2466. Effects of ginsenoside and Berberine on secretion of immunosuppressive cytokines in lung carcinoma cell line PG
2467. Effects of hypo-and hyperthermia, Berberine and the combination of Berberine with hyperthermia on osteosarcoma cells
2468. Effects of isoquinoline alkaloid Berberine on lipid peroxidation, antioxidant defense system, and liver damage induced by lead acetate in rats
2469. Effects of low retention enema with compound Berberine decoction on anal sinusitis
2470. Effects of Media Environment on the Fluorescence Spectra of Berberine
2471. Effects of Medicinal Herbs on Contraction Rate of Cultured Cardiomyocyte. Possible Mechanisms Involved in the Chronotropic Effects of Hawthorn and Berberine in Neonatal Murine Cardiomyocyte
2472. Effects of multiple washing on cotton fabrics containing Berberine microcapsules with anti-Staphylococcus aureus activity
2473. Effects of neutral sulfate Berberine on LPS-induced cardiomyocyte TNF-α secretion, abnormal calcium cycling, and cardiac dysfunction in rats
2474. Effects of neutral sulfate Berberine on LPS-induced cardiomyocyte TNF-α secretion, abnormal calcium cycling, and cardiac dysfunction in rats1
2475. Effects of oral administration of Berberine on distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats
2476. Effects of pH Value and Heat Treatment on the Antimicrobial Activity of Berberine
2477. Effects of Phosphate, Precursor and Exogenous Berberine on the Production of Alkaloid in Plant Cell Cultures
2478. Effects of probiotics, oligosaccharides, and Berberine combinationson growth performance of pigs
2479. Effects of rapeseed meal, terramycin, Berberine hydrochloride and andrographolide on thyroid function in fattening swine
2480. Effects of Resveratrol, Berberine and Their Combinations on Reactive Oxygen Species, Survival and Apoptosis in Human Squamous Carcinoma (SCC-25) Cells
2481. Effects of Simplex Component of Chinese Medicine Berberine and Ligustrazine on Production of Nitric Oxide of Porcine Oocyte in vitro Maturation [J]
2482. EFFECTS OF TEMPERATURE AND MOBILE PHASE COMPOSITION ON THE INTERACTION BETWEEN Berberine AND IMMOBILIZED β2-ADRENOCEPTOR BY …
2483. Effects of the complex prescription of metformin and Berberine on blood glucose and other indexes of the diabetic rats [J]
2484. Effects of the major alkaloid of Hydrastis canadensis L., Berberine , on rabbit prostate strips
2485. Effects of the Traditional Chinese Medicine Berberine on antiatheroscloresis and antioxidant activities in hyperlipoidemic model rats
2486. Effects of three preparation technologies on the oral bioavailability of Berberine α-hydroxy β-decanoylethyl sulfonate
2487. Effects of type 2 diabetes mellitus on the pharmacokinetics of Berberine in rats
2488. Effects of ultramicro-pulverization on the geniposide and Berberine dissolubility of Huanglianjiedusan
2489. Effects of Various Elicitors on the Production of Berberine in Plant Cell Suspension Cultures of Thalicrtrum rugosum
2490. Effects of veratrine, Berberine , nicotine and atropine on developmental characteristics and survival of the dark-sided cutworm, Euxoa messoria (Lepidoptera …
2491. Effects of water stress on Berberine , jatrorrhizine and palmatine contents in amur corktree seedlings
2492. Effects of β-cyclodextrin on the intestinal absorption of Berberine hydrochloride, a P-glycoprotein substrate
2493. Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized …
2494. Efficacy and safety of Berberine for congestive heart failure
2495. Efficacy and safety of Berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
2496. Efficacy and safety of Berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
2497. Efficacy and Safety of Berberine in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
2498. Efficacy and safety of Berberine in the treatment of type 2 diabetes with insulin resistance: Protocol for a systematic review
2499. Efficacy and tolerability of a nutraceutical combination (red yeast rice, policosanols, and Berberine ) in patients with low-moderate risk hypercholesterolemia: a …
2500. Efficacy of Berberine alone and in combination for the treatment of hyperlipidemia: a systematic review
2501. Efficacy of Berberine combined with ofloxacin on acute bacillary dysentery in infants and children by retentional enema treatment
2502. Efficacy of Berberine hydrochloride on biochemical parameters in Indian type 2 diabetic patients
2503. Efficacy of Berberine Hydrochloride Tablet in the Treatment of Non-alcoholic Fatty Liver Disease: A Me-ta-analysis
2504. Efficacy of Berberine in controlling foliar rice diseases
2505. Efficacy of Berberine in patients with non-alcoholic fatty liver disease
2506. Efficacy of Berberine in patients with type 2 diabetes mellitus
2507. Efficacy of Berberine , an antimicrobial plant alkaloid, as an endodontic irrigant against a mixed-culture biofilm in an in vitro tooth model
2508. Efficacy of Nutraceutical Combination of Monacolin K, Berberine , and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic …
2509. Electrochemical determination of Berberine at a multi-walled carbon nanotubes-modified glassy carbon electrode
2510. Electrochemical oxidation of Berberine and mass spectrometric identification of its oxidation products
2511. Electrochemical oxidation of Berberine and of its oxidation products at a glassy carbon electrode
2512. Electrochemical studies of Berberine and jatrorubine by pulse polarography
2513. Electropharmacological effects of Berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit.
2514. Electrophysiologic effects of Berberine on isolated sinoatrial and atrioventricular nodes of rabbit.
2515. Electrospun cellulose acetate/gelatin nanofibrous wound dressing containing Berberine for diabetic foot ulcer healing: in vitro and in vivo studies
2516. Elicitation, bioconversion and quantification of Berberine from Cissampelos pareira callus cultures
2517. Elicitor‐induced tyrosine decarboxylase in Berberine ‐synthesizing suspension cultures of Thalictrum rugosum
2518. Elimination of drug resistance plasmids from Shigella by norfloxacin and Berberine
2519. Elucidation of the signaling pathways that mediate Berberine -induced effects in cancer cells
2520. Encapsulation of Berberine in nano-sized PLGA synthesized by emulsification method
2521. Enhanced activity of strobilurin and fludioxonil by using Berberine and phenolic compounds to target fungal antioxidative stress response
2522. Enhanced anti-diabetic effect of Berberine combined with timosaponin B2 in Goto-Kakizaki rats, associated with increased variety and exposure of effective …
2523. Enhanced antimicrobial effect of Berberine in nanogel carriers with cationic surface functionality
2524. Enhanced circulating PCSK9 concentration by Berberine through SREBP-2 pathway in high fat diet-fed rats
2525. Enhanced DNA binding of 9-ω-amino alkyl ether analogs from the plant alkaloid Berberine
2526. Enhanced mineralization of antibiotic Berberine by the photoelectrochemical process in presence of chlorides and its optimization by response surface methodology
2527. Enhanced production of Berberine in In vitro regenerated cell of Tinospora cordifolia and its analysis through LCMS QToF
2528. Enhanced Production of Berberine Through Callus Culture of Tinospora cordifolia (Willd.) Miers ex Hook F. and Thoms.
2529. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of Berberine chloride in rats
2530. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of Berberine and evodiamine
2531. Enhancement of arsenic trioxide (As2O3)-mediated apoptosis using Berberine in human neuroblastoma SH-SY5Y cells
2532. Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins
2533. Enhancement of Berberine production by spermidine in Thalictrum minus cell suspension cultures
2534. Enhancement of Berberine production in suspension cultures of Coptis japonica by gibberellic acid treatment
2535. Enhancement of native fluorescence intensity of Berberine by (2-hydroxypropyl)-β-cyclodextrin in capillary electrophoresis coupled by laser-induced fluorescence …
2536. Enhancement of selectivity and sensitivity for Berberine determination by extraction-fluorophotometry
2537. Enhancement of sodium caprate on intestine absorption and antidiabetic action of Berberine
2538. Enhancing Effect of Berberine on Cyclosporine Against Skin Allograft Rejection in Mice [J]
2539. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of Berberine in rats
2540. Enhancing the antitumor activity of Berberine hydrochloride by solid lipid nanoparticle encapsulation
2541. Environmental impact of switching from the synthetic glucocorticoid prednisolone to the natural alkaloid Berberine
2542. Enzymatic extraction and dyeing ability of Berberine dyestuff from phellodenron [J]
2543. Enzymatic Synthesis of Chiral Amines using ω‐Transaminases, Amine Oxidases, and the Berberine Bridge Enzyme
2544. Enzyme-inducing effects of Berberine on cytochrome P450 1A2 in vitro and in vivo
2545. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis
2546. Equine Cutaneous Leishmaniasis: Treatment with Berberine Sulphate.
2547. Erratum to: Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation
2548. Estimation of Berberine in ayurvedic formulations containing Berberis aristata
2549. Estimation of biomarkers Berberine and gallic acid in polyherbal formulation punarnavashtak kwath and its clinical study for hepatoprotective potential
2550. Eulipidemic effects of Berberine administered alone or in combination with other natural cholesterol-lowering agents
2551. Eur J Endocrinol: A clinical study on the short term effect of Berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary …
2552. Evaluation of a 13-hexyl-Berberine hydrochloride topical gel formulation
2553. EVALUATION OF ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY OF RUTIN AND Berberine
2554. Evaluation of anti-cholinesterase and anti-inflammation activities of Berberine derivatives
2555. Evaluation of Anticoagulant and Antithrombotic Activities of Berberine : A Focus on the Ameliorative Effect on Blood Hypercoagulation
2556. Evaluation of Berberine as a natural fungicide: biodegradation and antimicrobial mechanism
2557. Evaluation of Berberine as an Alternative to Antibiotics in Nursery Pig Diets
2558. Evaluation of Berberine chloride as a new antibacterial agent against gram-positive bacteria for medical textiles
2559. Evaluation of Berberine /bovine serum albumin nanoparticles for liver fibrosis therapy
2560. Evaluation of biotransformed Berberine derivatives as anti inflammatory drugs: An in silico study
2561. Evaluation of Carvedilol and Berberine on Thiol Related Pathways
2562. Evaluation of cytotoxicity effects of combination Nano-Curcumin and Berberine in breast cancer cell line
2563. Evaluation of HPLC and spectrophotometric methods for analysis of bioactive constituent Berberine in stem extracts of Coscinium fenestratum
2564. Evaluation of synergetic anticancer activity of Berberine and curcumin on different models of A549, Hep-G2, MCF-7, Jurkat, and K562 cell lines
2565. Evaluation of the alpha-adrenoceptor antagonistic action of Berberine in isolated organs.
2566. Evaluation of the antimicrobial mode of Berberine by LC/ESI-MS combined with principal component analysis
2567. Evaluation of the biological potencies of newly synthesized Berberine derivatives bearing benzothiazole moieties with substituted functionalities
2568. Evaluation of the effect of a plant alkaloid (Berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro.
2569. Evaluation of the serum sex hormones levels and alkaline phosphatase activity in rats’ testis after administering of Berberine in experimental varicocele
2570. Evaluation of vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of Berberine as an anticancer …
2571. Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing Berberine , hypaconitine and skimmianine on the …
2572. Examination of Berberine dye using GC-MS after selective degradation treatments
2573. Examination of the In Vitro Dissolution of Berberine in the Coptis Root Powder of Different Granule Diameters
2574. Excretion of Berberine and its metabolites in oral administration in rats
2575. Experimental And Calculated By The DFT Method Vibration Spectra Of Berberine
2576. Experimental and quantum-chemical study of nucleophilic substitution mechanism in Berberine
2577. Experimental study of Berberine anti macrophages apoptosis induced by Tg and Fuc
2578. Experimental Study of Berberine on Diabetes Mellitus Complicated with Systemically Candida Albicans Infection [J]
2579. Experimental study of the antitrachoma action of Berberine .
2580. Experimental study on anti-bacter ial, anti-inflammatory and analgesic activities of the mixture of mangiferin and Berberine
2581. Experimental Study on Hypoglycemic Effect of the Mixture of Mangiferin and Berberine [J]
2582. Experimental Study on Inhibition Effect of Berberine in Escherichia coil Gene Transcription
2583. Experimental Study on SD Rats with Insulin Resistance (IR) Induced by High Fat Diet Intervened by Berberine
2584. Experimental study on the insulin-sensitivity-increasing effect of Berberine in insulin resistant rat models
2585. Experiments on the origin and function of Berberine in Berberis Darwinii
2586. Exploring the active mechanism of Berberine against HCC by systematic pharmacology and experimental validation
2587. Exploring thermodynamic parameters and the binding energetic of Berberine chloride to bovine serum albumin (BSA): Spectroscopy, isothermal titration calorimetry …
2588. Expression of the TetA gene encoding TetA efflux protein in E. coli contributes to its increased bacterial resistance toward Berberine
2589. Extensive intestinal first-pass elimination and predominant hepatic distribution of Berberine explain its low plasma levels in rats
2590. Extracellular signal-regulated kinase–dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine Berberine
2591. Extract Berberine from Rhizoma coptidis [J]
2592. Extract Berberine hydrochloride by aqueous two-phase system
2593. Extraction and Determination of Hydrochloric Acid Berberine from Aleuritopteris Argentea (Gmel) Fee [J]
2594. Extraction and Etermination of Berberine Hydrochloride in Jiaweizuojin Pills
2595. Extraction and isolation of jatrorrhizine choride in the preparation of Berberine chloride
2596. Extraction and Purification of Berberine Using Ion Erchange Fiber by Orthogonal Method [J]
2597. Extraction Berberine Hydrochloride from Coptis by [Bmim] BF_4/EA-(NH_4) _2SO_4-H_2O Aqueous Two-Phase System
2598. Extraction in cholinium-based magnetic ionic liquid aqueous two-phase system for the determination of Berberine hydrochloride in Rhizoma coptidis
2599. Extraction kinetical deviations of Berberine alkaloids in Rhizoma Coptidis and Zuojin Formulae
2600. Extraction of Berberine and removal of cadmium from Coptis chinensis Franch.
2601. Extraction of Berberine by Liquid Surfactant Membrane from Liquor of Berberis Amurensis Rupr [J]
2602. Extraction of Berberine dye and its dyeing behavior on nylon 6 fabric
2603. Extraction of Berberine from Rhizoma Coptidis
2604. Extraction of Berberine from Rhizomacoptidis by improved method [J]
2605. Extraction of Berberine from rhizome of Coptis chinensis Franch using supercritical fluid extraction
2606. Extraction of Berberine hydrochloride from Mahonia bealei (Fort.) Carr
2607. Extraction of Berberine Hydrochloride from Phellodendron Bark [J]
2608. Extraction Process of Berberine Hydrochloride in the Bitter Melon Fruit
2609. Extraction Study of Berberine from Cortex Phellodendri by Ultrasonic Wave-Cellulase [J]
2610. Extraction-spectrophotometric determination of Berberine in crude drugs by the formation of a new ion associate
2611. Extraction-Spectrophotometric Determination of Berberine in Pharmaceutical Preparations with 2, 6-Dichlorophenolindophenol
2612. Fabrication of novel hydrogel with Berberine -enriched carboxymethylcellulose and hyaluronic acid as an anti-inflammatory barrier membrane
2613. Facilitating effects of Berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity
2614. Failure of Berberine to Inhibit Pig Heart Glutamic-Aspartic Transaminase
2615. Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially
2616. FeMoO4-graphene oxide photo-electro-catalyst for Berberine removal and hydrogen evolution
2617. Field Control Effects of 0.3% Matrine· Berberine · Flavone Aqueous Solution on Tomato Late Blight
2618. Field Trails on Tomato Virus Control with 0.3% Radix Sophorea Flavesentis-Berberine -Flavone Bacteriocide AS [J]
2619. First case of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) due to Berberine , an over-the-counter herbal glycemic control agent
2620. Five salts of Berberine
2621. Five solvates of a multicomponent pharmaceutical salt formed by Berberine and diclofenac
2622. Flow cytometric analysis of cellular Berberine contents in high-and low-producing cell lines of Coptis japonica obtained by repeated selection
2623. Flow Injection Analysis Determined Berberine by Fouorimetry
2624. Flowcytometric analysis of the effect of Berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells
2625. Flow-injection chemiluminescence determination of Berberine hydrochloride
2626. Fluconazole assists Berberine to kill fluconazole-resistant Candida albicans
2627. Fluconazole inhibits cellular ergosterol synthesis to confer synergism with Berberine against yeast cells
2628. Fluorescence Anisotropy Study on the Effect of Phellodendri Cortex’s Berberine on Regulation of the Function of DNA
2629. Fluorescence assay based on preconcentration by a self-ordered ring using Berberine as a model analyte
2630. Fluorescence characteristics of the interaction between cycle DNA plasmid pUC118 and ligand Berberine
2631. Fluorescence microscopy demonstration of mitochondria in tissue culture cells using Berberine
2632. Fluorescence of Berberine in microheterogeneous systems
2633. Fluorescence Quenching Study on the Interaction of Berberine Derivatives with Bovine Serum Arlbumin
2634. Fluorescence spectra studies on the interaction of Berberine with nucleic acid
2635. Fluorescence Spectral Study of Berberine -K2HgI4 Associated Particle System and its Analytical Application
2636. Fluorescence Spectrophotometric Determination of Berberine Hydrochloride Content in Two Medicaments [J]
2637. Fluorescence Study of Liver‐Alcohol‐Dehydrogenase Complexes with Berberine and Other Ligands
2638. Fluorescent Berberine binding as a marker of internal glycosaminoglycans sulfate in bovine oocytes and sperm cells
2639. Fluorescent Berberine binding as a marker of secretory activity in mast cells
2640. Fluorescent organic ion pairs based on Berberine : counter-ion effect on the formation of particles and on the uptake by colon cancer cells
2641. Fluorophotometric Determination of Berberine with Micellar Sensitization [J]
2642. Force degradation studies of bioactive Berberine and Tinospora cordifolia extract
2643. Force Degradation Study of Berberine Chloride by Using Stability Indicating HPLC Method
2644. Formation and conformation of baicalin–Berberine and wogonoside–Berberine complexes
2645. Formation rules of baicalin-Berberine complex
2646. Formulation and in vitro evaluation of Berberine containing liposome optimized by 32 full factorial designs
2647. Formulation Design and in vitro Evaluation of Berberine Hydrochloride self-microemulsion [J]
2648. Formulation design and in vitro evaluation of Berberine -loaded self-nanoemulsifying drug delivery system
2649. Formulation of Berberine hydrochloride and hydroxypropyl-β-cyclodextrin inclusion complex with enhanced dissolution and reduced bitterness
2650. Four Arabidopsis Berberine bridge enzyme‐like proteins are specific oxidases that inactivate the elicitor‐active oligogalacturonides
2651. FoxO proteins’ nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in Berberine -treated HepG2 cells
2652. Function of Berberine on porcine in vitro fertilization embryo development and differential expression analysis of microRNAs
2653. Functional cross-talking between differentially expressed and alternatively spliced genes in human liver cancer cells treated with Berberine
2654. Functional study of the upregulation of miRNA-27a and miRNA-27b in 3T3-L1 cells in response to Berberine
2655. Fungicidal and herbicidal activities of Berberine related alkaloids
2656. Fungistasis of Berberine and Chitosan and Preparation of Composite Membrane [J]
2657. Further Studies on Competition of Berberine with Pyridoxal Phosphate in the Tryptophanase System of Escherichia coli.
2658. GADD153 mediates Berberine -induced apoptosis in human cervical cancer Ca ski cells
2659. Galactinol Synthase Gene of Coptis japonica Is Involved in Berberine Tolerance
2660. Gastrointestinal distribution of Berberine hydrochloride colon-specific tablets taken orally by rats
2661. Generation of reactive oxygen species by a novel Berberine –bile acid analog mediates apoptosis in hepatocarcinoma SMMC-7721 cells
2662. Genetic evidence for inhibition of bacterial division protein FtsZ by Berberine
2663. Genetic toxicity of Berberine on mouse heart
2664. Genetic variants of LDLR and PCSK9 associated with variations in response to antihypercholesterolemic effects of Armolipid Plus with Berberine
2665. Genome-scale microRNA identify small RNA modulators of the effect of Berberine on pancreatic cancer cell growth
2666. Genomic screening for targets regulated by Berberine in breast cancer cells
2667. Genotoxicity of the isoquinoline alkaloid Berberine in prokaryotic and eukaryotic organisms
2668. Genus Berberis and Berberine HPLC: An Overview
2669. Giloy is a rich source of columbin, palmatine, Berberine , choline, tinosporic acid, tinosporal, jatrohizine, starch (positive starch test with iodine solution), protein, calcium, phosphorus and several others. This is also known as “Divine Herbs” due to their high medicinal value.
2670. Global gene expression of Berberine against Yersiniapestis in vitro
2671. Global transcriptional profiles of Staphylococcus aureus treated with Berberine chloride
2672. Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine Berberine
2673. Gold nanoparticle and Berberine entrapped into hydrogel matrix as drug delivery system
2674. Gold Nanoparticle associated to Berberine induces vasorelaxation and cytosolic Ca2+ decrease in rat aorta
2675. Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of Berberine via efflux pump inhibition
2676. Gram‐scale production of carrier‐free fluorescent Berberine microrods for selective liver cancer therapy
2677. Growth performance, innate immune responses and disease resistance of fingerling blunt snout bream, Megalobrama amblycephala adapted to different Berberine -dietary feeding modes
2678. Growth suppression of HER2-overexpressing breast cancer cells by Berberine via modulation of the HER2/PI3K/Akt signaling pathway
2679. Growth-suppressive effect of Berberine on endometrial carcinoma cells: Role of mitochondrial and PI3K/Akt pathway
2680. Guizhou Berberis Wilsonae. Var. Guhtzunica Root in the Determination of Berberine Hydrochloride
2681. Gut microbiota-mediated personalized treatment of hyperlipidemia using Berberine
2682. Gut microbiota-regulated pharmacokinetics of Berberine and active metabolites in beagle dogs after oral administration
2683. GW24-e1352 Berberine mitigated cardiac hypoxiareoxygenation injury by Suppressed Autophagy and Reduced Cell Death via inhibition of the activation of AMPK …
2684. GW24-e2332 Berberine alleviates mesenteric artery endothelial dysfunction by improving insulin sensitivity in type 2 diabetic rats
2685. GW25-e2190 Berberine decrease β-amyloid level in N2a-APP695 cells through PPAR-gamma-IDE signaling pathway
2686. GW25-e3180 Berberine attenuates cardiac dysfunction, fibrosis, inflammatory in diabetic cardiomyopathy
2687. GW25-e4414 Berberine improves coronary vasodilation and prevents endothelial apoptosis via activating Akt-eNOS in diabetic rats
2688. GW26-e2333 Berberine Abolished the Decrease of Action Potential Duration Induced by Acetylcholine for Rabbits Atrial Tissue and Myocytes
2689. GW26-e4763 Berberine Prevents Atherosclerosis In Apolipoprotein E Knock Out Mice
2690. GW28-e0423 Berberine inhibits cardiomyocytes inflammation induced by ischemia though down-regulating toll-like receptors
2691. GW28-e0988 Berberine attenuates cardiac fibrosis via downregulating IGF1R in diabetic rats
2692. Habitat‐Dependent Variations in Berberine Content of Berberis asiatica Roxb. ex. DC. in Kumaon, Western Himalaya
2693. Hepatobiliary excretion of Berberine
2694. Hepatocyte nuclear factor 1α plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound Berberine
2695. Hepatoprotection of Berberine Against Hydrogen Peroxide‐induced Apoptosis by Upregulation of Sirtuin 1
2696. Hepatoprotective activity of Berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl4-intoxicated mice
2697. Hepatoprotective effect of Berberine against methotrexate induced liver toxicity in rats
2698. Hepatoprotective effects of Berberine on acetaminophen-induced hepatotoxicity in mice
2699. Hepatoprotective effects of Berberine on carbon tetrachloride-induced acute hepatotoxicity in rats
2700. Hepatoprotective effects of Berberine on liver fibrosis via activation of AMP-activated protein kinase
2701. Hepatoprotective properties and biotransformation of Berberine and berberrubine by cell suspension cultures of Dodonaea viscosa and Ocimum basilicum
2702. Hepatoprotective role of Berberine against paraquat-induced liver toxicity in rat
2703. HepG2 cell IR: Establishment of model and improvement by Berberine
2704. Herbicidal Spectrum, Absorption and Transportation, and Physiological Effect on Bidens pilosa of the Natural Alkaloid Berberine
2705. hERG1 is involved in the pathophysiological process and inhibited by Berberine in SKOV3 cells
2706. Heterologous expression of the plant proteins strictosidine synthase and Berberine bridge enzyme in insect cell culture
2707. Heterotropic Cooperativity for CYP3A4-Mediated 1′-Hydroxylation of Midazolam by Berberine : An In Silico Modeling and Simulation Study
2708. High Berberine -producing cultures of Coptis japonica cells
2709. High density culture of Coptis japonica cells increases Berberine production
2710. High-content analysis of chelidonine and Berberine from Iranian Chelidonium majus L. ecotypes in different ontogenetical stages using various methods of extraction
2711. High-Content Analysis of Chelidonine and Berberine from Iranian Chelidonium majus L. Ecotypes in Different Ontogenetical Stages Using Various Methods of …
2712. Highly efficient degradation of Berberine chloride form wastewater by a novel three-dimensional electrode photoelectrocatalytic system
2713. Highly selective fluorescent visual detection of perfluorooctane sulfonate via blue fluorescent carbon dots and Berberine chloride hydrate
2714. Highly selective, sensitive and fluorescent sensing of dimeric G-quadruplexes by a dimeric Berberine
2715. Highly sensitive fluorescence response to inclusion complex formation of Berberine alkaloid with cucurbit [7] uril
2716. High-performance capillary electrophoresis for determining the contents of Berberine , jatrorrhizine and palmatine in Gegenqinlian decoction.
2717. High‐performance liquid chromatography determination of hydrastine and Berberine in dietary supplements containing goldenseal
2718. Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie Berberine improvement of learning and memory in streptozotocin-diabetic rats
2719. Histamine (H1) Receptors, Cyclooxygenase Pathway and Nitric Oxide Formation Involved in Rat Tracheal Smooth Muscle Relaxant Effect of Berberine
2720. Histochemistry of Berberine of coptis chinensis franch. Rhizome
2721. Histological observation of direct pulp-capping with biomembrane of Berberine compound in minipigs
2722. HNF1α plays a critical role in PCSK9 gene transcription and regulation by a natural hypocholesterolemic compound Berberine
2723. Homology modeling and docking studies of Plasmodium falciparum telomerase reverse transcriptase with Berberine and some of its derivatives
2724. Hop rho iso-alpha acids, Berberine , vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial
2725. Hop rho iso-alpha acids, Berberine , vitamin D₃ and vitamin K₁ favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial
2726. Hormetic effect of Berberine attenuates the anticancer activity of chemotherapeutic agents
2727. Hormonal regulation of Berberine production in cell suspension cultures of Thalictrum minus
2728. HPCE Determination of Berberine Content in Coptidis Rhizoma [J]
2729. HPCE Determination of Berberine in Qingjing Capsules
2730. HPLC analysis of paeoniflorin, Berberine hydrochloride and glycyrrhizic acid in Weiyankang capsules [J]
2731. HPLC Determination of Berberine Chloride in Lianpu Shuangqing Tablet
2732. HPLC Determination of Berberine Hydrochloide in Qianlie Tong Tablet
2733. HPLC Determination of Berberine Hydrochloide in Qianlie Tong Tablet [J]
2734. HPLC determination of Berberine hydrochloride and palmatine hydrochloride in Zhibai Dihuang pills
2735. HPLC Determination of Berberine Hydrochloride Content in Yujinyinxie Pill
2736. HPLC determination of Berberine hydrochloride in compound Berberine [J]
2737. HPLC Determination of Berberine Hydrochloride in GuZhiNing Liniment
2738. HPLC determination of Berberine hydrochloride in Milinqing capsules [J]
2739. HPLC Determination of Berberine Hydrochloride in Shihu Yeguang Pills [J]
2740. HPLC Determination of Berberine Hydrochloridein Shibawei Hezi Liniaowan Capsulas
2741. HPLC Determination of Berberine in “Shaoshang Zhitong Ointment”
2742. HPLC determination of Berberine in medicinal herbs and a related traditional Chinese medicine
2743. HPLC determination of Berberine in plasma of patients with ischemic heart failure
2744. HPLC Determination of Content of Berberine Hydrochloride in the Baian Washing Lotion [J]
2745. HPLC determination of trimethoprim and Berberine sulfate in compound Berberine injection
2746. HPLC estimation of Berberine in Tinospora cordifolia and Tinospora sinensis
2747. HPLC Method for Measuring Berberine Bydrochloridein in Qingre Zhidai Granul
2748. HPLC quantitative analysis of Berberine absorpted with macroporous resin in Rhizoma Coptidis and its preparation zuo jin wan
2749. HPLC-dad determination of Berberine , chelerythrine and sanguinarine in the mexican prickly poppy (Argemone mexicana L. Papaveraceae), a medicinal …
2750. HPTLC ANALYSIS OF Berberine IN ARGEMONE MEXICANA L
2751. HPTLC analysis of Berberine in stem extracts of Fibraurea darshani
2752. HPTLC Determination of Synthetic Berberine Mixed in Fibrauretinum as Adulterant [J]
2753. HPTLC fingerprinting profile of marker compound (Berberine ) in roots of Berberis aristata DC
2754. HPTLC method development for Divya Arshkalp Vati containing marker compound Berberine
2755. HPTLC method for estimation of Berberine in ayurvedic formulations containing Berberis aristata by an acid dye method
2756. Human MDR1 and MRP1 recognize Berberine as their transport substrate
2757. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and Berberine to lung carcinoma
2758. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of Berberine chloride for an efficient suppression of Ehrlich ascites tumors
2759. Hybrid materials based on luminescent alkaloid Berberine and saponite
2760. Hydrophobic ring substitution on 9-O position of Berberine act as a selective fluorescent sensor for the recognition of bovine serum albumin
2761. Hypercrosslinked poly (styrene-co-divinylbenzene) resin as a specific polymeric adsorbent for purification of Berberine hydrochloride from aqueous solutions
2762. Hypoglycemic Activity of Berberine [J]
2763. Hypoglycemic and insulin-sensitizing effects of Berberine in high-fat diet-and streptozotocin-induced diabetic rats
2764. Hypoglycemic Pharmacodynamics and Clinical Efficacy of Berberine [J]
2765. Hypolipidemic Berberine Derivatives with a Reduced Aromatic Ring C
2766. Hypoxia-inducible factor 1 mediates the anti-apoptosis of Berberine in neurons during hypoxia/ischemia
2767. I. The alkaloids of corydalis cava. II. On the relation between the absorption spectra & the chemical structure of corydaline, Berberine , and other alkaloids
2768. Identification and characterization of Berberine in tinospora cordifolia by liquid chromatography Quadrupole time of flight mass spectrometry (LC MS/MS q-tof) and …
2769. Identification and characterization of bioactive compound Berberine in the Berberis vulgaris root extract using HR-LC-MS analysis
2770. Identification and quantitative determination of Berberine hydrochloride of Niaoyanqing tablet
2771. Identification and verification of potential therapeutic target genes in Berberine -treated zucker diabetic fatty rats through bioinformatics analysis
2772. Identification of a novel and potent inhibitor of phospholipase A2 in a medicinal plant: Crystal structure at 1.93 Å and Surface Plasmon Resonance analysis of phospholipase A2 complexed with Berberine
2773. Identification of actin as a direct proteomic target of Berberine using an affinity-based chemical probe and elucidation of its modulatory role in actin assembly
2774. Identification of Berberine as a direct thrombin inhibitor from traditional Chinese medicine through structural, functional and binding studies
2775. Identification of Berberine as a novel agonist of fatty acid receptor GPR40
2776. Identification of Berberine in ancient and historical textiles by surface‐enhanced Raman scattering
2777. Identification of Chief Effective Component of Jiawei Sanhuang Tablet with Thin-Layer Chromatography(TLC) and Determination of Content of Berberine in Jiawei Sanhuang Tablet with TLC Scanning
2778. Identification of Lianhuang Zhichuang suppository by TLC and determination of Berberine hydrochloride by HPLC [J]
2779. Identification of medicinal material for Jinji granules and determination of Berberine hydro-chloride [J]
2780. Identification of Molecular Target Proteins in Berberine ‐treated Cervix Adenocarcinoma HeLa Cells by Proteomic and Bioinformatic Analyses
2781. Identification of three sulfate-conjugated metabolites of Berberine chloride in healthy volunteers’ urine after oral administration.
2782. Immunocytological localization of two enzymes involved in Berberine biosynthesis
2783. Immunoquantitative analysis for Berberine and its related compounds using monoclonal antibodies in herbal medicines
2784. Immunotoxicity induced in mice by subacute exposure to Berberine
2785. Impact of Berberine on broiler thiram-induced tibial cartilage dysplasia
2786. Impact of Berberine on human gut bacteria
2787. Impact of~(60) Co-γ irradiation on the active ingredient from Berberine
2788. Impact on absorption of Berberine and palmatine in different compatibilities of Wuji pill
2789. Impacts of Berberine on oxidized LDL-induced proliferation of human umbilical vein endothelial cells
2790. Impacts of Berberine on the growth, migration and radiosensitivity of breast cancer cells
2791. Impacts of multicomponent environment on intrinsic dissolution rate of Berberine in biopharmaceutics classification system of Chinese materia medica
2792. Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with Berberine …
2793. Improved methods for content determination of Berberine hydrochloride tablets
2794. Improved sample preparation method for content determination of Berberine in Renshen Zaizao pills
2795. Improved tablet disintegration and dissolution performance by incorporation of “baicalin-Berberine ” complex
2796. Improvement of anti-inflammatory and anti-angiogenic activity of Berberine by novel rapid dissolving nanoemulsifying technique
2797. Improvement of drug delivery using gold nanoparticle and Berberine associated to a new hydrogel system
2798. Improvement of extracting Berberine hydrochloride from cortex phallodendri [J]
2799. Improvement of Extracting Process of Berberine Hydrochlorlde in Cotex phallodendri [J]
2800. Improvement of intestinal transport, absorption and anti-diabetic efficacy of Berberine by using Gelucire44/14: In vitro, in situ and in vivo studies
2801. Improvement of light fastness of Berberine colorant by natural antioxidants
2802. Improvement of superoxide dismutase and catalase in streptozotocin–nicotinamide-induced type 2-diabetes in mice by Berberine and glibenclamide
2803. Improvement of the HPLC Determination of Berberine in Compound Berberine Tablets on ChP, 2000, Vol. I
2804. Improving solid-state properties of Berberine chloride through forming a salt cocrystal with citric acid
2805. In situ Berberine separation with immobilized adsorbent in cell suspension cultures ofThalictrum rugosum
2806. In situ intestinal absorption kinetics of Berberine and jatrorrhizine from extractive Rhizoma Coptidis in rats
2807. In situ thin layer chromatography-fourier transform-surface-enhanced Raman spectrum study on ingredients of Berberine
2808. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii
2809. In vitro and in vivo activity of Berberine on the blood trypomastigote from Trypanosoma cruzi
2810. In vitro and in vivo antitumor efficacy of Berberine -nanostructured lipid carriers against H22 tumor
2811. In Vitro and in Vivo Antitumor Efficacy of Berberine -solid Lipid Nanoparticles Against H22 Tumor
2812. In Vitro Antibacterial Activities of Berberine Against the Five Mycoplasmal Species [J]
2813. In vitro antibacterial activity of allicin in combination with Berberine hydrochloride
2814. In vitro antibacterial effect of Berberine hydrochloride and enrofloxacin to fish pathogenic bacteria
2815. In vitro antifungal activity of the Berberine and its synergism with fluconazole
2816. In Vitro Anti-Helicobacter pylori Activity of Berberine and Barberry Extracts: A Preliminary Report
2817. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid Berberine
2818. In vitro antiviral activity of a Berberine derivant HB-13 against herpes simplex virus
2819. In vitro biological assessment of berberis vulgaris and its active constituent, Berberine : antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer …
2820. In vitro characterization and inhibition of the interaction between ciprofloxacin and Berberine against multidrug-resistant Klebsiella pneumoniae
2821. In vitro cytotoxicity of Berberine against HeLa and L1210 cancer cell lines
2822. In vitro effect of some chemical compositions in Wuzhuyu on Berberine metabolism in rat liver microsomes
2823. In vitro effects of Berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis
2824. In vitro Effects of Berberine versus Sodium Hypochlorite on Dentin Flexural Strength
2825. In vitro Effects of the Traditional Chinese Medicine, Berberine , Matrine and Baicalin, on the Proliferation and Lipid Synthesis of Immortalized Human Sebocyte SZ95
2826. In vitro inhibitory effect of Berberis vulgaris (Berberidaceae) and its main component, Berberine against different Leishmania species
2827. In vitro regeneration and genetic transformation of the Berberine ‐producing plant, Thalictrum flavum ssp. glaucum
2828. In Vitro Research on the Effects of Berberine , Oleanolic Acid and Allitridi on Glucose Metabolism
2829. In vitro studies of antifibrotic and cytoprotective effects elicited by proto-Berberine alkaloids in human dermal fibroblasts
2830. In vitro studies of Berberine metabolism and its effect of enzyme induction on HepG2 cells
2831. In vitro studies on the multi-target anti-Alzheimer activities of Berberine -like alkaloids from Coptidis rhizoma
2832. In vitro study on the effects of trial denture cleansers with Berberine hydrochloride
2833. In Vitro Susceptibility of Berberine Combined with Antifungal Agents Against the Yeast Form of Talaromyces marneffei
2834. In vitro susceptibility testing of Candida albicans to Berberine hydrochdoride
2835. In vitro synergism between Berberine and miconazole against planktonic and biofilm Candida cultures
2836. In vivo and in vitro antiviral effects of Berberine on influenza virus
2837. In vivo and in vitro study on drug-drug interaction of lovastatin and Berberine from pharmacokinetic and HepG2 cell metabolism studies
2838. In vivo anti-apoptosis activity of novel Berberine -loaded chitosan nanoparticles effectively ameliorates osteoarthritis
2839. In vivo antibacterial activity of the compound Berberine gelatin
2840. In vivo anticoccidial activity of Berberine [18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium]–an isoquinoline alkaloid present in the …
2841. In vivo hemodynamic visualization of Berberine -induced effect on the cerebral cortex of a mouse by photoacoustic tomography
2842. In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine
2843. In Vivo Small Intestinal Absorption of Berberine and Jatrorrhizine from Rhizoma coptidis Powder in Rats
2844. Inclusion complex formation of ionic liquids with 4-sulfonatocalixarenes studied by competitive binding of Berberine alkaloid fluorescent probe
2845. Inclusion complex formation of ionic liquids with cucurbit [7] uril studied by competitive binding of Berberine fluorescent probe
2846. Increase in action potential duration and inhibition of the delayed rectifier outward current IK by Berberine in cat ventricular myocytes.
2847. Increased Bioavailable Berberine Protects Against Myocardial Ischemia Reperfusion Injury Through Attenuation of NFκB and JNK Signaling Pathways
2848. Increased oxidative stress in cultured 3T3-L1 cells was attenuated by Berberine treatment
2849. Increased serotonergic neurotransmission is not responsible for the anticompulsive effect of Berberine in a murine model of obsessive–compulsive disorder
2850. Indirect determination of Berberine hydrochloride by atomic absorption spectrometry
2851. Indirect Determination of Berberine in Tabellae Berberine Hydrochloride by Atomic Emission Spectrometry
2852. Individual and combined effects of Berberine and santonin on spore germination of some fungi
2853. Induction of a specific methyltransferase activity regulating Berberine biosynthesis by cytokinin in Thalictrum minus cell cultures
2854. Induction of apoptosis by Berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κB
2855. Induction of Berberine biosynthesis by cytokinins in Thalictrum minus cell suspension cultures
2856. Induction of G1 cell cycle arrest and apoptosis by Berberine in bladder cancer cells
2857. Induction of G2/M arrest by Berberine via activation of PI3K/Akt and p38 in human chondrosarcoma cell line
2858. Induction of interleukin‐12 production in mouse macrophages by Berberine , a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response
2859. Industrial production of shikonin and Berberine
2860. Influe of Berberine on T-cell mediated immunity
2861. Influence factors on in vitro release of Berberine hydrochloride from carboxymethyl konjac glucomannan pellets
2862. INFLUENCE OF Berberine AND SODIUM NITROPRUSSIDE ON THE ACTION OF SEVERAL AGONISTS IN THE AORTIC STRIPS OF RABBITS
2863. Influence of Berberine on cardiac function and plasma nitric oxide for chronic congestive heart failure secondary to ischemic or dilated cardiomyopathy
2864. Influence of Berberine on expression of hepatic X receptors and their target genes in liver of Chinese hamsters with type 2 diabetes mellitus [J]
2865. Influence of Berberine on left ventriculer remodeling in rats with hypertrophic cardiomyopathy induced by 2K1C
2866. Influence of Berberine on nerve conduction velocity in rats with type 2 diabetic neuropathy [J]
2867. Influence of Berberine on the blood pressure of rabbits
2868. Influence of Berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli.
2869. Influence of borneol on Berberine absorption in rat intestine
2870. Influence of compatibility on content of Berberine in Gegen Qinlian Decoction
2871. Influence of compatibility on content of Berberine in Maxingganshi decoction
2872. Influence of different extracting method on the content of Berberine in rhizoma coptis and antifungal performance
2873. Influence of Different Extraction Technologies on the Content of Berberine Hydrochloride in Miniaoning Granules
2874. Influence of drought stress on plant physiology and Berberine content of leaves in Phellodendron amurense seedlings.
2875. Influence of Environmental Factors on Production of Berberine Content in Berberis asiatica Roxb. ex DC in Kumaun West Himalaya, India
2876. Influence of Guizhi Fuling Pill Combined with Berberine on Polycystic Ovary Syndrome with Insulin Resistance
2877. Influence of Habitat Characteristics and Altitude on Berberine Content in Berberis jaeschkeana CK Schneid
2878. Influence of huanglian and Berberine on the erythrocytic osmotic fragilitas of experimental glucose-6-phosphate dehydrogenase deficiency in rats
2879. Influence of Ligustrazine and Berberine on Maturation of Porcine Oocytes in vitro [J]
2880. Influence of Mixed Decoction of Cortex Phellodendri, Radix Glycyrrhizae and Ramulus Loranthi on Ex-traction Rate of Berberine [J]
2881. Influence of penetration enhancer on transdermal permeation of Berberine hydrochloride in vitro [J]
2882. Influence of plasticizers on the physical performance and antimicrobial activity of a chitosan-Berberine composite membrane
2883. Influence of processing on the content of Berberine hydrochloride in Er Miao decoction
2884. Influence of quercetin, naringenin and Berberine on glucose transporters and insulin signalling molecules in brain of streptozotocin-induced diabetic rats
2885. Influence of various compatibilities on the content of baicalin and Berberine in Gegen Qinlian Decoction [J]
2886. Inherited cytoplasmic changes induced in yeasts by acriflavine and Berberine .
2887. Inhibit of Berberine combined with cyclophosphamide on Lewis pulmonary carcinoma in mice
2888. Inhibiting roles of Berberine in gut movement of rodents are related to activation of the endogenous opioid system
2889. Inhibition by Berberine and Cytosine Deaminase Enzyme Suicide Gene on Rectum Cancer Cells
2890. Inhibition by Berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells
2891. Inhibition Effect of Berberine Chloride Against Helminthosporium turcicum and Bipolaris maydis [J]
2892. Inhibition effect of Berberine on the corrosion of copper in acidic medium
2893. Inhibition of activator protein 1 activity by Berberine in human hepatoma cells
2894. Inhibition of autophagy by Berberine enhances the survival of H9C2 myocytes following hypoxia
2895. Inhibition of Berberine on growth of human nasopharyngeal carcinoma cells CNE-2 in vivo and in vitro
2896. Inhibition of Berberine on IKr, IKs and IK1 in thyroxine induced cardiomyopathic guinea pig ventricular myocytes.
2897. Inhibition of Berberine on organ anion transporters and its bidirectional trans-membrane transport
2898. Inhibition of Berberine on organ cation transporters
2899. Inhibition of biofilm formation and quorum sensing mediated phenotypes by Berberine in Pseudomonas aeruginosa and Salmonella typhimurium
2900. Inhibition of Candida rugosa Lipase by Berberine and Structurally Related Alkaloids, Evaluated by High-Performance Liquid Chromatography
2901. Inhibition of chemical carcinogenesis by Berberine in rats and mice
2902. Inhibition of cholinesterase activity and amyloid aggregation by Berberine -phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids
2903. Inhibition of compounding of gentamycin, sanhuangtang and Berberine to E. coli in vitro
2904. Inhibition of CYP1 by Berberine , palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling
2905. Inhibition of CYP450 1A and 3A by Berberine in crucian carp Carassius auratus gibelio
2906. Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of Berberine
2907. Inhibition of electrolyte transport in isolated guinea-pig ileum by Berberine
2908. Inhibition of endothelial microparticles-mediated oxidative stress by Berberine and its relation with endothelial function in humans
2909. Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid Berberine and extracts of goldenseal (Hydrastis …
2910. Inhibition of human pregnancy plasma diamine oxidase with alkaloids of Argemone mexicana–Berberine and sanguinarine.
2911. Inhibition of in‐vitro lymphocyte transformation by the isoquinoline alkaloid Berberine
2912. INHIBITION OF LADH BY Berberine AND SOME RELATED ALKALOIDS
2913. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of Berberine
2914. Inhibition of M1 macrophage activation in adipose tissue by Berberine improves insulin resistance
2915. Inhibition of Mice Implanted Tumor by Berberine [J]
2916. Inhibition of Microbially-induced Inflammation by the Naturally Occurring Plant Compounds Tetra-O-methyl nordihydroguaiaretic acid (terameprocol) and Berberine
2917. Inhibition of migration and invasion by Berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line.
2918. Inhibition of oral streptococci growth induced by the complementary action of Berberine chloride and antibacterial compounds
2919. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of Berberine
2920. Inhibition of p38 mitogen-activated protein kinase potentiates the apoptotic effect of Berberine /tumor necrosis factor-related apoptosis-inducing ligand …
2921. Inhibition of pancreatic lipase by Berberine and dihydroBerberine : an investigation by docking simulation and experimental validation
2922. Inhibition of PCSK9 transcription by Berberine involves down-regulation of hepatic HNF1α protein expression through the ubiquitin-proteasome degradation pathway
2923. Inhibition of PCSK9 Transcription by Berberine Involves Down-regulation of HNF1 Protein Cellular Levels Through Ubiquitin-proteasome Pathway
2924. Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of Berberine in murine and human macrophages
2925. Inhibition of photosynthesis-related gene expression by Berberine in Microcystis aeruginosa.
2926. Inhibition of progression of erythroleukemia induced by Friend virus in BALB/c mice by natural products-Berberine , Curcumin and Picroliv.
2927. Inhibition of proprotein convertase subtilisin/kexin type 9: A novel mechanism of Berberine and 8-hydroxy dihydroBerberine against hyperlipidemia
2928. Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by Berberine
2929. Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the neuroprotective effect of Berberine against cerebral ischemia
2930. Inhibition of the respiratory chain by the alkaloids Berberine sulfate, alpinigenine, and tetrahydropalmatine
2931. Inhibition of thymocyte apoptosis by Berberine
2932. Inhibitive effects of Berberine hydrochloride on biofilm forming of Staphylococcus epidermidis [J]
2933. Inhibitory action of Berberine on glucose absorption
2934. Inhibitory Actions of Berberine on Growth and Arylamine N-Acetyltransferase Activity in Strains of Helicobacter Pylori from Peptic Ulcer Patients
2935. Inhibitory activity of Berberine on DNA strand cleavage induced by hydrogen peroxide and cytochrome c
2936. Inhibitory effect and transcriptional impact of Berberine and evodiamine on human white preadipocyte differentiation
2937. Inhibitory effect of Berberine from Coptidis rhizoma on melanin synthesis of murine malignant melanoma
2938. Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies
2939. Inhibitory effect of Berberine on differentiation of rat bone marrow mesenchymal stem cells to adipocytes
2940. Inhibitory effect of Berberine on Epstein-Barr DNA replication
2941. Inhibitory effect of Berberine on human skin squamous cell carcinoma A431 cells
2942. Inhibitory effect of Berberine on inflammation-induced dopaminergic neuron-degeneration [J]
2943. Inhibitory effect of Berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells
2944. Inhibitory effect of Berberine on potassium channels in guinea pig ventricular myocytes
2945. Inhibitory effect of Berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver
2946. Inhibitory effect of Berberine on the activation and proliferation of T lymphocytes
2947. Inhibitory effect of Berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2
2948. Inhibitory effect of Berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma
2949. Inhibitory effect of Berberine on the motivational effects of ethanol in mice
2950. Inhibitory effect of Berberine on the TNF-α-induced Expression of IL-8 and MCP-1 is mediated through suppression of NF-κB activation in HT29 Human Colon …
2951. Inhibitory effect of Berberine on zeste homolog 2 (Ezh2) enhancement in human esophageal cell lines
2952. Inhibitory effect of Coptidis Rhizoma and Berberine on the proliferation of human esophageal cancer cell lines
2953. Inhibitory Effect of Panax notoginseng and Berberine on LPS-induced
2954. Inhibitory Effect of Sulbactum and Berberine on Extended-Spectrum β-Lactamases from E. colic in Fowl [J]
2955. Inhibitory Effect of Two Traditional Chinese Medicine Monomers, Berberine and Matrine, on the Quorum Sensing System of Antimicrobial-Resistant …
2956. Inhibitory effects of Berberine against morphine-induced locomotor sensitization and analgesic tolerance in mice
2957. Inhibitory Effects of Berberine Hydrochloride on Trichophyton mentagrophytes and the Underlying Mechanisms
2958. Inhibitory effects of Berberine on ATP-sensitive K+ channels in cardiac myocytes
2959. Inhibitory effects of Berberine on c fos expression and intracellular free calcium elevation induced by glutamate in dissociated brain cells of neonatal rats [J]
2960. Inhibitory Effects of Berberine on Chlamydia Pneumoniae Induced-Vascular Endothelial Cell Migration via PI3K [J]
2961. Inhibitory Effects of Berberine on growth of K562 cell
2962. Inhibitory effects of Berberine on IK1, IK, and HERG channels of cardiac myocytes
2963. Inhibitory effects of Berberine on IK1, IK, and HERG channels of cardiac myocytes.
2964. Inhibitory effects of Berberine on ion channels of rat hepatocytes
2965. Inhibitory effects of Berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages
2966. Inhibitory effects of Berberine on proliferation and migration in rat aortic smooth muscle cells
2967. Inhibitory Effects of Berberine on Proliferation of Mouse Lymphoma Cells
2968. Inhibitory effects of Berberine on the activation and cell cycle progression of human peripheral lymphocytes
2969. Inhibitory effects of Berberine on the formation of cholesterol gallstone and its mechanism in rabbits
2970. Inhibitory effects of Berberine on the migratory and invasive abilities of cancer cells
2971. Inhibitory effects of Berberine on voltage-and calcium-activated potassium currents in human myeloma cells
2972. Inhibitory effects of Berberine -type alkaloids on elastase
2973. Inhibitory effects of Coptidis rhizoma and Berberine on cocaine-induced sensitization
2974. Inhibitory effects of emodin, baicalin, schizandrin and Berberine on hefA gene: Treatment of Helicobacter pylori-induced multidrug resistance
2975. Inhibitory effects of golden thread (Coptis chinensis) and Berberine on Microcystis aeruginosa
2976. Inhibitory effects of isoquinoline alkaloid Berberine on ischemia-induced apoptosis via activation of phosphoinositide 3-kinase/protein kinase B signaling …
2977. Inhibitory effects of Zoagumhwan water extract and Berberine on angiotensin II-induced monocyte chemoattractant protein (MCP)-1 expression and monocyte …
2978. Inhibitory effort of Berberine on pseudopod formation and the motility of CNE1 via Ezrin phosphoarylation
2979. Initial empirical study of human buccal mucosa fibroblasts inflammatory reaction after Berberine excitation.
2980. Innate Lymphoid Cells—A New Medium That Berberine Affect Glycolipid Metabolism
2981. Inotropic and chronotropic activity of Berberine on isolated guinea pig atria.
2982. In-silico bioprospecting of the enzymes involved in the biosynthetic pathway of the alkaloid Berberine and its distance study Through R
2983. Inspect the Content of Berberine and Baicalin in Sanhuang Tablets from Different Manufacturers [J]
2984. Insulin sensitizing and insulinotropic action of Berberine from Cortidis rhizoma
2985. Insulin-Dependent Type 2 Diabetes Treated with Berberine , Alpha-Lipoic Acid and a Ketogenic Diet: A Case Report
2986. Integration of microRNA–mRNA profiles and pathway analysis of plant isoquinoline alkaloid Berberine in sgc-7901 gastric cancers cells
2987. Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to Berberine
2988. Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with Berberine compounds
2989. Intensification of extracting Berberine by dual-frequency ultrasound
2990. Interaction Between Berberine and Human Gamma Globulin in Membrane Mimetic Environments
2991. Interaction between bovine serum albumin and Berberine chloride extracted from Chinese herbs of coptis chinensis franch
2992. Interaction between drugs and water-soluble polymers. VII. Binding of Berberine with bovine serum albumin
2993. Interaction between isopoly-tungstic acid and Berberine hydrochloride by resonance Rayleigh scattering spectrum
2994. Interaction between nucleic acids and Berberine sulfate
2995. Interaction between the plant alkaloid Berberine and fullerene C70: Experimental and quantum-chemical study
2996. Interaction mechanism between Berberine and the enzyme lysozyme
2997. Interaction of [HgX4] 2-with Berberine by Absorption and Resonance Rayleigh-Scattering Spectra and Their Analytical Applications
2998. Interaction of 9-O-(ω-amino) alkyl ether Berberine analogs with poly(dT)·poly(dA)*poly(dT) triplex and poly(dA)·poly(dT) duplex: a comparative study
2999. Interaction of anticancer herbal drug Berberine with DNA immobilized on the glassy carbon electrode
3000. Interaction of baicalin with Berberine for glucose uptake in 3T3-L1 adipocytes and HepG2 hepatocytes
3001. Interaction of Baicalin with Berberine for Intestinal Absorption in Rats [J]
3002. Interaction of Berberine chloride with deoxyribonucleic acids: evidence for base and sequence specificity.
3003. Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells
3004. Interaction of Berberine with human platelet α2 adrenoceptors
3005. Interaction of Berberine , palmatine, coralyne, and sanguinarine to quadruplex DNA: a comparative spectroscopic and calorimetric study
3006. INTERACTION OF DRUGS WITH DNA Ⅰ. Berberine AS LUMINESCENT SWITCHES FOR CALF THYMUS DNA AND EFFECTS OF pH
3007. Interaction of fluorescent Berberine alkyl derivatives with respiratory chain of rat liver mitochondria
3008. Interaction of herbal compounds with biological targets: A case study with Berberine
3009. Interaction of human serum albumin with Berberine hydrochloride by fluorescence method
3010. Interaction of Isoquinoline Alkaloids with an RNA Triplex: Structural and Thermodynamic Studies of Berberine , Palmatine, and Coralyne Binding to Poly(U).Poly(A)* …
3011. Interaction of liposomes with homologous series of fluorescent Berberine derivatives: new cationic probes for measuring membrane potential
3012. Interaction of plant alkaloid, Berberine , with zwitterionic and negatively charged phospholipid bilayers
3013. Interaction study between double-stranded DNA and Berberine using capillary zone electrophoresis
3014. Interactions of Berberine with poly (A) and tRNA
3015. Interactions of G-quadruplex DNA binding site with Berberine derivatives and construct a structure-based QSAR using docking descriptors
3016. Interpenetrating polymer network scaffold of sodium hyaluronate and sodium alginate combined with Berberine for osteochondral defect regeneration
3017. Interspecific differences among swallowtail larvae (Lepidoptera: Papilionidae) in susceptibility to aristolochic acids and Berberine
3018. Interventioal effect of Berberine liposome on impaired glucose tolerance accompanied with hyperlipemia
3019. Intervention effect of Berberine on expressions of TNF-alpha and receptor type I in Abeta25-35-induced inflammatory reaction in SH-SY5Y cell lines
3020. Intervention effect of Berberine on expressions of TNF-α and receptor type I in Aβ_ (25-35)-induced inflammatory reaction in SH-SY5Y cell lines
3021. Intervention Effect of Berberine on the Level of Serum IL-1?, Hs-CRP, Monocytes Infilitrating and the Expression of HSP-70 in Diet-induced Hyperlipidemic and Cpn …
3022. Intervention effect of Berberine on the level of serum IL-1β, Hs-CRP, monocytes infiltrating and the expression of HSP-70 in diet-induced hyperlipidemic and Cpn …
3023. Intervention Effect of Berberine on the Level of Serum Lipids, OX-LDL and Vascular Intimal Injury in Diet-induced Hyperlipidemic and Chlamydia Pneumoniae-infected …
3024. Intervention of Berberine on lipid deposition in liver cells of non-alcoholic fatty liver disease rats induced by high fat diet
3025. Intestinal absorption mechanisms of Berberine , palmatine, jateorhizine, and coptisine: involvement of P-glycoprotein
3026. Intestinal absorption of Berberine alone and in combinations by rats single pass intestinal perfusion in situ
3027. Intestinal absorption of Berberine and 8-hydroxy dihydroBerberine and their effects on sugar absorption in rat small intestine
3028. Intracellular compartmentation of two enzymes of Berberine biosynthesis in plant cell cultures
3029. INTRODUCTION OF A NEW DRUG DOSAGE FORM FOR Berberine
3030. Inverted binding due to a minor structural change in Berberine enhances its phospholipase A2 inhibitory effect
3031. Inverting the Regioselectivity of the Berberine Bridge Enzyme by Employing Customized Fluorine‐Containing Substrates
3032. Investigate the Effect of Berberine on Neuropeptide Y in Rats Colon Tissue and Plasma of Thyroid Hormone-Induced Diarrheic
3033. INVESTIGATING THE INTRACTION BETWEEN Berberine AND HUMAN TELOMER G-QUADRAPLEX DNA
3034. Investigating the possible role of Berberine on the metastatic behavior of esophageal cancer cells
3035. Investigation into the Mode of Antifungal Action of Berberine
3036. Investigation of differentially expressed proteins due to the inhibitory effects of Berberine in human liver cancer cell line HepG2
3037. Investigation of dose-dependent effects of Berberine against renal ischemia/reperfusion injury in experimental diabetic rats
3038. Investigation of In Vitro Antibacterial Effect of Berberine Sulfate with Colistin Sulfate
3039. Investigation of Interaction Models Between Berberine Hydrochloride and Cucurbit (N= 8) Uril Inclusion Complex
3040. Investigation of the interaction between Berberine and human serum albumin
3041. Investigation of the interaction between Berberine and nucleosomes in solution: Spectroscopic and equilibrium dialysis approach
3042. Investigation on binding interaction of Berberine chloride with bovine serum albumin immobilized onto chromatographic supports by frontal chromatography
3043. Investigation on intermolecular interaction between Berberine and β-cyclodextrin by 2D UV–Vis asynchronous spectra
3044. Investigation on the Interaction of Berberine with Human Serum Albumin by Equilibrium Dialysis [J]
3045. Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified Berberine chloride nanoparticles
3046. In-vitro Synergistic Effect of Metformin and Berberine on High Glucose-induced Lipogenesis
3047. In-vivo studies on the pharmacokinetics of Berberine on middle cerebral artery occlusion rat and sham-operated rat
3048. Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine -induced apoptosis of cancer cells
3049. Involvement of mitochondrial and B-RAF/ERK signaling pathways in Berberine -induced apoptosis in human melanoma cells
3050. Involvement of mitochondrial and survival signaling in Berberine -induced apoptosis in melanoma cells
3051. Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by Berberine , a benzodioxoloquinolizine alkaloid
3052. Involvement of P-glycoprotein and multidrug and toxin extrusion protein 1 in hepatic and renal Berberine efflux in mice
3053. Involvement of reactive oxygen species and caspase-dependent pathway in Berberine -induced cell cycle arrest and apoptosis in C6 rat glioma cells
3054. Ionic mechanism responsible for prolongation of cardiac action-potential duration by Berberine
3055. IR absorption and surface-enhanced Raman spectra of the isoquinoline alkaloid Berberine
3056. Is Berberine Superior to Metformin in Management of Diabetes Mellitus and its Complications?
3057. Isolation and analysis of a gene bbe1 encoding the Berberine bridge enzyme from the California poppy Eschscholzia californica
3058. Isolation and Characterization of a Bacterial Strain Capable of Efficient Berberine Degradation
3059. ISOLATION AND CHARACTERIZATION OF Berberine HCl AND CYTOTOXIC EFFECT ON THE CELL LINE OF BREAST CANCER
3060. Isolation and identification of Berberine and berberrubine metabolites by Berberine -utilizing bacterium Rhodococcus sp. strain BD7100
3061. Isolation and Identification of Berberine from Cell Cultures of Coptis chinensis [J]
3062. Isolation and identification of Berberine from cell cultures of Coptis chinensis.
3063. Isolation and identification of Berberine from endophytic fungi HL-Y-3
3064. Isolation and identification of producing endophytic fungi of Berberine from the plant Phellodendron amurense
3065. Isolation and identification of urinary metabolites of Berberine in rats and humans
3066. Isolation and Purification of Berberine in Cortex Phellodendri by Centrifugal Partition Chromatography
3067. Isolation of Berberine from Berberis aristata by an acid dye method and optimization of parameters
3068. Isolation of Berberine from Berberis vulgaris Linn. and standardization of aqueous extract by RP-HPLC.
3069. Isolation of Berberine from the Rhizome of $ Coptis $$ chinensis $ by Centrifugal Partition Chromatography
3070. Isolation of Berberine tannate using a chromatography activity-guided fractionation from root bark of Berberis hispanica Boiss. & Reut.
3071. Isolation of the alkaloids, Berberine and berbamine, from Mahonia swaseyi
3072. ISOLATION, MOLECULAR STRUCTURAL ANALYSIS OF Berberine ALKALOID IN MAHONIA LESCHENAULTII-A TODA MEDICINAL PLANT BY USING IR …
3073. Isolation, sequence, and bacterial expression of a cDNA for (S)-tetrahydroBerberine oxidase from cultured Berberine -producing Coptis japonica cells
3074. Isoquinoline alkaloid Berberine acts as an inhibitor of osteoclast differentiation
3075. Isoquinoline alkaloid Berberine inhibits IL-5-dependent growth of pro-B Y16 cells through arresting cell cycle at G1 phase and inducing mitochondria-dependent …
3076. Isotope effects suggest a stepwise mechanism for Berberine bridge enzyme
3077. iTRAQ-based pharmacoproteomics reveals potential targets of Berberine , a promising therapy for ulcerative colitis
3078. Janus nanocarrier-based co-delivery of doxorubicin and Berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence
3079. Kidney Injury in Type 2 Diabetic: The Role of Berberine Treatment
3080. Kinetic difference of Berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract
3081. Kinetic study of superheated water extraction of Berberine from Berberis vulgaris root
3082. Kinetics and thermodynamics of Berberine inclusion in cucurbit [7] uril
3083. Kinetics study on photocatalytic degradation of Berberine hydrochloride in Nano-TiO_2 suspension system
3084. Knockdown of Berberine bridge enzyme by RNAi accumulates (S)-reticuline and activates a silent pathway in cultured California poppy cells
3085. Label-free fluorescence DNA walker for protein analysis based on terminal protection and dual enzyme assisted cleavage induced G-quadruplex/Berberine …
3086. Label-free fluorescent aptasensor Berberine -based strategy for ultrasensitive detection of Hg2+ ion
3087. Label-free fluorescent aptasensor for potassium ion using structure-switching aptamers and Berberine
3088. Laboratory studies of Berberine used alone and in combination with 1, 3-bis (2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
3089. LC/MS determination of Berberine and palmatin in rats plasma after oral administration of extracts Rhizoma Coptidis and its pharmacokinetics study
3090. LC-MS/MS Rapid Determination of Berberine in Plasma
3091. LC-MS-based metabolomics analysis of Berberine treatment in ulcerative colitis rats
3092. Learning from Berberine : Treating chronic diseases through multiple targets
3093. Leishmania donovani: Amastigote inhibition and mode of actior of Berberine
3094. Lekou Granules in HPLC Determination of Berberine and its Preparation Process of the Dynamic Analysis
3095. Letrozole, Berberine , or a combination for infertility in Chinese women with polycystic ovary syndrome: a multicentre, randomised, double-blind, placebo-controlled …
3096. Letrozole, Berberine , or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double-blind randomised controlled …
3097. Leukocytes from diabetic patients kill retinal endothelial cells: effects of Berberine
3098. Lipid profiling of the therapeutic effects of Berberine in patients with nonalcoholic fatty liver disease
3099. Lipid-based floating multiparticulate delivery system for bioavailability enhancement of Berberine hydrochloride
3100. Lipid-lowering effect of Berberine in human subjects and rats
3101. Liposome encapsulated Berberine treatment attenuates cardiac dysfunction after myocardial infarction
3102. Liposome-encapsulated Berberine treatment reduces adverse ventricle remodeling after myocardial infarction
3103. LIPOSOMES LOADED WITH Berberine HYDROCHLORIDE: DEVELOPMENT, OPTIMISATION AND IN VITRO CITOTOXICITY
3104. Liquid crystalline nanoreservoir releasing a highly skin-penetrating Berberine oleate complex for psoriasis management
3105. Liver-target nanotechnology facilitates Berberine to ameliorate cardio-metabolic diseases
3106. Long non‑coding RNA CASC2 enhances Berberine ‑induced cytotoxicity in colorectal cancer cells by silencing BCL2
3107. Long-term effects of nutraceuticals (Berberine , red yeast rice, policosanol) in elderly hypercholesterolemic patients
3108. LVII.—The conversion of Berberine into β-homochelidonine (α-allo cryptopine)
3109. LXV.—A study of some derivatives of Berberine closely allied to derivatives of cryptopine
3110. LXV.—On the relation between the absorption spectra and the chemical structure of corydaline, Berberine , and other alkaloids
3111. LXXI.—Contributions from the Laboratories of the Heriot Watt College, Edinburgh. On Berberine . Part II
3112. LXXXII.—Researches on pseudo-bases. Part II. Note on some Berberine derivatives and remarks on the mechanism of the condensation reactions of pseudo-bases
3113. Magnetic nanoparticles directed delivery of Berberine —a cytotoxic phytoceutical for tumor control
3114. Make the Berberine extraction and separation experiment into comprehensive experiment
3115. MAPK pathways are involved in the inhibitory effect of Berberine hydrochloride on gastric cancer MGC 803 cell proliferation and IL-8 secretion in vitro and in …
3116. Mathematical Model for Adsorption of Berberine on Encapsulated Adsorbent
3117. MDM2 inhibition-mediated autophagy contributes to the pro-apoptotic effect of Berberine in p53-null leukemic cells
3118. Measurement of Berberine Hydrochloride Content of Guilin Watermelon Frost by UV Spectrometry [J]
3119. Measurement of unbound pravastatin in rat blood and bile on the perspective of hepatobiliary excretion and its interaction with cyclosporin A and Berberine
3120. Mechanical Deoppilation with Guide Wire Combined with Medical Macrogol Berberine Solution for the Treatment of Infertility Due to Fallopian Tube Obstruction
3121. Mechanism and pharmacological rescue of Berberine -induced hERG channel deficiency
3122. Mechanism and pharmacological rescue of Berberine -induced hERG channel deficiency [Corrigendum]
3123. Mechanism Guided Discovery of New Therapeutics Agents for Type 2 Diabetes from Berberine
3124. Mechanism of action of Berberine on Vibrio cholerae and vibrio cholerae biotype eltor.
3125. Mechanism of Berberine in the Regulation of CYP3A4 and P-gp via PXR Signaling Pathway
3126. Mechanism of Berberine regulating glucose and lipid metabolism studied with RT PCR array
3127. Mechanism of Berberine -mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates
3128. Mechanism of Electro-Coagulation with Al/Fe Periodically Reversing Treating Berberine Pharmaceutical Wastewater
3129. Mechanism of radiosensitization effect of Berberine on human nasopharyngeal carcinoma in hypoxia
3130. Mechanism of the aortic relaxation induced by low concentrations of Berberine
3131. Mechanism of UV‐driven Photoelectrocatalytic Degradation of Berberine Chloride Form Using the ESR Spin‐trapping Method
3132. Mechanism of vasodilatory effect of Berberine in rat mesenteric artery
3133. Mechanisms for protection of Berberine against LPS-induced acute lung injury in mice
3134. Mechanisms involved in the cytotoxic effects of Berberine on human colon cancer HCT-8 cells
3135. Mechanisms of Berberine (natural yellow 18)–induced mitochondrial dysfunction: Interaction with the adenine nucleotide translocator
3136. Mechanisms underlying the protection of Berberine against liver injury induced by lipopolysaccharide in mice
3137. Mechanistic studies on the growth inhibitory effects of Berberine on human osteosarcoma cells
3138. Media influence on the enhancement of the fluorescence of Berberine hydrochloride
3139. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of Berberine in lung cancer cells
3140. Membrane of Candida albicans as a target of Berberine
3141. Mercury-induced neurotoxicity and neuroprotective effects of Berberine
3142. Mesophase formation in binary mixtures of Berberine and glacial acetic acid
3143. Meta-analysis of the effect and safety of Berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
3144. Metabolic and cardiovascular effects of Berberine : from preclinical evidences to clinical trial results
3145. Metabolic characterization and pathway analysis of Berberine protects against prostate cancer
3146. Metabolic effect of Berberine –silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials
3147. Metabolic effects of Berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: an additional mechanism for the hypolipidemic effects of Berberine
3148. Metabolic profile associated with glucose and cholesterol lowering effects of Berberine in Sprague–Dawley rats
3149. Metabolic profiling analysis of Berberine , palmatine, jatrorrhizine, coptisine and epiBerberine in zebrafish by ultra-high performance liquid chromatography coupled …
3150. Metabolism: Efficacy of Berberine in patients with type 2 diabetes mellitus
3151. Metabolites identification of Berberine in rats using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry
3152. Metabolomics profiling to investigate the pharmacologic mechanisms of Berberine for the treatment of high-fat diet-induced nonalcoholic steatohepatitis
3153. Metabolomics study of type 2 diabetes mellitus and the antidiabetic effect of Berberine in zucker diabetic fatty rats using Uplc‐ESI‐Hdms
3154. Metformin and Berberine prevent olanzapine-induced weight gain in rats
3155. Metformin and Berberine , two versatile drugs in treatment of common metabolic diseases
3156. Metformin in contrast to Berberine reversed arsenic‐induced oxidative stress in mitochondria from rat pancreas probably via Sirt3‐dependent pathway
3157. Methods of Double Wavelengths Fusion and HPLC to Determine Berberine Hydrochloride and Atractylodin in Ermiao Pill
3158. Methylglyoxal and insulin resistance in Berberine -treated type 2 diabetic patients
3159. Microarray expression profiling and Raman spectroscopy reveal anti-fatty liver action of Berberine in a diet-induced larval zebrafish model
3160. Microarray expression profiling of Yersinia pestis in response to Berberine
3161. Microbial Extraction of Berberine from Phellodendron for Simultaneous Product Purification and Waste Resource Utilization
3162. Microbial limit test of Berberine hydrochloride ointment
3163. Microbiota transplantation reveals beneficial impact of Berberine on hepatotoxicity by improving gut homeostasis
3164. Microcalorimetric investigation of effect of Berberine alkaloids from Coptis chinensis Franch on intestinal diagnostic flora growth
3165. Microcalorimetric investigation of the effect of Berberine alkaloids from Coptis chinensis Franch on Staphylococcus aureus growth
3166. Microcalorimetric investigation of the toxic action of Berberine on Tetrahymena thermophila BF5
3167. Micropropagation, Berberine content and antitumor activity of Jeffersonia dubia (Maxim.) Benth et Hook
3168. Micropropagation, isolation and characterization of Berberine from leaves of Naravelia zeylanica (L.) DC
3169. MicroRNA-21-3p, a Berberine -induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth
3170. microRNA-21-mediated inhibition of mast cell degranulation involved in the protective effect of Berberine on 2, 4-dinitrofluorobenzene-induced allergic contact …
3171. Microwave accelerated extraction and capillary electrophoresis analysis of Berberine from the cortices of Phellodendron wilsonii and Phellodendron amurense
3172. Microwave Aqueous Synthesis of Mesoporous Carbons for Highly Effective Adsorption of Berberine Hydrochloride and Matrine
3173. Microwave assisted extraction of Berberine from Mahonia bealei
3174. Mild Hyperthermia (39 C) Attenuates Berberine Chloride Cytotoxicity against Osteosarcoma Cells
3175. Mitochondria and NMDA receptor-dependent toxicity of Berberine sensitizes neurons to glutamate and rotenone injury
3176. Mitochondria play an important role in the cell proliferation suppressing activity of Berberine
3177. Mitochondrial membrane potential played crucial roles in the accumulation of Berberine in HepG2 cells
3178. Mitochondrial protein cyclophilin-D-mediated programmed necrosis attributes to Berberine -induced cytotoxicity in cultured prostate cancer cells
3179. Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted Berberine derivative for cancer treatment by inducing mitochondrial apoptosis …
3180. Mitochondrially targeted effects of Berberine [Natural Yellow 18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium] on K1735-M2 mouse …
3181. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-Berberine conjugate for synergetic cancer treatment with enhanced …
3182. Mitophagy confers the nephroprotective effect of Berberine in hyperglycemic NRK-52E cells via Sirt1-FoxO3a-Bnip3 axis
3183. Mode of binding of the cytotoxic alkaloid Berberine with the double helix oligonucleotide d (AAGAATTCTT) 2
3184. Modification to the functional status of the hemostatic system with the use of Berberine sulfate
3185. Modified Berberine and protoBerberine s from Enantia chlorantha as potential inhibitors of Trypanosoma brucei.
3186. Modulating gut microbiota as an anti-diabetic mechanism of Berberine
3187. Modulation action of Berberine on NO-cGMP signal pathway in isolated corpus cavernosum smooth muscle
3188. Modulation of adenylate cyclase signaling in association with MKK3/6 stabilization under combination of SAC and Berberine to reduce HepG2 cell survivability
3189. Modulation of apoptosis by Berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells
3190. Modulation of benzylisoquinoline alkaloid biosynthesis by overexpression Berberine bridge enzyme in Macleaya cordata
3191. Modulation of Berberine bridge enzyme levels in transgenic root cultures of California poppy alters the accumulation of benzophenanthridine alkaloids
3192. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting Berberine liposomes
3193. Modulation of glucagon-like peptide-1 release by Berberine : in vivo and in vitro studies
3194. Modulation of gut microbiota by Berberine and decocted Coptis chinensis Franch. in a high-fat diet-induced metabolic syndrome rat model
3195. Modulation of gut microbiota by Berberine and metformin during the treatment of high-fat diet-induced obesity in rats
3196. Modulation of gut microbiota by Berberine improves steatohepatitis in high-fat diet-fed BALB/C mice
3197. Modulation of gut microbiota with Berberine improves nonalcoholic steatohepatitis in mice
3198. Modulation of microbiota-gut-brain axis by Berberine resulting in improved metabolic status in high-fat diet-fed rats
3199. Modulation of Radioresponse by an Isoquinoline Alkaloid Berberine in Cultured HeLa Cells Exposed to Different Doses of γ–Radiation
3200. Modulation of the expression of folate cycle enzymes and polyamine metabolism by Berberine in cisplatin-sensitive and-resistant human ovarian cancer cells
3201. Modulations of cytochrome P450 expression in diabetic mice by Berberine
3202. Modulatory effect of Berberine on adipose tissue PPARγ, adipocytokines and oxidative stress in high fat diet/streptozotocin-induced diabetic rats
3203. Modulatory Effects of Berberine Chloride on Lipid Profile, Oxidant Status and Insulin Signaling Molecules in Streptozotocin Induced Diabetic Rats
3204. Molecular and crystal structures of three Berberine derivatives
3205. Molecular basis of inhibitory activities of Berberine against pathogenic enzymes in Alzheimer’s disease
3206. Molecular characterization of Berberine bridge enzyme genes from opium poppy
3207. Molecular characterization of carnitine palmitoyltransferase IA in Megalobrama amblycephala and effects on its expression of feeding status and dietary lipid and Berberine
3208. Molecular characterization of microtubule-associated protein 1-light chain 3B in Megalobrama amblycephala fed with high fat/Berberine diets
3209. Molecular cloning, expression, and induction of Berberine bridge enzyme, an enzyme essential to the formation of benzophenanthridine alkaloids in the response of …
3210. Molecular determinants of response of tumor cells to Berberine
3211. Molecular encapsulation of Berberine by a modified β-cyclodextrin and binding of host: guest complex to G-quadruplex DNA
3212. Molecular mechanism for Berberine to improve insulin resistance in 3T3-L1 adipocytes
3213. Molecular mechanism of Berberine improving insulin resistance induced by high glucose in 3T3-L1 adipocytes through targeting NF-κB p65 [J]
3214. Molecular mechanism of Berberine in improving insulin resistance induced by free fatty acid through inhibiting nuclear trascription factor-kappaB p65 in 3T3-L1 …
3215. Molecular mechanism of Berberine on improving insulin resistance of 3T3-L1 adipocytes induced by high glucose through IKKβ Ser 181 phosphorylation [J]
3216. Molecular mechanisms of action of herbal antifungal alkaloid Berberine , in Candida albicans
3217. Molecular Modeling on Berberine Derivatives toward BuChE: An Integrated Study with Quantitative Structure–Activity Relationships Models, Molecular Docking, and …
3218. Molecular modeling, dynamics simulations, and binding efficiency of Berberine derivatives: A new group of RAF inhibitors for cancer treatment
3219. Molecular modelling of Berberine derivatives as inhibitors of human smoothened receptor and hedgehog signalling pathway using a newly developed algorithm on …
3220. Molecular spectroscopy evidence of Berberine binding to DNA: comparative binding and thermodynamic profile of intercalation
3221. Molecular structure of an ancient folk medicine: Berberine hydrogen sulfate
3222. MONITOR THE BLOOD-DRUG CONCENTRATION OF Berberine BY MICELLA FLUOROMETRY
3223. Monitoring and kinetic parameter estimation for the binding process of Berberine hydrochloride to bovine serum albumin with piezoelectric quartz crystal impedance …
3224. Monodisperse microparticles loaded with the self-assembled Berberine -phospholipid complex-based phytosomes for improving oral bioavailability and enhancing …
3225. Mordant dyeing of modified acrylic fabric with Berberine
3226. Morphological Changes of Trichophytosis rubrum Treated by Berberine hydrochloride [J]
3227. Morphological changes of Trichophytosis rubrum treated by Berberine hydrochloride.
3228. MPB, a novel Berberine derivative, enhances lysosomal and bactericidal properties via TGF-β–activated kinase 1-dependent activation of the transcription factor EB
3229. Multicomponent therapeutics of Berberine alkaloids
3230. Multipath effects of Berberine on peach brown rot fungus Monilinia fructicola
3231. Multiple effects of Berberine derivatives on colon cancer cells
3232. Mutagenesis of a Berberine -producing endophytic fungus
3233. Myelosuppression and Nephrotoxicity Induced by Cisplatin in Female Rats: The Role of Berberine Nanoparticles
3234. Myocardial hypertrophy is improved with Berberine treatment via long non‐coding RNA MIAT‐mediated autophagy
3235. Myocardial salvaging effects of Berberine in experimental diabetes co-existing with myocardial infarction
3236. NACHT, LRR and PYD domains-containing protein 3 inflammasome is activated and inhibited by Berberine via toll-like receptor 4/myeloid differentiation …
3237. Nandina domestica (Heavenly Bamboo): In Vitro Culture and the Production of Jatrorrhizine, Berberine , and Other Alkaloids
3238. Nandinine, a derivative of Berberine , inhibits inflammation and reduces insulin resistance in adipocytes via regulation of AMP-kinase activity
3239. NANO ENCAPSULATION OF Berberine AND COLLAGEN
3240. Nano strategies for Berberine delivery, a natural alkaloid of Berberis
3241. Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics
3242. Nanoemulsion Improves Hypoglycemic Efficacy of Berberine by Overcoming its Gastrointestinal Challenge
3243. NANOENCAPSULATION OF Berberine INTO LYOTROPIC LIQUID CRYSTALLINE MESOPHASES TO ENHANCE ANTICANCER ACTIVITY
3244. Nanostructured electrochemical DNA biosensors for detection of the effect of Berberine on DNA from cancer cells
3245. Narrowbore high performance liquid chromatography of Berberine and palmatine in crude drugs and pharmaceuticals with ion-pair extraction using cobalt thiocyanate …
3246. Natural Alkaloid Berberine Activity against Pseudomonas aeruginosa MexXY-Mediated Aminoglycoside Resistance: In Silico and in Vitro Studies
3247. Natural and synthetic G-quadruplex interactive Berberine derivatives
3248. Natural aromatic compounds as scaffolds to develop selective G-Quadruplex ligands: from previously reported Berberine derivatives to new palmatine analogues
3249. Natural Berberine -Based Chinese Herb Medicine Assembled Nanostructures with Modified Antibacterial Application
3250. Natural deep eutectic solvents (NADES) to enhance Berberine absorption: an in vivo pharmacokinetic study
3251. NATURAL PLANT PRODUCT Berberine /CISPLATIN BASED RADIOTHERAPY FOR CERVICAL CANCER: THE NEW AND EFFECTIVE METHOD TO TREAT …
3252. Natural products Berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin
3253. Naturally occurring proteinaceous nanoparticles in Coptidis Rhizoma extract act as concentration-dependent carriers that facilitate Berberine absorption
3254. Near Infrared Diffuse Reflection Optical Spectra Combined with PCR Rapid Determination Content of Berberine Hydrochloride in Berberis Heteropoda Cortex
3255. Neuronal activities of Berberine in Schistosoma mansoni-infected mice
3256. Neuropharmacological and pharmacokinetic properties of Berberine : a review of recent research
3257. Neuroprotection of early and short-time applying Berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB …
3258. Neuroprotective effect of Berberine against environmental heavy metals-induced neurotoxicity and Alzheimer’s-like disease in rats
3259. Neuroprotective effect of Berberine against learning and memory deficits in diffuse axonal injury
3260. Neuroprotective effect of Berberine agonist against impairment of learning and memory skills in severe traumatic brain injury via Sirt1/p38 MAPK expression
3261. Neuroprotective effect of Berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia
3262. Neuroprotective effect of Berberine is mediated by MAPK signaling pathway in experimental diabetic neuropathy in rats
3263. Neuroprotective effects of Berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
3264. Neuroprotective effects of Berberine in neurodegeneration model rats induced by ibotenic acid
3265. Neuroprotective effects of Berberine on recognition memory impairment, oxidative stress, and damage to the purinergic system in rats submitted to …
3266. Neuroprotective effects of Berberine on stroke models in vitro and in vivo
3267. Neurotoxic effects of Berberine on long-term l-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
3268. Neurotoxicity induced by Berberine in cultured cortical and cerebellar granule neurons of rat
3269. Neutral sulfate Berberine modulates cytokine secretion and increases survival in endotoxemic mice1
3270. New 13-pyridinealkyl Berberine analogues intercalate to DNA and induce apoptosis in HepG2 and MCF-7 cells through ROS mediated p53 dependent pathway …
3271. New aspects of Saccharomyces cerevisiae as a novel carrier for Berberine
3272. New Clinical Application of Berberine
3273. New Oral Delivery System to Improve Absorption of Berberine : Likely Interaction of Cationized Chitosan with PG-P Pump.
3274. New progress inhypoglycemic mechanism and clinical application of Berberine
3275. New Synthetic Approach to the Berberine Alkaloids
3276. NLRP3 inflammasome as a target of Berberine in experimental murine liver injury: interference with P2X7 signalling
3277. NMR studies on antitumor drug candidates, Berberine and berberrubine
3278. Non-antibiotic anti-diarrhoeal drugs: factors affecting oral bioavailability of Berberine and loperamide in intestinal tissue
3279. Nonaqueous capillary electrophoresis coupled with laser‐induced native fluorescence detection for the analysis of Berberine , palmatine, and jatrorrhizine in Chinese …
3280. Non-coding RNAs and Berberine : a new mechanism of its anti-diabetic activities
3281. Nonoxynol-9 Berberine plural gel has little effect on expression of SLPI, SP-D and lactoferrin in mice’s vagina
3282. Nootropic Effect of Berberine in Colchicines Induced Experimental Alzheimer’s Disease Model: Effect on Cholinergic Neurotransmission
3283. NOTE ON THE ESTIMATION OF Berberine .
3284. Note on the use of Berberine tannate (BertamixND) for increasing the productivity of meat yielding in pig breeding in Vietnam
3285. Notes on Berberine Sulphate in Oriental Sore
3286. Notes on the Treatment of Oriental Sore with Berberine Acid Sulphate
3287. Novel Berberine derivatives: Design, synthesis, antimicrobial effects, and molecular docking studies
3288. Novel Berberine triazoles: synthesis, antimicrobial evaluation and competitive interactions with metal ions to human serum albumin
3289. Novel Berberine -based derivatives with potent hypoglycemic activity
3290. Novel carbohydrate modified Berberine derivatives: synthesis and in vitro anti-diabetic investigation
3291. Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine Berberine chloride: Optimization and pharmacokinetics
3292. Novel drug delivery approaches for improving therapeutic applications of Berberine
3293. Novel effect of Berberine on thermoregulation in mice model induced by hot and cold environmental stimulation
3294. Novel mitochondria-targeted antioxidants: plastoquinone conjugated with cationic plant alkaloids Berberine and palmatine
3295. Novel mitochondria-targeted compounds composed of natural constituents: conjugates of plant alkaloids Berberine and palmatine with plastoquinone
3296. Novel Nanoparticles Berberine Chloride Oral Delivery Approaches Targeting PCSK9
3297. Novel potential artificial MRSA DNA intercalators: synthesis and biological evaluation of Berberine -derived thiazolidinediones
3298. Novel role of Berberine in LOX1-mediated endothelial dysfunction
3299. Novel salt cocrystal of chrysin with Berberine : Preparation, characterization, and oral bioavailability
3300. Novel skin penetrating Berberine oleate complex capitalizing on hydrophobic ion pairing approach
3301. Novel triazolyl Berberine derivatives prepared via CuAAC click chemistry: synthesis, anticancer activity and structure-activity relationships
3302. Nubia and the Berberine
3303. Nuclear magnetic resonance spectral analysis and molecular properties of Berberine
3304. Nutr Metab Cardiovasc Dis: effects of a nutraceutical combination (Berberine , red yeast rice and policosanols) on lipid levels and endothelial function randomized …
3305. Nutraceutical combination (red yeast rice, Berberine and policosanols) improves aortic stiffness in low-moderate risk hypercholesterolemic patients
3306. Nutraceutical pill containing Berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial …
3307. Nutritional supplementation of hop rho iso-alpha acids, Berberine , vitamin D3, and vitamin K1 produces a favorable bone biomarker profile supporting healthy bone …
3308. Observation of bending, cracking and jumping phenomena on cooling and heating of tetrahydrate Berberine chloride crystals
3309. Observation of Berberine ion-transmission and ultrashort wave on chronic prostatitis
3310. Observation of Clinical Effect of Berberine Combined with Birid Triple viable in Treatment of Diarrhea Predominant Irritable Bowel Syndrome [J]
3311. Observation of therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and Flupentixol and Melitracen tablets
3312. Observation of therapeutic effect of diarrhea-predominant irritable bowel syndrome treated by combination of Berberine and lived combined B. Subtilis and E. Faecium …
3313. Observation on Effect of Berberine and Potassium Magnesium Aspartate for Treating Chronic Pulmonary Heart Disease Complicated by Arrhythmia in 60 Cases
3314. Of Berberine and puerarin on dexamethasone-induced insulin resistance in porcine ovarian thecal cells
3315. O-hexadecyl-dextran entrapped Berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes
3316. On Berberine -treating simulated sewage through periodically alternating electrocoagulation [J]
3317. On the mechanism of antidepressant-like action of Berberine chloride
3318. On the mechanism of Berberine –INF55 (5-Nitro-2-phenylindole) hybrid antibacterials
3319. On the mechanism of vasodilating action of Berberine : possible role of inositol lipid signaling system.
3320. ON THE OCCURRENCE OF Berberine IN XANTHORRHIZA APIIFOLIA.
3321. Oncosis-like cell death is induced by Berberine through ERK1/2-mediated impairment of mitochondrial aerobic respiration in gliomas
3322. One new Berberine from the branches and leaves of Polyalthia obliqua Hook.f. & Thomson
3323. On-line concentration by head-column field amplified sample injection for the analysis of Berberine , palmatine and jatrorrhizine in herbal medicine by flow injection …
3324. Optical fiber sensor for Berberine based on fluorescence quenching of 2-(4-diphenylyl)-6-phenylbenzoxazole
3325. Optical sensor for Berberine utilizing its intrinsic fluorescence enhanced by the formation of inclusion complex with butylated-β-cyclodextrin
3326. Optimization and Determination of Berberine and Baicalin in Wanshi Niuhuang Qingxin Wan by High Performance Liquid Chromatography
3327. Optimization and preparation of Berberine hydrochloride liposomes using Box-Behnken design methodology
3328. Optimization for the production of liposomal Berberine with the comparison of antihepatoma effects, and the apoptotic pathways of Berberine solution or liposomal Berberine on HepG2 cells
3329. Optimization of a novel mucoadhesive drug deliver system with ion-exchange resin core loaded with Berberine hydrochloride using central composite design …
3330. Optimization of Enzyme-alkali Method Extraction Process of Berberine from Cortex Phellodendri by Orthogonal Experiments
3331. Optimization of ex vivo permeability characteristics of Berberine in presence of quercetin using 32 full factorial design
3332. Optimization of Extraction Conditions of Berberine in Rhizoma Coptidis with Orthogonal Test [J]
3333. Optimization of Extraction Process for Berberine Hydrochloride in Rhizoma Copotidis by Orthogonal Experiment
3334. Optimization of Extraction Technology for Berberine in Cortex Phellodendri and Its Inhibition Effect on Plant Pathogen
3335. Optimization of Fermentation Conditions of a Mutagenized Berberine -Producing Strain
3336. Optimization of floating pellet containing Berberine hydrochloride formulation by central composite design-response surface methodology
3337. Optimization of mesoporous carbons for efficient adsorption of Berberine hydrochloride from aqueous solutions
3338. Optimization of oleic acid-, induced insulin resistance HepG2 cell model and anti-hyperglycemic effect of Berberine , baicalin, puerarin and liquiritin
3339. Optimization of Preparation Technology of Berberine -β-Cyclodextrin Inclusion Complex by Central Composite Design and Response Surface Method [J]
3340. Optimization of Salting-out Extraction of Berberine from Huanglian by Orthogonal Experiment [J]
3341. Optimization of the extraction process in Berberine hydrochloride from Coptis Chinensis Franch. by the genetic algorithm
3342. Optimization of the percotion processes on Berberine hydrochloride in Coptis Chinensis Franch by orthogonal design [J]
3343. Optimization of the process of Berberine liposome preparation using supercritical CO_2
3344. Optimization of thermosensitive in situ gel system containing Berberine hydrochloride for ocular use
3345. Optimization of β-cyclodextrin grafting on wool fibers improved by plasma treatment and assessment of antibacterial activity of Berberine finished fabric
3346. Optimizing manufacture of liposomal Berberine with evaluation of its antihepatoma effects in a murine xenograft model
3347. Orally administered Berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-γ and subsequent expression of HGF …
3348. Orally administered Berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway
3349. Orengedokuto and Berberine improve indomethacin-induced small intestinal injury via adenosine
3350. Organic anion-transporting polypeptides contribute to the hepatic uptake of Berberine
3351. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and Berberine
3352. Organic cation transporter-mediated drug–drug interaction potential between Berberine and metformin
3353. Oriental Sore treated by Berberine Sulphate. An Analysis of Fifty Cases.
3354. Oxidation of monolignols by members of the Berberine bridge enzyme family suggests a role in plant cell wall metabolism
3355. Oxidative damage and antioxidant responses in Microcystis aeruginosa exposed to the allelochemical Berberine isolated from golden thread
3356. Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of Berberine in rats
3357. OxyBerberine , a novel gut microbiota-mediated metabolite of Berberine , possesses superior anti-colitis effect: impact on intestinal epithelial barrier, gut microbiota …
3358. P-010 Berberine inhibits the migration and invasion depending on HNF4αvia Wnt/beta-catenin pathway in gastric cancer
3359. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by Berberine
3360. p53 cooperates Berberine ‐induced growth inhibition and apoptosis of non‐small cell human lung cancer cells in vitro and tumor xenograft growth in vivo
3361. p53, Bcl-2 and cox-2 are involved in Berberine hydrochloride-induced apoptosis of HeLa229 cells
3362. Palmatine and Berberine isolation artifacts
3363. Parmacokinetics of bacalin and Berberine Gonglao Quhuo tablets in rats
3364. Participation of an active transport system in Berberine -secreting cultured cells of Thalictrum minus
3365. Patterns of accumulation of Berberine alkaloid and chemical profiling of natural populations of Coscinium fenestratum (Menispermaceae) in the Central Western Ghats …
3366. PEG–lipid–PLGA hybrid nanoparticles loaded with Berberine –phospholipid complex to facilitate the oral delivery efficiency
3367. Percutaneous penetration of [sup 3] H-Huangbai extracts and H [sup 3]-Berberine
3368. Percutaneous penetration of 3H-Huangbai extracts and H3-Berberine
3369. Performance and modeling of a pilot-scale up-flow anaerobic sludge blanket (UASB) treating pharmaceutical wastewater containing Berberine
3370. P‐glycoprotein–mediated transport of Berberine across Caco‐2 cell monolayers
3371. Pharmacodynamics Research Progress of Berberine and the Derivatives
3372. Pharmacodynamics Study of Tablet of Complex Prescription Rhizoma Coptidis to Lower Glucose (复方黄连降糖片) and Berberine on Sugar-lipid Metabolism [J]
3373. Pharmacokinetic and NMR metabolomics approach to evaluate therapeutic effect of Berberine and Coptidis Rhizoma for sepsis
3374. Pharmacokinetic and pharmacodynamic characteristics of Berberine and jateorhizine in Coptidis Rhizoma powder and their monomeric compounds in type 2 diabetic …
3375. Pharmacokinetic comparison of Berberine in rat plasma after oral administration of Berberine hydrochloride in normal and post inflammation irritable bowel syndrome …
3376. Pharmacokinetic comparisons of Berberine and palmatine in normal and metabolic syndrome rats
3377. Pharmacokinetic difference of Berberine between normal and chronic visceral hypersensitivity irritable bowel syndrome rats and its mechanism
3378. Pharmacokinetic interaction between tacrolimus and Berberine in a child with idiopathic nephrotic syndrome
3379. Pharmacokinetic interactions and tolerability of Berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy …
3380. Pharmacokinetic interactions between metformin and Berberine in rats: Role of oral administration sequences and microbiota
3381. Pharmacokinetic studies of novel Berberine derivatives with ultra-performance liquid chromatography–tandem mass spectrometry
3382. Pharmacokinetic Study of 9-O-glucosyl-Berberine in Rats
3383. Pharmacokinetic study of Berberine from rasont and implication of lysergol for its bioavailability enhancement
3384. Pharmacokinetic Study of Berberine Hydrochloride in Chickens
3385. Pharmacokinetic study of Berberine hydrochloride of cortex phellodendri in rat plasma [J]
3386. Pharmacokinetic study of Berberine in ultramicro-pulverised powder of Huanglian jiedusan in rabbits
3387. Pharmacokinetic Study of Berberine in Ultramicro-Pulverised Powder of Huanglian jiedusan in Rabbits [J]
3388. Pharmacokinetic study on Berberine in the extract of rhizoma coptidis-radix aucklandiae drug-pair in rats
3389. Pharmacokinetic study on compatibility of Berberine and citrus aurantium extract in rats
3390. Pharmacokinetics and relative bioavailability study of Berberine hydrochloride phytosome in rabbits
3391. Pharmacokinetics Comparison of Berberine in Gengenqinlian Decoction Between Normal Rats and Diabetic Rats [J]
3392. Pharmacokinetics of Berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry
3393. Pharmacokinetics of Berberine chloride after a single and multiple oral dose in Beagle dogs [J]
3394. Pharmacokinetics of Berberine in Puerariae and Scutellariae and Coptidis Decoction in Vivo of Dog
3395. Pharmacokinetics of Berberine in Puerariae and Scutellariae and Coptidis Decoction in Vivo of Dog [J]
3396. Pharmacokinetics of Berberine in Rat Thalamus After Intravenous Administration of Coptidis Rhizoma Extract
3397. Pharmacokinetics of cyclosporin A coadministrated with Berberine in Chinese healthy volunteers
3398. Pharmacokinetics of Palmatine and Berberine of Yulian Cataplasm [J]
3399. Pharmacokinetics of synergistic effect of coadministration of cyclosporin A with Berberine hydrochloride in renal transplantation recipients
3400. Pharmacokinetics studied on Berberine hydrochloride acted by rhizoma coptidis-fructus evodiae herbal couple in acute gastric ulcer rats
3401. Pharmacokinetics study on Berberine hydrochloride in rats administered with Coptidis rhizoma-Evodiae fructus
3402. Pharmacologic preconditioning with Berberine attenuating ischemia-induced apoptosis and promoting autophagy in neuron
3403. Pharmacological Action of Berberine .
3404. Pharmacological actions of Berberine on the central nervous system
3405. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent Berberine
3406. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, Berberine
3407. Pharmacological Effect of Berberine Chloride in Propyl Thiouracil Induced Thyroidal Dysfunction-A Time Bound Study in Female Rats
3408. Pharmacological effects of Berberine and its derivatives: a patent update
3409. Pharmacological Effects of Berberine and Palmatine on the Prostatic and Urethral Smooth Muscle of the Rabbit.
3410. Pharmacological effects of Berberine on mood disorders
3411. Pharmacological effects of Berberine on the longitudinal muscle of the guinea-pig isolated ileum.
3412. Pharmacological evaluation of Berberine against nimesulide induced hepatoxicity
3413. PHARMACOLOGICAL EVALUATION OF HEPATIC PROFILE OF NIMESULIDE ALONG WITH Berberine
3414. Pharmacological investigations of Berberine sulphate
3415. Pharmacological studies on antidiarrheal effects of a preparation containing Berberine and geranii herba
3416. Pharmacological studies on antidiarrheal effects of Berberine and geranii herba
3417. Pharmacological/Biological effects of Berberine
3418. Pharmacologically relevant concentrations of Berberine transiently stimulate dihydrotestosterone-inducible androgen receptor-mediated luciferase activity in …
3419. Pharmacophore optimization of Berberine as HER2 inhibitor
3420. Phellodendri and a Total of Extract Atractylodes of Phellodendri in Berberine Rate of Extraction Experiments [J]
3421. Phellodendron amurense (Cork Tree): In Vitro Culture, Micropropagation, and the Production of Berberine
3422. Phellodendron amurense and its major alkaloid compound, Berberine ameliorates scopolamine-induced neuronal impairment and memory dysfunction in rats
3423. Phenanthroline-linked Berberine dimer and fluorophore-tagged DNA conjugate for the selective detection of microRNA-185: Experimental and molecular docking …
3424. Phenol oxidation and biosynthesis. Part VIII. Investigations on the biosynthesis of Berberine and protopine
3425. Photochemical and phototoxic activity of Berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells
3426. Photochemistry and Photocytotoxicity of Alkaloids from Goldenseal (Hydrastis canadensis L.) 1. Berberine
3427. Photodynamic effect of Berberine sulfate on the growth rate of Allium cepa roots
3428. Photodynamic Therapy Enhanced the Antitumor Effects of Berberine on HeLa Cells
3429. Photometric Determination of Berberine Hydrochloride in Drugs Based on Its Reaction with Nanogold [J]
3430. Photophysical and calorimetric studies on the binding of 9-O-substituted analogs of the plant alkaloid Berberine to double stranded poly (A)
3431. Photostabilization of biocontrol agents by Berberine
3432. Physicochemical characterization of Berberine chloride: a perspective in the development of a solution dosage form for oral delivery
3433. Physicochemical properties of Berberine and palmatine upon binding to DNA
3434. Physiological effects of Berberine
3435. Physiology of Berberine production in suspension-cultured plant cell lines of Thalictrum.
3436. PI3K p55γ promoter activity enhancement is involved in the anti-apoptotic effect of Berberine against cerebral ischemia–reperfusion
3437. PICTET AND GAMS’Berberine SYNTHESIS
3438. Pilot study on the additive effects of Berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control
3439. Pilot-scale treatment of pharmaceutical Berberine wastewater by Fenton oxidation
3440. Pioglitazone-induced bone loss in diabetic rats and its amelioration by Berberine : A portrait of molecular crosstalk
3441. PL-03 Harnessing multidrug resistance gene expression for effective antifungal strategies by a natural product Berberine
3442. Plasma and hippocampal pharmacokinetics of Berberine after intravenous or intranasal administration in rats
3443. Plasmodium DNA fluoresces with Berberine : a novel approach for diagnosis of malarial parasites
3444. Podoplanin mediates the renoprotective effect of Berberine on diabetic kidney disease in mice
3445. Polarographic determination of Berberine in the presence of H2O2 in medicinal plants
3446. Polyethylene glycol 400 (PEG400) affects the systemic exposure of oral drugs based on multiple mechanisms: Taking Berberine as an example
3447. Polygonum cuspidatum, compared with baicalin and Berberine , inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 …
3448. Polypharmacology of Berberine based on multi-target binding motifs
3449. Porphyrin dimer as neutral ionophore for a Berberine -sensitive potentiometric sensor
3450. Porphyrin–metalloporphyrin composite based optical fiber sensor for the determination of Berberine
3451. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of Berberine chloride
3452. Possible role of P-glycoprotein in the neuroprotective mechanism of Berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction
3453. Possible therapeutic potential of Berberine in diabetic osteopathy
3454. Possible therapeutic potential of Berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis
3455. Potent antiprotozoal activity of a novel semi-synthetic Berberine derivative
3456. Potent in vitro synergism of fluconazole and Berberine chloride against clinical isolates of Candida albicans resistant to fluconazole
3457. Potent in vitro synergism of fusidic acid (FA) and Berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
3458. Potential antibacterial activity of Berberine against multi drug resistant enterovirulent Escherichia coli isolated from yaks (Poephagus grunniens) with haemorrhagic …
3459. Potential antimutagenic activity of Berberine , a constituent of Mahonia aquifolium
3460. Potential benefits of Berberine in the management of perimenopausal syndrome
3461. Potential cerebral perfusion agents. Synthesis and evaluation of Berberine analogues
3462. Potential compounds for oral cancer treatment: resveratrol, nimbolide, lovastatin, bortezomib, vorinostat, Berberine , pterostilbene, deguelin, andrographolide …
3463. Potential cytotoxic and anti-metastatic effects of Berberine on gynaecological cancers with drug-associated resistance
3464. Potential of Berberine to enhance antimicrobial activity of commonly used antibiotics for dairy cow mastitis caused by multiple drug-resistant Staphylococcus …
3465. Potential Prophylactic Effect of Berberine against Rat Colon Carcinoma Induce by 1, 2-Dimethyl Hydrazine
3466. Precipitation reaction between Berberine and rheinic acid by capillary electrophoresis
3467. Pre-clinical toxicity of a combination of Berberine and 5-aminosalicylic acid in mice
3468. Precursor-directed biosynthesis of non-natural Berberine and galanthamine analogues
3469. Prediction of the selectivity coefficients of a Berberine selective electrode using artificial neural networks
3470. Predictive QSAR modeling study on Berberine derivatives with hypolipidemic activity
3471. Preferential induction of CYP1A1 over CYP1B1 in human breast cancer MCF-7 cells after exposure to Berberine
3472. PRELIMINARY INVESTIGATION OF Berberine ON THE FUNCTION OF SINO-ATRIAL NODE (SAN)
3473. Preliminary investigation of the effect of Berberine -oryzanol on intestinal mircoflora in the type Ⅱ diabetes
3474. Preliminary Investigation of the effect of the Intestinal mircoflora in the type Ⅱ diabetes by Berberine and Oryzanol
3475. Preliminary studies of Berberine and its semi-synthetic derivatives as a promising class of multi-target anti-parkinson agents
3476. Preliminary Study of Production Traditional Medicinal Ointments for Closed Soft Tissue Injury——Experimental Study of Extraction Process about Berberine …
3477. Preliminary study on application of some dosage methods of Berberine chloride in raw material and berberin tablets
3478. Preliminary Study on Effects of Berberine on Experimental Autoimmune Encephalomyelitis in Lewis Rats [J]
3479. Preliminary study on RC membrane permeability and mechanism of seven traditional Chinese medicine alkaloids such as Berberine
3480. Prelimitary study of 18F Berberine derivatives as a potential cardiac PET imaging agent
3481. Preparation and adsorption behavior of Berberine hydrochloride imprinted polymers by using silica gel as sacrificed support material
3482. Preparation and adsorption characteristics of rosin-based polymer microspheres for Berberine hydrochloride and separation of total alkaloids from coptidis rhizoma
3483. Preparation and Antibacterial of Berberine Complexes with Rare Earth
3484. Preparation and Application of DNA Fluorescence Capillary Biosensor Labelled with Berberine [J]
3485. Preparation and characteristics of Berberine polylactic acid microspheres [J]
3486. Preparation and characterization of Berberine Hydrochloride and Trimethoprim Chitosan/SBE7-β-CD microspheres
3487. Preparation and Characterization of Berberine Hydrochloride Ternary Complexes
3488. Preparation and Characterization of Erythrocyte Membrane-Camouflaged Berberine Hydrochloride-Loaded Gelatin Nanoparticles
3489. Preparation and Determination of Release of Berberine Sustained-release Tablets Containing Chitosan in Vitro
3490. Preparation and evaluation of a microemulsion for oral delivery of Berberine
3491. Preparation and evaluation of antidiabetic agents of Berberine organic acid salts for enhancing the bioavailability
3492. Preparation and evaluation of Berberine alginate beads for stomach-specific delivery
3493. Preparation and evaluation of Berberine -Cl imprinted polymers by using silica-gel as sacrificed materials [J]
3494. Preparation and evaluation of chitosan-coated alginate/gelatin sustained releasing microspheres containing Berberine hydrochloride in vitro
3495. Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of Berberine hydrochloride
3496. Preparation and in vitro characterization of Berberine hydrochloride–self-emulsifying microsphere by membrane emulsification technology
3497. Preparation and in vitro evaluation of self-assembled beads drug delivery system of Berberine hydrochloride
3498. Preparation and in vitro-in vivo evaluation of intestinal retention pellets of Berberine chloride to enhance hypoglycemic and lipid-lowing efficacy
3499. Preparation and Medical Efficacy of Germicidal Emulsion of Rare Earths Berberine Complex
3500. Preparation and optimization of a drug delivery system based on Berberine chloride-immobilized MgAl hydrotalcite
3501. Preparation and physicochemical characteristics of Berberine hydrochloric nanoemulsion
3502. Preparation and Property of Berberine Hydrochloride Bioadhesive-coated Tablets
3503. Preparation and Quality Control of Berberine Hydrochloride Colon-specific Enteric-coated Tablets
3504. Preparation and Quality Evaluation of Berberine Hydrochloride Liposomes [J]
3505. Preparation and quality evaluation of Berberine hydrochloride sustained-release pellets
3506. Preparation and release characteristics of Berberine calcium alginate gel beads
3507. Preparation and release characteristics of Berberine chitosan nanoparticles in vitro
3508. Preparation and release in vitro of Berberine tannate colon-specific coated tablets [J]
3509. Preparation and sustained release in vitro of Berberine loaded in different carrier-system fibers [J]
3510. Preparation and the Berberine hydrochloride release behavior in vitro of β-cyclodextrin polymer microspheres
3511. Preparation and the dissolution research of the dispersible tablet of Berberine hydrochloride and paeonol
3512. Preparation characterization and antitumor activity in vitro of Berberine hydrochloride polymeric micelles
3513. Preparation of a stir bar with molecularly imprinted polymer and its application in analysis of Berberine hydrochloride in cortex phellodendri chinensis by HPLC
3514. Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of Berberine
3515. Preparation of Berberine Hydrochloride Liposomes by a New pH Gradient Method [J]
3516. Preparation of Berberine hydrochloride long-circulating liposomes by ionophore A23187-mediated ZnSO4 gradient method
3517. Preparation of Berberine Hydrochloride Microcapsules for Taste Masking by Fluidized Bed Coating
3518. Preparation of Berberine Hydrochloride Poloxamer 188 Solid Dispersion
3519. Preparation of Berberine hydrochloride prolipsomes and study of its physicochemical properties
3520. Preparation of Berberine hydrochloride-resinates sustained microcapsules by intra-liquid desiccation
3521. Preparation of Berberine -loaded Chitosan Microspheres and Their Fungistasis [J]
3522. Preparation of Berberine -montmorillonite-metolachlor formulations from hydrophobic/hydrophilic mixtures
3523. Preparation of Colon Controlled Release Pellets of Berberine Hydrochloride
3524. Preparation of enzyme-controlled colon-positioning tablets of Berberine Hydrochloride [J]
3525. Preparation of Free Berberine and Characterization of Its Solution Properties
3526. Preparation of gastroretentive floating tablets of Berberine hydrochloride [J]
3527. Preparation of micropipette tip-based molecularly imprinted monolith for selective micro-solid phase extraction of Berberine in plasma and urine samples
3528. Preparation of oral Berberine bisulfate liposomes
3529. Preparation of porous biodegradable chitosan/Berberine hydrochloride composite xerogel and its antibacterial and hemostatic properties
3530. PREPARATION OF PVC MEMBRANE Berberine SELECTIVE ELECTRODE
3531. Preparation of thermosensitive in situ gel containing Berberine hydrochloride for ophthalmic use and pharmacokinetics in aqueous humors of rabbit eyes [J]
3532. Preparation, characterization and in vivo studies of amorphous solid dispersion of Berberine with hydrogenated phosphatidylcholine
3533. Preparation, Crystal Structures, and Oral Bioavailability of Two Cocrystals of Emodin with Berberine Chloride
3534. Preparation, pharmacokinetics and tumour‐suppressive activity of Berberine liposomes
3535. Preparation, Quality and Safety Evaluation of Berberine Nanoemulsion for Oral Application [J]
3536. Prescription screening of Berberine Hydrochloride transdermal absorption ointment
3537. Pressurized hot water extraction of Berberine , baicalein and glycyrrhizin in medicinal plants
3538. Pressurized liquid extraction and multiple, ultrasonically-assisted extractions of hydrastine and Berberine from goldenseal (Hydrastis canadensis) with subsequent …
3539. Pressurized liquid extraction of Berberine and aristolochic acids in medicinal plants
3540. Pretreatment of rats with increased bioavailable Berberine attenuates cerebral ischemia-reperfusion injury via down regulation of adenosine-5′ monophosphate …
3541. Pretreatment with a combination of ligustrazine and Berberine improves cardiac function in rats with coronary microembolization
3542. Pre-treatment with Berberine enhances effect of 5-fluorouracil and cisplatin in HEP2 laryngeal cancer cell line.
3543. Prevention effect of emodin and Berberine on insulin resistance in HepG2 cells [J]
3544. Prevention of acute heart allograft rejection by Berberine combined with cyclosporine A in rats
3545. Prevention of HIV protease inhibitor-induced inflammatory response and ER stress by Berberine in macrophages
3546. Preventive and curative effects of Berberine on experimental colon cancer in rats and its relationship to expression of peroxisome proliferator-activated receptor γ
3547. Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers
3548. Preventive effect of Berberine against DMBA-induced breast cancer in female Sprague Dawley rats
3549. Preventive effect of Coptis chinensis and Berberine on intestinal injury in rats challenged with lipopolysaccharides
3550. Preventive effects of Berberine on experimental colon cancer and relationship with cyclooxygenase-2 expression
3551. Preventive effects of Berberine on glucocorticoid-induced osteoporosis in rats
3552. Preventive use of Berberine in inhibition of lead-induced renal injury in rats
3553. Primary study on fluro [19F] Berberine derivative for human hepatocellular carcinoma targetting in vitro
3554. Probiotics Plus Berberine as an Anti-Diabetic Regimen in Patients with Type 2 Diabetes, Particularly in the Elderly: A Multicentre Randomised Controlled Trial
3555. Process‐induced phase transformation of Berberine chloride hydrates
3556. Production and investigation of sustained Berberine pellet drug release system
3557. Production of Berberine in cultured cells of Coptis japonica
3558. Production of Berberine in immobilized plant cell culture ofThalictrum rugosum
3559. Production of singlet oxygen by sanguinarine and Berberine
3560. Profiling of Traditional Chinese Medicine Compound Berberine as Anticancer Agent in Melanoma
3561. Progress about Clinical Application of Berberine [J]
3562. Progress in pharmacological effects and clinical applications of Berberine
3563. Progress in the Study of Berberine Biosynthetic Enzymes of Coptis [J]
3564. Progress of Berberine for treatment of type 2 diabetes
3565. Proliferation effects of Berberine on rat neural stem cells induced by hydrogen peroxide
3566. Protecting effect of Berberine for gut mucosal barrier during early phase of sepsis by cecal ligation and puncture in rat [J]
3567. Protection and mechanism of Berberine against chronic brain injury induced by aluminumoverload in rats
3568. Protection by and anti‐oxidant mechanism of Berberine against rat liver fibrosis induced by multiple hepatotoxic factors
3569. Protection Effect of Berberine Ischemia-Reperfusion for Renal Tubular Epithelial Cell of Rats
3570. Protection Mechanism of Berberine against Liver Injury Induced by Isoniazid in Mice
3571. Protection of Berberine in NIDDM rat brain [J]
3572. Protection of Berberine on intestinal mucosa following autologous orthotropic liver transplantation and its correlationship with p-AMPK activation and p-mTOR …
3573. Protection of cholinergic and antioxidant system contributes to the effect of Berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes
3574. Protective effcts of Berberine on cerebral ischemia in mice and rats [J]
3575. Protective effect of Berberine against cardiac ischemia/reperfusion injury by inhibiting apoptosis through the activation of Smad7
3576. Protective Effect of Berberine Against Cerebral Ischemic “Insult” in Rats
3577. Protective effect of Berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling
3578. Protective effect of Berberine against oxidative stress-induced apoptosis in rat bone marrow-derived mesenchymal stem cells
3579. Protective effect of Berberine chloride on Plasmodium chabaudi-induced hepatic tissue injury in mice
3580. Protective effect of Berberine on aconite‑induced myocardial injury and the associated mechanisms
3581. Protective effect of Berberine on acute cardiomyopathy associated with doxorubicin treatment
3582. Protective Effect of Berberine on Acute Hypoxia Induced by Sodium Nitrite in Mice
3583. Protective effect of Berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver
3584. Protective effect of Berberine on aortic endothelial dysfunction in diabetic rat